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Medicines optimisation requires healthcare professionals to work collaboratively 
to meet the medication needs of patients.  
A grounded theory was produced which explains how doctors, nurses and 
pharmacists work to optimise the use of medicines in acute hospital settings in 
Northern Ireland. Seventeen semi-structured, one-to-one interviews were 
conducted with doctors, nurses and pharmacists. Concurrent data collection 
and analysis was carried out using coding, particular to grounded theory, 
adopting a constant comparative approach, writing memos and using theoretical 
sampling as described by Strauss and Corbin (1998).  
The core category was managing risk. Participants had an implicit 
understanding of the need to continually manage risk when working with the 
complex and the routine.  They used personal and systemic checks and 
balances which could be viewed either as duplication of effort or indicative of a 
culture of safety. Multi-professional interdependencies and support for new, 
professional, non-medical roles were highlighted. Working together was a 
further strategy to ensuring each patient gets the right medicine. Establishing an 
agreed framework for working with medicines at ward level could support the 
safer use of medicines.  
It is anticipated that this theory will contribute to the design of systems involved 
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Glossary of terms 
 
AKI     Acute Kidney Injury 
BNF     British National Formulary 
C diff     Clostridium difficile 
COPD Chronic Obstructive Pulmonary Disease  
Critical Medicines            Medicines for which timely administration is 
crucial 
CT4  Core Trainee year 4 
ECR  Electronic Care Record 
FY1 / F1 Foundation Year doctors, in their pre-
registration year  
GFR Glomerular Filtration Rate 
GPSI General Practitioner with a Specialist Interest 
HRO High Reliability Organisation 
IMM Integrated Medicines Management – a ward-
based medicines system involving 
pharmacists and pharmacy technicians in 
Northern Ireland 
Kardex  Hospital inpatient prescription chart 
Medicines reconciliation  Process of creating the most accurate list of 








Medication review Critical examination of a person’s medicines 
with the objective of reaching agreement, with 
the person about treatment, optimising the 
impact of medicines, minimising the number 
of medication-related problems and reducing 
waste 
Mid-line A short, fine, hollow tube which is inserted 
into one of the large veins in your arm, usually 
in the bend of the elbow, through which 
certain intravenous drugs can be 
administered. 
NMPs     Non-medical prescribers. 
NOAC  Novel Oral Anti-Coagulant drug.  
PEG  Percutaneous Endoscopic Gastrostomy.  
PRN When required. 
Sando K Oral potassium supplement. 
Specialty Doctor A senior, career grade doctor working in a 
hospital. 
Registrar A junior doctor who has completed their 
foundation training but is still in training in a 
specialty area of medicine. 
Therapeutic drug monitoring Monitoring blood- levels of drugs with a 
narrow therapeutic index to ensure patients 
receive a safe and effective dose.  









The purpose of the first chapter in a thesis is to introduce the research 
(Evans et al 2014). This chapter will establish the initial context in which the 
study was carried out, state the aim and scope of the research and its 
significance within Health and Social Care in Northern Ireland.  
 
1.1 Establishing the context 
This research was prompted in 2015 by the recent introduction of the term, 
“medicines optimisation.” I was interested in developing a theory to explain 
how different healthcare professionals worked to use medicines effectively in 
acute hospitals. This would act as baseline information to inform the future 
design of a safe process for optimising medicines use in hospitals which 
would ensure best patient outcomes.  
The planning for this study began at the same time as the Department of 
Health in Northern Ireland published its policy document, the Medicines 
Optimisation Quality Framework (2016). The Framework described the 
Northern Ireland approach to medicines optimisation, a term which had just 
superseded “medicines management” to describe the use of medicines in 
healthcare settings. 
  
1.1.1 Medicines management  
Medicines management is defined as the process which, “encompasses the 
way medicines are selected, procured, delivered, prescribed, prepared, 
administered, stored and reviewed to optimise the contribution they make to 
producing informed and desired outcomes for patient care” (Audit 
Commission 2001). 
The Audit Commission document, A Spoonful of Sugar (2001), described an 




highlighted professional barriers to change such as some doctors and nurses 
having, “neither the will nor incentives to change traditional ways of working” 
(2001:6), serious staff recruitment and retention problems and hospital 
pharmacists being content with their traditional dispensing roles.  
The Royal Pharmaceutical Society (RPS) has just published its Professional 
guidance on the safe and secure handling of medicines (2018). The 
document provides guidance for all health professionals on how medicines 
should be handled. It has been endorsed by a number of professional 
organisations including the Royal College of Nursing, the Royal College of 
Anaesthetists and the Royal College of General Practitioners. This inter-
professional collaboration shows that healthcare professionals are working 
more closely together with respect to managing medicines, which involves a 
series of tasks carried out by doctors, nurses and pharmacists.  
 
1.1.2 Medicines optimisation 
 
Medicines optimisation is defined as, “a person-centred approach to safe and 
effective medicines use to ensure that people obtain the best possible 
outcomes from their medicines” (NICE 2015). The recent change to 
medicines optimisation built on the medicines management theme, ensuring 
a focus on patients, getting best outcomes from medicines and shared 
decision making involving patients and healthcare professionals. In its good 
practice guide, the RPS described medicines optimisation as, “a holistic 
approach, an enhanced level of patient centred professionalism, and 
partnership between clinical professionals and a patient” (2013:3). This guide 
highlighted that healthcare professionals will need to work together to, 
“individualise care, monitor outcomes more carefully, review medicines more 
frequently and support patients when needed” (RPS 2013: 3).   
This change from systems-based medicines management to the more 
personal and outcomes-focused medicines optimisation may challenge 




relating to medicines. The literature relating to this at the outset of the study 
will be discussed in Chapter 2.  
1.2 Personal statement of the problem 
 
In parallel to the above, my personal, initial incentive for looking at the roles 
and approaches of different healthcare professionals was an insight which I 
had when talking to a consultant in my role as Trust Head of Pharmacy and 
Medicines Management. We were discussing a recent audit, from which one 
of the recommendations for Trusts was to issue guidance on where drug 
administration should be recorded. To me, the solution was clear however 
the consultant had a different view. We spent some time together, working 
through different examples and reviewing the paperwork. We eventually 
reached a solution which met the recommendations of the report. However I 
was struck by how differently we thought about and addressed this problem, 
each having the same goal of patient safety in mind. I was interested in 
exploring this further.    
I am accountable for the safe management of medicines in a Health and 
Social Care Trust and I acknowledge that this, “positions me in my writing” 
(Creswell 2013: 216). It is important that I ensure reflexivity in this work. I 
have included a reflexive personal statement in Appendix 1.  
 
1.3 Aim and scope of the study 
 
The aim of this study is to produce a theory of how doctors, nurses and 
pharmacists work to optimise the use of medicines in acute hospital settings 
in Northern Ireland (NI).  
Initial research questions included: 
 Do healthcare professionals work to optimise the use of medicines? 
 What is each healthcare professional’s contribution to working in a 




 Why do they work in this way? 
 How do individual healthcare professionals define their role with 
medicines? 
The scope of the study incorporates the work solely of doctors, nurses and 
pharmacists who were working in acute hospitals across Northern Ireland at 
the time of data collection. Other healthcare professionals sit outside the 
scope of the work.  
By using qualitative methodology, the findings from this study will not be 
reached using statistical methods. Data on the lived experiences of the 
participants will be collected. Whilst results may not be statistically significant 
and therefore generalizable, it is planned that through  rigorous and 
transparent study design, the collection and analysis of data and the 
generation of theory, that the findings will provide key insights into how 
doctors, nurses and pharmacists work to optimise medicines across acute 
healthcare in the United Kingdom.  
  
1.4 Significance of the study 
 
The safe and effective use of medicines is a global concern. The World 
Health Organisation recently identified, “Medication without Harm,” as its 
theme for the third global patient safety challenge (2017). This challenge 
prompted the United Kingdom’s Secretary of State for Health and Social 
Care to establish a Short Life Working Group to report on, reducing 
medication-related harm. The Working Group recommended further 
development of technology solutions such as electronic prescribing, 
establishing support to encourage patient-involvement in shared decision-
making about their medicines with clinical staff, improved training for 
healthcare professionals on the safe and effective use of medicines and a 
need for further research, making explicit evidence of good practice 





Lord Carter of Coles’ independent report for the Department of Health, 
Operational productivity and performance in English NHS acute hospitals: 
unwarranted variations (2016) had a particular focus on efficiency and 
productivity of hospital pharmacy. It recommended that hospital pharmacists 
should spend the majority of their time in patient-facing roles, prioritising 
medicines optimisation and developing pharmacist prescribing. The expertise 
of pharmacy should be harnessed in helping with patient flow, including 
working across transitions of care to ensure safer patient transfers. 
Subsequently a Hospital Pharmacy Transformation Programme has been put 
in place.  
In Northern Ireland, the Department of Health’s Medicines Optimisation 
Quality Framework (2016) sets the policy steer for the use of medicines 
across all sectors. It is underpinned by the Department of Health’s Medicines 
Optimisation Regional Efficiency Programme. These documents reflect the 
changes seen in NHS England and Wales.  
These medicines-related changes come in the wake of reports into patient 
safety in the National Health Service. The Report of the Mid Staffordshire 
NHS Foundation Trust Public Enquiry (Francis Report) was published in 
February 2013. In this report, Francis made a number of recommendations 
which focused on prioritising patients’ needs, using standards which 
everyone can understand and against which performance is measured and 
ensuring there is an open and transparent culture.  
Sir Bruce Keogh (2013a), in his review into the quality or care and treatment 
provided by fourteen NHS hospital trusts, highlighted the importance of 
professionalism, leadership, staff engagement with respect to mortality rates, 
seeing junior doctors as the leaders of today and not working in 
professional/academic isolation.   
In November 2018, the Government published its response to the Report of 
the Gosport Independent Panel (Department of Health and Social Care 




deaths at Gosport War Memorial Hospital (GWMH) between 1988 and 2000, 
with an emphasis on finding the truth of what happened for the families 
affected. In its response, the Government made a number of 
recommendations relating to duty of candor, the use of controlled drugs, 
having a, “culture that listens, learns and challenges,” as well as a number of 
recommendations relating to future case investigations and the role of 
healthcare regulators.   
In Northern Ireland, the Department of Health’s strategy, Quality 2020 was 
launched in 2011, with a focus on improving quality in Health and Social Care 
in the Province. The strategy defined quality under the headings of safety, 
quality and patient and client focus. It also highlighted the need to ensure 
health and social care operated with values such as empowerment, 
involvement, respect, partnership, community, continuity and equity. 
The Donaldson Report, The Right Time, the Right Place (2014) looked at the 
application of Health and Social Care (HSC) governance arrangements in 
Northern Ireland. The Report stated that the greatest risk to safe patient 
healthcare comes from the way the system as a whole is designed and 
operated. It particularly highlighted the important role which pharmacists 
must play in the future with respect to the safe and effective use of 
medicines. 
Systems not Structures, Changing Health and Social Care (in Northern 
Ireland), was published in 2016 by an expert panel chaired by Professor 
Rafael Bengoa. The first recommendation of the panel was that, reform 
would place, “an increased emphasis on the experience of those who deliver 
care” (2016:8). This key document is being used as a roadmap for 
transformation of Health and Social Care (HSC) services in Northern Ireland. 
In May 2016, the Northern Ireland Medicines Optimisation Quality Framework 
was published (Department of Health, Social Services and Public Safety). 
This Framework built on earlier work on medicines optimisation (NICE 2015) 
and provided a regional approach to the use of medicines in hospital, general 
practice, community pharmacy and social care. It described the service which 




emphasised the multi-professional nature of this work, with input from 
pharmacists in each area and a focus on delivering best practice that is co-
designed with patients. The framework is aligned with the themes of safety, 
effectiveness and patient and client focus seen in Quality 2020.  
This work has to be set within the financial situation where the primary care 
cost of medicines per head of population in Northern Ireland exceeds that in 
the other three home countries - £249 per head in Northern Ireland compared 
to £172 per head in England (Black 2014). A Department of Health-led 
Medicines Optimisation Regional Efficiency Programme (2016) is in place to 
deliver upon value for money and efficiencies with respect to medicines use.  
This is a time of change within Health and Social Care in Northern Ireland. At 
the outset it is important to understand what is currently happening within 
acute hospital practice. This information can be used both as a baseline 
measure for future comparisons as well as to inform next steps in moving 
forward in transforming the service for patients.  
I believe that there is a need for a theory which defines how healthcare 
professionals work with medicines in acute hospitals. When scoping out the 
aim of this research, I have spoken to a range of healthcare professionals 
within the hospital setting and the Department of Health in Northern Ireland to 




In this first chapter, I have established the initial context for carrying out the 
research, making specific reference to the change from a systems-based 
medicines management approach to a more patient-focused medicines 
optimisation strategy. I have stated the aim and initial objectives of the study 
and highlighted its significance within the World Health Organisation’s global 
focus on medicines safety, making reference to the related governmental 
policy context in the United Kingdom, with particular focus on NHS England 








In this chapter, I will outline the purpose of a literature review. I will identify 
the place of the literature review in a grounded theory study, making 
reference to carrying out both, an initial, and non-committal, outline literature 
review at the start of the study and a second, more detailed review following 
emergence of the theory.  
I will highlight the importance of being able to review the literature in a 
systematic manner, how that was carried out in this study and the approach 
taken to critically analysing the literature. Finally, I will lay out the initial 
literature review which was carried out at the start of the study.  
     
2.2 The purpose of a literature review   
 
The purpose of a literature review is to investigate what other researchers 
have found, as well as the methods they have used. It also helps in 
identifying potential gaps in knowledge to be targeted in the design of a given 
study (Wisker 2008). New research can then link with and reinforce the 
findings of the current literature in the field as well as extend it. 
Wisker (2008:170) described the researcher as, “engaging in dialogue” with 
the literature as opposed to stating facts. This should be an ongoing dialogue 
with the researcher adopting a rigorous approach to updating literature 
searches and synthesising the information (Evans et al 2014). Afolabi (1992) 
stated that the important elements of a literature review are, “describing, 
criticising and relating.”  This includes summarising the key elements of a 
paper as well as laying out its strengths and weaknesses. Therefore the 
process starts with initially summarising the literature and then synthesising 





The literature review conducted early in a doctoral study serves different 
purposes in quantitative and grounded theory studies, with the latter 
generally referred to as an, “initial literature review” (Holloway and Walker 
2000:91). This is not as wide, detailed or structured as the literature review 
which informs a quantitative study.   
    
2.3 The literature review in grounded theory studies    
 
It is noted that in classical grounded theory, the theory is derived from the 
data gathered, as opposed to testing a pre-determined theory from an initial 
literature review. Whilst an initial, in-depth literature review of the subject is 
frowned upon, an awareness of the literature can help in a number of ways 
(Corbin and Strauss 2008). These include justifying a gap in the current 
research and providing questions for early interviews, thus supporting 
research and ethics submissions; signposting questions during data analysis, 
improving sensitivity and possibly confirming outcomes (or not!).  
Grounded theory is not concerned with proving or disproving a particular 
theory or null hypothesis (Urquart 2013). The place of the literature review in 
grounded theory methodology has been a controversial subject (Urquart and 
Fernandez 2006; Urquart 2013). Glaser and Strauss, in their seminal work, 
the Discovery of Grounded Theory (1967), commented that the literature 
should not be reviewed until after data collection, analysis and theory 
generation. Glaser and Strauss however also stated that the researcher will 
not begin the work as a blank slate (‘tabula rasa’ 1967:3), but will have a, 
“perspective that will help him see relevant data and extract significant 
categories” (1967:3). This footnote to the text is often ignored in the 
discussion of the appropriateness of an initial literature review. Glaser (1992) 
later explained that the authors were concerned that such an early literature 
review may impede the researcher from truly generating theory from the 




Urquart (2013) defined a delayed literature review as being carried out after 
the theory has emerged. This allows the researcher to discuss the new 
theory in the context of the current literature. It serves a number of purposes 
including demonstration of the credibility of the theory, identifying new theory 
and fulfilling the academic requirements for doctoral study. Urquart explained 
that the grounded theorist is obligated to review the literature at this later 
stage. 
Martin (2006) highlighted carrying out the literature review, using two phases. 
The first is a “non-committal” review which supports the researcher in 
developing theoretical sensitivity and pinning down the research problem. 
The second is an “integrative” literature review where the new theory is 
integrated with the current literature in the field, resulting in a theory of 
greater value. This approach allows the researcher to be true to the ethos 
and approach of especially the earlier grounded theorists and also to meet 
the academic requirements of their doctoral studies. Therefore, I adopted this 
approach to reviewing the literature in this research.      
 
2.4 Theoretical sensitivity 
 
Theoretical sensitivity was defined by Strauss and Corbin as, “the ability to 
respond to the subtle nuances of, and cues to, meanings in data” (1998:35). 
The researcher needs to maintain a balance between remaining objective 
and adopting a reflexive approach but also understand the nuances of and 
language used in the field. Sensitivity can come from both a professional or 
personal experience of the subject area, against which the researcher can 
view, “the range of meanings given by others” (Strauss and Corbin 1998:48). 
The timing of reviewing the literature in a grounded theory study is discussed 
in this chapter. The use of a preliminary literature review in,” acquiring and 
developing theoretical sensitivity” is controversial (Thistoll et al 2016). The 
latter can be dealt with by carrying out an extensive review of the literature 
after data collection analysis and emergence of the theory. This allows the 




critically discuss it in light of the current literature. This will identify new 
findings from the research which is a key doctoral criterion.  
The researcher will rarely begin their work with no understanding of the 
research area. This is the case in this study where the researcher is the 
Head of Pharmacy and Medicines Management in a Health and Social Care 
Trust in Northern Ireland. It is important that a balance between having 
theoretical sensitivity and using that knowledge to completely shape the 
theory, ensuring reflexivity is adopted and this will be discussed in Chapter 3.  
  
2.5 Search strategy 
 
It is important to be able to demonstrate the ability to adopt a systematic 
approach to reviewing the literature in doctoral research (Holloway and 
Walker 2000). The most frequently used method is searching on-line 
databases such as Medline, CINAHL and EMBASE. These require the use of 
relevant search terms and act as an efficient and comprehensive approach to 
accessing relevant papers. It is advisable to devise a search strategy which 
demonstrates a structured approach and is kept up-to-date. Researchers 
should also devise a method of summarising and storing relevant references 
for future use. I have included the search strategies used for both the initial 
and detailed review in Appendices 2 and 3. 
Evans et al (2014:52) used the analogy of, “gateways and paths” in 
describing a particular, systematic way of reviewing the literature. This 
recognised that using on-line databases will not yield all of the relevant 
literature due to the lack of uniformity of search terms both between 
databases and with respect to the literature itself. The gateway in the analogy 
is a relevant research paper and the paths included the references listed by 
the authors as well as the key words cited. Paths can also include the 
subsequent studies which have cited a particular reference. I found this 
approach particularly helpful in finding additional relevant papers as well as 
becoming more aware of the wider literature surrounding a subject and the 




2.6 The approach taken in this study 
 
In line with the approach outlined by Martin (2006) and Urquart (2013), I 
carried out two literature reviews. The first was completed at the outset of my 
work, when I was writing my research proposal, to establish a research 
problem and then demonstrate that my work would address a gap in the 
literature. This was not a detailed literature review but provided justification 
for the research and yielded some headings which I could use in initial 
interviews. The search strategy which I used can be seen in Appendix 2. 
The second literature review was more detailed, was conducted after data 
collection, analysis and theory development were completed and was used to 
integrate the new theory with current knowledge in the field (Martin 2006). I 
used different search terms and accessed data on a number of different 
topics compared to the first search, as the latter did not prove to be wholly 
relevant to the theory which had emerged. The search strategy for this 
second, integrative literature review has been included in Appendix 3. 
I did not access the literature in the area of research until after the data was 
collected, analysed and the theory had emerged. This approach is in line with 
the original view of Glaser and Strauss (1967). This required an element of 
discipline and a reflexive approach, as I work with healthcare professionals in 
acute hospitals each day to ensure medicines optimisation. I have been part 
of professional discussions of the subject; however I did not conduct a 
detailed literature search. My success in this was evidenced by my 
experiencing a complete gear-change in my thinking from collecting, 
analysing data and developing theory to beginning to relate this theory to the 
literature. 
To demonstrate that I had searched and reviewed the literature using a 
systematic approach, I used the PRISMA flow diagram to map out the 
process which I followed for both literature searches (Liberati et al 2009). The 
completed PRISMA flow diagram for each literature search has been 





2.7 Critically appraising the literature 
 
Greenhalgh (2006) commented that designing a tool to critically appraise 
qualitative research papers would be a challenge, although she listed some 
examples (Giacomini and Cook 2000a, Giacomini and Cook 2000b, 
Horsburgh 2003). Other authors believed that the use of a rigid checklist to 
evaluate a qualitative paper could force researchers to adopt a rigid 
approach to their work (Barbour 2001).  
I assessed the quality of the papers used to discuss my findings using a six-
point, quality checklist for qualitative studies revised from standardised tools 
by Mukadam et al (2011). Quality scores, along with descriptors of the key 
papers accessed, are summarised in Appendix 4.  Primary literature was 
used, although this was challenging to find for some widely accepted 
approaches such as those on High Reliability Organisations as well as the 
work on error by Reason (2000).  
I have incorporated a critical review of some of the key papers found as a 
result of the second literature search in Section 7.4.  
 
2.8 Initial review of the literature  
 
With the above approach in mind, an initial literature review was carried out 
before I began the research, using the search strategy outlined in Appendix 
2. This indicated a gap in the literature. The main themes found in the 
literature at this stage included concerns relating to medicines management 
and optimisation (described in chapter 1), perceptions of healthcare 
professionals’ roles and new ways of working with respect to medicines. I will 




2.8.1 Perceptions of healthcare professionals’ roles with respect to 
medicines 
 
There is a range of literature on how healthcare professionals perceive each 
other’s roles as well as on collaborative, multidisciplinary working but little on 
how they perceive their own roles. 
Neufeld et al (1998) described the differences in opinion in expectations of 
doctors’ performance between doctors and other healthcare professionals, 
with particular reference to responsibility and power of doctors within the 
overall system.  
Ray (1998) defined interdisciplinary (as opposed to multidisciplinary) patient 
care where there is equal input into decision making. He described 
professions having overlapping roles where there was shared knowledge and 
interests.  Pharmacists working in such a way must have a number of 
attributes including being confident and competent, contributing to setting 
objectives for patient outcomes with respect to medicines and understanding 
team working. 
The World Health Organisation defined inter-professional collaboration 
(2010) happening when a range of healthcare professionals work together 
with patients, families, carers and communities to provide high-quality care.  
Stringer et al (2013:3) highlighted work to explore pharmacists’ expectations 
of the competencies of family practitioners in Canada with the goal of 
improving inter-professional collaboration (IPC) between the two groups 
through, “joint understanding of our competencies.” Lapkin et al (2013) 
described how identifying roles and expectations are experienced as barriers. 
Drinka and Clark (2000) stated that in clinical practice, healthcare 
professionals needed to be able to describe their own competencies to 
others and also have a sense of others competencies with respect to their 





Gillespie et al (2012) evaluated perceptions of the benefits of ward-based 
clinical pharmacists in Sweden from GPs, hospital-based physicians and 
nurses. Benefits such as enhanced patient safety and better drug therapy 
were highlighted with advice accepted more often when it was presented 
during inter-professional team rounds. The authors described the challenges 
of forming such teams due to the transient nature of physicians.  
Elvey et al (2013) looked at how pharmacists perceived their own 
professional identity and how others viewed pharmacists. Hind et al (2003) 
identified how students from healthcare professions perceived each other’s 
roles. The roles of community pharmacists and relationships with GPs have 
also been looked at (Lasselain 1991, Hughes and McCann 2003). However 
Elvey et al (2013:331) found that nine different identities were attributed to 
pharmacists. She determined that this high number may reflect, “role 
ambiguity and lack of clear direction and ownership.” The clinical role of the 
pharmacist seemed to predominate in the hospital setting, although a 
hospital pharmacist described her, “discomfort with having to diagnose”, 
preferring to work within a traditional pharmacist role.     
Rixon et al (2015) looked at how healthcare professionals interacted with 
respect to medicines in hospital settings in Australia. They described 
pharmacists, nurses and doctors working beside each other as opposed to 
adopting true inter-disciplinary working with communication mainly focusing 
on solving particular problems. They saw differences between each 
professional group’s attitudes towards managing medicines. 
There is an emerging theme of the value of healthcare professionals 
understanding their own roles and abilities as well as those of others when 
working together and subsequently impacting on achieving good outcomes 
for patients. The use of a range of terminology in the literature to describe 
this working together may suggest that it does not follow a defined model – 
“multidisciplinary”, “inter-collaborative”, “inter-disciplinary” – and may not be 
team-working at all but a working alongside each other, carrying out discreet 
roles. The transient nature of medical teams may contribute to this (Gillespie 




2.8.2 New ways of working 
 
Over the last 18 years, there have been multiple changes in professional 
practice and regulatory responsibilities with respect to medicines. These 
have been defined in legislation as well as good practice guidance from 
professional bodies.  
Pharmacy in the Future - Implementing the NHS Plan (Department of Health 
2000) described significant changes in healthcare professionals’ job design 
with respect to managing medicines. 
The Audit Commission (2001) also mentioned concerns that the core medical 
curriculum did not provide an in-depth knowledge of how to prescribe and 
administer medicines safely.  
The integrated medicines management (IMM) approach, developed in and 
adopted by hospitals in Northern Ireland, focused on providing evidence-
based input from pharmacists and pharmacy technicians at admission, 
discharge and during the inpatient stay and has been shown to reduce 
hospital length of stay, re-admission rates and improve the appropriateness 
of medicines (Scullin et al 2007; Scullin et al 2011).  
Nurses and pharmacists, and more recently optometrists, physiotherapists 
and podiatrists, can practice as non-medical prescribers. Buckley et al (2006) 
interviewed a range of individuals (clinical and operational) to determine how 
nurse and pharmacist supplementary prescribers would be perceived by 
patients and doctors as well as by each other. Participants were also asked if 
they believed pharmacists and nurses may wish to take on these new 
prescribing roles. In general, nurse and pharmacist supplementary 
prescribing was supported but within certain contexts, for example, writing 
discharge prescriptions and prescribing within defined protocols. Trust, team-




Independent nurse and pharmacist prescribing were not supported by 
medical staff. Participants felt that there would be intra-professional conflict 
between prescribing and non-prescribing nurses and pharmacists. Nurses 
and doctors perceived pharmacists as being removed from the patient, with 
this concept being seen as a barrier to improved patient outcomes. A 
functional role of a pharmacist writing discharge prescriptions (more a 
transcribing role) was supported by nurses. 
The Health and Care Professions Council (2011) explored views on 
professionalism in healthcare professionals. The report summarised that, 
professionalism may be better regarded as a, “meta-skill, comprising 
situational awareness and contextual judgement, which allows individuals to 
draw on the communication, technical and practical skills appropriate for a 
given professional scenario” (2011:3). It may be helpful to focus on my 
participants’ views of professionalism at the outset of this study.  
 
2.9 Summary of the initial literature review 
 
In summary, the dynamics of how healthcare professionals interact and the 
roles they carry out have changed in both a planned and unplanned way over 
time. These changes have happened within professions with changes to 
professional codes of practice, legislation and regulation and the gradual 
development of new roles, especially for non-medical healthcare 
professionals. At the same time, medical students received less training on 
pharmacology and the use of medicines (Audit Commission 2001). 
Simultaneously the acuity of patients being cared for in hospital has 
increased with each patient taking increased numbers of medicines. The 
traditional consultant-led team structure has changed following the 
implementation of the European Union Working Time Directive and this has 
changed the way doctors work and learn. All of this change presents 
challenges in ensuring patients get high quality and safe care from a team of 
healthcare professionals who are competent, clear about their role and the 




I will use some of the themes identified in the literature to inform my initial 
interviews. These themes include professional barriers to change, traditional 
boundaries, changes in education, the transient nature of teams, 
professionalism and a joint understanding of each other’s roles in using 
medicines. Whilst these are very specific, I will use broader, open questions 

























The Methodology chapter should lay out the research method which was 
used; explain why this particular method was chosen and how it was applied 
during the research process. The terms “methodology” and “method” should 
not be used interchangeably. Evans et al (2014) defined “methodology” as 
relating to the approach or stance taken by the researcher whilst “method” 
relates to the particular research techniques which were used.  
In this chapter, I will describe how I designed this research project to meet 
the aim of the research and justify the choices made in both the methodology 
and methods used.  
  
3.2 Research paradigm  
 
In designing a research project, it is important to be aware of and describe, 
“the philosophical intent or motivation for undertaking a study” (Cohen and 
Manion 1994:23). This is known as a theoretical paradigm and examples 
such as positivist and post-positivist (which tend to relate to quantitative 
research), constructivist, interpretivist and transformative paradigms are 
discussed at length in the literature (Creswell 2013).  
The motivation for undertaking this study is to inform the improvement and 
redesign of medicines optimisation and medicines management systems in 
acute hospital settings in Northern Ireland by listening to the experiences of 
doctors, nurses and pharmacists who work there. In doing this, I am 
conscious that I work within this environment. I wish to acknowledge this but 
also adopt a methodology which works through this fact, assuring credibility 
and rigor in the research. I will describe my philosophical intent further with 








A research strategy should be chosen based on the task in hand (Silverman 
2010). It must be fit for purpose (Denscombe 2010) and chosen for its 
suitability, feasibility and ethical appropriateness. It must use a methodology 
and methods which will address the research questions being asked 
(Spencer et al 2003). 
Creswell (2013) described three main research methodologies which sit 
along a continuum - quantitative, qualitative and mixed-methods approaches. 
In this section, I will define each of these and explain my decision for 
choosing a particular methodology.   
 
3.3.2 Quantitative research 
 
Quantitative methodology involves testing specific theories, using numbers 
and statistical analysis. Quantitative researchers use statistics in deciding 
upon a representative sample size, for example, in research which uses 
surveys or structured interviews to collect data. This allows findings to be 
generalised to a wider population. Experimental research builds in controls 
against which a new theory may be tested, for example, placebo-controlled 
or standard-treatment controlled trials, the choice of which is determined by 
ethical considerations.     
Quantitative methodology traditionally has been the main and most respected 
research methodology until the development of qualitative research as a 
methodology in its own right from the 1960s and subsequently the adoption 





3.3.3 Qualitative research 
 
Qualitative research has developed from being used to scope out the 
potential for what was believed to be more rigorous quantitative research to 
being a respected methodology in its own right. This has been helped by the 
interest in building rigor into qualitative methods as seen, for example, in the 
work of Glaser and Strauss with respect to grounded theory (1967) and as 
detailed by Mays and Pope (2000).  
Qualitative methodology is chosen when the research is focusing on the 
meaning from peoples’ lived experiences, using an “interpretive” analysis.  
This is used to, “‘discover concepts and relationships in raw data and 
organising these into a theoretical, explanatory scheme” (Strauss and Corbin 
1998:11). It can be used to provide a “thick description” of what is happening 
(1998:29), including an understanding of implicit ways of working (Holloway 
2005). This methodology has been referred to as being both artistic and 
scientific in nature which can be challenging when evaluating the rigor of a 
study (Strauss and Corbin 1998). 
Researchers can be involved in qualitative data collection to varying degrees, 
for example, by sharing an experience with participants in ethnographic 
studies to conducting interviews and focus groups, using methods to ensure 
that the researcher does not influence outcomes, for example “bracketing” in 
phenomenological studies. The role of the researcher in qualitative research 
has been the subject of much debate and varies, often depending on the 
world-view of the researcher. This can be seen, for example, in the different 
approaches to grounded theory methodology defined by Glaser and Strauss 
in 1967 (post-positivist) and later in the constructivist approach taken by 
Charmaz (2006). The qualitative researcher must be able to identify and 






3.3.4 Mixed methods research  
 
Mixed methods research integrates the data obtained by using both 
qualitative and quantitative methods. This design is used when the 
researcher believes that the findings will be enhanced by such integration, 
with the limitations of each method being “neutralised” through their 
combination (Creswell and Creswell 2018:14).   
Mixed methods researchers can take a number of approaches, for example, 
carrying out a quantitative study to inform further qualitative work or switching 
the timings, using qualitative methods first. A third commonly used design is 
known as, “convergent mixed methods” where data from the two methods is 
collected around the same time and integrated in the analysis of the results.  
This form of research has been used more routinely in healthcare over the 
last twenty years.  
 
3.3.5 Choosing a research methodology 
 
The research methodology must address both the aim and purpose of the 
study (Creswell 2013). The aim of this work is to produce a theory of how 
healthcare professionals work to optimise the use of medicines in acute 
hospitals in Northern Ireland. The purpose of the research is to inform ways 
of improving medicines optimisation and management systems. This builds 
on the overall research aim, describing how the outcomes of the research will 
be used. This is important to establish when setting about any research 
study. 
Initially I considered collecting data using a survey. Such a quantitative 
approach would allow me to collect data from a representative sample of 
doctors, nurses and pharmacists and generalise my findings to a wider 
population. However, from my experience, I wanted to determine the 
“essence” of how these healthcare professionals worked with medicines; to 




the nuances and perceptions of each professional. Therefore I was not 
focusing on gathering numerical data but was seeking explanation and 
meaning from a group of individuals. This suggested the use of direct 
observation, interviews and focus groups, signposting a qualitative approach. 
Vivar et al (2007: 2) described qualitative research as drawing upon the, 
“meaning of human experience.”  I could have used mixed methods, but 
when scoping out the work, I did not believe that integrated data from two 
different methods would significantly enhance the findings. Therefore, I 
decided to use a qualitative approach.   
Creswell (2013) stated that use of a recognised approach to research 
enhances the rigor and sophistication of the research design. He described 
five traditions of qualitative research: narrative, phenomenological, grounded 
theory, ethnographic and case study.  In my qualitative study, I initially 
favoured naturalistic and ethnographic methods as they involved the direct 
observation of medicines optimisation processes carried out by healthcare 
professionals in the natural setting. However these were discounted as there 
was a potential to introduce bias into the study due to the researcher’s 
presence. This could have been minimised by recording interactions between 
participants as carried out by other researchers in the field (Rixon et al 2015; 
Wilson et al 2016). However again this could have been intrusive on wards 
and may have had implications with respect to confidentiality and data 
protection. Also such approaches would require additional time in the field 
which may not have yielded proportionate additional benefits. The success of 
the case study approach revolves around selection of a particular case 
(Creswell 2013) and this focus may have ethical implications especially when 
the research is being carried out in the small geographical area of Northern 







3.3.6 Choosing a qualitative tradition 
 
3.3.6.1 Grounded theory 
 
Grounded theory is used to, “generate or discover a theory, grounded in data 
from participants who have experienced the process” (Corbin and Strauss 
2008:107). The methodology was developed in 1967 by Glaser and Strauss 
and has been modified by, for example, Strauss and Corbin (1990; 1998), 
Charmaz (2006) and Corbin and Strauss (2008).  
Through grounded theory, Glaser and Strauss (1967) moved away from the 
use of qualitative research solely to inform future quantitative work and 
added a rigor and structure to methodology which developed a theory as 
opposed to simply a description of the phenomenon. Interviews, often in-
depth, one-to-one interviews, are used to collect data with analysis being 
structured, using specific coding procedures. The individual views of Glaser 
and Strauss differed with time and this resulted initially in two main schools of 
grounded theory – one of Glaser and another from the collaboration of 
Strauss and Corbin. Charmaz (2006), and other second generation grounded 
theorists, developed these further.   
Despite the range of approaches, Charmaz listed the central components 
which demonstrate that a grounded theory approach is being taken. These 
are, “simultaneous data collection and analysis, analysis of actions as 
opposed to themes, using comparative methods, drawing on data to develop 
new conceptual categories and developing abstract, analytical categories 
through systematic data analysis” (2014:15). 
Hill Bailey (1997) highlighted that the ontological and epistemological 
aspects, relating to a study depend on the researcher.  
Markey et al (2014), in their work guiding researchers new to grounded 
theory, described the variety of grounded theory approaches and the 
importance of novice researchers determining their own research beliefs to 




The main epistemological stances are objectivism, subjectivism and 
constructivism (Markey et al 2014). Objectivism suggests that “objective” and 
“valid” knowledge can be produced, separating the, “researcher and the 
researched” (Markey et al 2014:17). Glaser and Holton (2004) described the 
researcher as gathering data objectively, acting as an independent observer, 
suggesting an objectivist stance. Subjectivism underlines the role which the 
researcher plays in that it suggests that, “the reality of all objects relies 
entirely on an individual’s subjective mindfulness of it” (Markey 2014:17). 
This seems to describe, to an extent, the approach of Strauss and Corbin 
(1990; 1998) where there is interaction between the data and the researcher. 
Constructivism describes generation of knowledge from the researcher’s, 
“knowledge and reflection” (Markey et al 2014:17) and is the approach taken 
by Charmaz (2000) where the researcher’s interpretation of the data is 
highlighted.  These differences in approach, for me, highlight the challenge 
with respect to recognising the researcher’s role within a grounded theory 
study. I will describe my philosophy and its influence on my choice of 




Creswell (2013:76) stated that a phenomenological study describes the, 
“common meaning for several individuals of their lived experience of a 
concept or phenomenon.” This approach attempts to, “grasp the very nature 
of the thing” (van Manen 1990:177). The phenomenon in this instance would 
be optimising medicines use in acute hospitals and the proposed 
methodology would be to carry out one-to-one interviews and use focus 
groups to gather a description of the essence of the phenomenon,- 
describing the what and the how of participants’ experiences. 
Phenomenology deals with the role of the researcher through a, “suspension 
of all judgements of what is real” (Creswell 2013), known as “epoch” from 




Therefore, in phenomenology, the researcher needs to separate their own 
personal views and beliefs, known as bracketing, while conducting the study. 
Data analysis follows a systematic approach moving from individual 
statements to higher-level units of meaning (Moustakas 1994) and then more 
comprehensive descriptions which summarise participants’ experiences. 
Coding is not used. The outcome from a phenomenological study will be a 
description of the essence of the phenomenon whereas a grounded theory 
approach will go a stage further in generating a theory. 
A phenomenological approach was chosen initially as the researcher was 
more familiar with the methodology and the processes used to reduce the 
impact of the researcher who has responsibility for managing medicines in 
one Trust in Northern Ireland. However, through further reading and 
comparison of the two approaches, I decided to use grounded theory for a 
number of reasons.  
Firstly it holds greater academic currency in comparison to phenomenology 
and that is important when considering dissemination of results. Generation 
of a theory which can influence future practice and policy, I believe, will have 
greater benefits to future work. The impact of the researcher can be 
controlled or recognised through either approach and the rigor of the coding 
methodology used in grounded theory supports its use.  
Researchers use a theoretical framework to have a structure for looking at a 
problem.  It helps with exploring, “relationships between variables to interpret 
and explain the data” (Vivar et al 2007: 65). By using a grounded theory 
approach, I am using a methodology which produces its own theory from the 
data collected and analysed and therefore adopting a theoretical framework 
is not appropriate (Strauss and Corbin 1998). 
In summary, grounded theory is best able to meet the aim of the study. In the 
next section I will discuss the range of approaches described in the literature 
on developing grounded theory and the reasons for choosing the particular 





3.4 Choosing a grounded theory approach  
 
There is a range of literature guiding researchers new to grounded theory in 
their choice of grounded theory approach (Glaser and Strauss 1967, Strauss 
and Corbin 1998, Locke 2001, Holloway 2005: Bryant and Charmaz 2007; 
Oktay 2012: Creswell 2013; Urquart 2013; Achora and Matua 2016). Writers 
have differing views of the philosophical paradigms which grounded theory 
lies within. Grounded theory has been described as, “an alternative to all 
paradigms,” (Jones and Alony 2011:97) who continued to state that the 
research approach should fit the, “needs of the research” and not the 
philosophical approach of the researcher (2011: 98). This is in line with a 
Glasserian approach. 
Birks and Mills stated that, from the outset, the researcher planning to use 
grounded theory must understand his own philosophical view of the world, 
“encompassing the questions and mechanisms for finding answers that 
inform that view” (2015:2).  
The range of schools of grounded theory continued to develop with a second 
generation of grounded theorists such as Charmaz (2000) and Clarke (2005). 
However despite ontological and epistemological differences, each school 
continued to adopt the main attributes of grounded theory which are theory 
production, coding and categorising data, concurrent data collection and 
analysis, writing memos and theoretical sampling (Birks and Mills 2015, 
Corbin and Strauss 2015). The researcher should also incorporate constant 
comparison of data, achieving theoretical saturation before integrating and 
putting together a grounded theory, which has a core category (Glaser and 
Strauss 1967, Birks and Mills 2015, Achora and Matua 2016). 
In deciding on an approach, I wanted to be able to follow a structured 
methodological process as I had not used grounded theory before. I also 
wanted to acknowledge my role as the researcher in the study, and any 
personal or professional preconceptions of the subject area, and further show 
that I am aware of the potential for bias and therefore adopt a reflexive 




relativist, falling between the extremes of Glaser and Charmaz. Therefore, I 
have chosen to use the approach described by Strauss and Corbin (1998).  
The key elements of Strauss and Corbin’s’ approach (1998) are listed and 
compared to those of both Glaser and Charmaz in Table 1. Central to this 
approach are constant comparison, asking questions and, “sampling based 





















Table 1: The key differences between the various schools of grounded theory (from 
Achora and Matua 2016) 



































Open, axial and 
selective. 
 
Initial, focused and 
theoretical. 
 







































In summary, I will use the grounded theory approach defined by Strauss and 
Corbin (1998). The specific methods used will be laid out in Section 3.5.    
  
3.5 Methods  
 
The descriptions of the methods of data collection and data analysis have 
been put together in this section because in grounded theory, data collection 
and analysis are carried out concurrently (Bryant and Charmaz 2007).  
Different researchers have adapted the classical grounded theory approach 
to data collection and analysis.  Bryant and Charmaz (2007) made it clear 
that the “full package” of a specific approach to grounded theory must be 
adopted as opposed to picking methodologies from a range of grounded 
theorists. This purist approach has not been adopted by all researchers using 
grounded theory and has led to some studies inappropriately claiming that 
they have used a grounded theory approach. I have tried to adopt a purist 
approach to the methodology described by Strauss and Corbin (1998).  
 
3.5.1 Data collection 
 
Data in qualitative studies fall under four main headings - interviews, 
observations, documents and audio-visual materials (Creswell 2013). Urquart 
(2013) commented that when generating grounded theory, any data in text 
format which can be coded can be used. The researcher in grounded theory 
studies has been described as being a detective seeking out clues, exploring 
how participants, “make sense of situations” (Morse 2007).  
A range of new forms of data is described in the literature, especially those 
which involve the use of the internet. Whilst there are financial and time-
saving benefits in carrying out, for example, on-line interviews and focus 
groups, there are also disadvantages. Nicholas et al (2010) compared using 
face-to-face to internet focus groups for children with chronic diseases. They 




for participants (2010:108) as well as longer access to the data which 
allowed member-checking over time as well as providing transparency of the 
interaction. This method however may reduce participation from certain 
socioeconomic groups with both researchers and participants needing to be 
able to be internet-literate.  
In a grounded theory study, the most commonly used methods of collecting 
data are by interviewing or observing participants (Corbin and Strauss 2015). 
Documents and audio-visual material can be used to supplement data. It is 
important that a method is chosen, not because of its frequent use but 
because it is the most suitable method to collect data to answer the research 
question (King and Horrocks 2010). I will explore the first two methods in 




The interview can be seen as a conversation between the researcher and the 
participant (Holloway 2005). Wisker (2008) however commented that 
interviews are more complex than this, needing a level of organisation and 
design. She referred to, “a continuum of interviews” (2008:194), going on to 
describe three main types - unstructured, semi-structured and structured. 
Corbin and Strauss (2015), in this later text, gave more detail on methods of 
data collection in grounded theory studies. They stated that unstructured 
interviews resulted in, “the richest form of data for theory building” (2015:38). 
They allow participants to have more control within the interview and to 
speak about what is important to them at a length and depth which reflects 
their experiences. Interviewers can steer the subject back to the original 
focus if needed, but in doing so, they must also reflect on why the participant 
took a particular path and its relevance to the data.   
In conducting semi-structured interviews, the interviewer has a pre-
determined list of themes or questions which can be asked in any order 
(Wisker 2008, Corbin and Strauss 2015). These themes may come initially 




interviews as the researcher wishes to explore areas which have emerged 
from previous interviews. This is a form of theoretical sampling, which is 
central to grounded theory methodology. Participants are invited to add other 
thoughts or comments that they wish. Semi-structured interviews provide 
assurance for the researcher that specific topics are covered but also allow 
sensitivity to the flow of the conversation.   
Structured interviews involve the use of an interview guide and each 
participant is asked the same questions. Corbin and Strauss (2015) viewed 
structured interviews as not providing rich data which support the 
development of a grounded theory. Participants are not encouraged to give 
their own views and the researcher is unable to alter the questions based on 
earlier interviews.  
Advantages of one-to-one interviews in general include their simplicity to 
organise and control; the ability to attribute ideas to a specific participant; 
explore ideas in depth and allow a flexible approach (Denscombe 2010). The 
validity of the data can also be checked at the time of the interview.  
There are disadvantages of using interviews. These include the researcher’s 
ability to access appropriate participants, data reflecting what the participants 
say as opposed to what they may do in practice and the influence of the skills 
and background of the interviewer. The experience and confidence of the 
interviewer is important (Taylor 2005). It can affect the quality of the data 
provided and interviewers should reflect on each interview, for example, 
asking themselves whether they asked leading or closed questions. 
Interviewers should also be sensitive to body language, silences and 
changes in tone.   
 
3.5.1.2 Focus groups 
 
Focus groups are used to collect data through the interaction and discussion 
between groups of participants. They allow participants to determine the 




natural conversational style as opposed to answering individual interview 
questions (Kitzinger 1994). Focus groups can be used along with other 
methods of data collection, for example, following one-to-one interviews, 
where they may allow further development of ideas within a freer, interactive 
conversation. The researcher will develop questions to be given to the group 
and may decide to use other materials, such as cards and objects, to prompt 
group discussion. Care should be taken to ensure all participants have given 
informed consent. Ground rules should be set at the outset, dealing with 
confidentiality and approach and after the session, the interviewer may have 
to correct any inaccurate information provided by group members during the 
discussion.  
 
3.5.1.3 Observation   
 
Although more time-consuming than interviewing, observational fieldwork 
allows the researcher to be situated in a particular setting and view what is 
happening. Observations may show differences between what a participant 
has said during a previous interview and their lived reality and so this method 
also can be used alongside other methods of data collection. Creswell and 
Creswell (2018) described two key types of observation. Participant 
observation (also referred to by Strauss 1987) involves the researcher 
spending time in the setting, integrating and adopting the language of 
participants. In non-participant observation, the researcher can observe a 
particular episode or view from a distance.  Researchers however must be 
able to seek clarification from participants afterwards to ensure they have 
understood what was happening in certain situations. Wallace (2005) 
suggested approaching this clarification by asking open questions such as, 
“how things might have been otherwise” (2005:73) to elicit fuller descriptions 
of what was happening.  Wisker (2008) referred to using an observation 
structure and schedule to prevent being inundated with data, although she 
recommended starting out with general observations which may influence the 
approach taken. Corbin and Strauss (2015) did not advise using an 




can restrict what the researcher sees and hears. Again, an iterative approach 
can be taken from one observation to the next, allowing ideas to be 
developed. Many authors have concluded that the researcher can see what 
they want to during observation, therefore reflexivity is important and indeed 
the researcher’s notes on this may become part of the data collected 
(Woolgar 1988).  
The observation itself has the potential to affect the activity being observed. 
This has been referred to as, “reactance” by Wallace (2005) who made 
reference to the literature on this including the ‘Hawthorne Effect.’  
Researchers using this method must give thought to ethical issues such as 
whether to intervene or not when they have a concern, getting fully-informed 
consent in a naturalistic environment and keeping participants’ contributions 
anonymous. More recent studies using this method (Rixon et al 2015) 
described recording observations. This may help with member checking, 





Documents such as policies, historical information, diaries, drawings and 
photographs can also be used as data.  
           
3.5.1.5 Choice of method 
 
One-to-one, semi-structured interviews were chosen as the method of data 
collection in this study. Silverman (2010) questioned whether a method is 
chosen because it is commonly or easily used as opposed to being the most 
appropriate method following analysis of the literature.  In this study, I need 
to gather data from doctors, nurses and pharmacists, on how they use 
medicines and also how they believe their professional colleagues use them. 




interested in being able to explore each individual’s views of medicines-use 
in depth and on balance this would be better explored through one-to-one 
interviews. There may have been benefits in having a multi-professional 
conversation about using medicines but the richness, honesty and open 
expression of views could have been restricted, depending on the 
relationship and power balances between group members.  Observational 
studies have become more common in generating grounded theory (Lewis 
and Tully 2009, Rixon et al 2015, Wilson et al 2016). By using this method, 
the researcher can see what is happening as opposed to hearing 
participants’ perceptions. However as a Trust Head of Pharmacy and 
Medicines Management, I had particular concerns about observing practice 
in a different hospital. Although I would be there as a researcher, I believed 
that it would be difficult to observe without participants (and other Trust 
Heads of Pharmacy) viewing me as an inspector of their practice. I 
anticipated having potential problems should I need to intervene when I had 
concerns about practice and the impact that would have on the data 
collected. Therefore I did not engage in observations. 
In summary, one-to-one interviews were chosen as an appropriate method to 
use when exploring, “complex and subtle phenomena” in depth, when looking 
to involve key players and explore, “how systems operate” (Denscombe 
2010:187). Interviews also served to provide “slices of data that are many 
and varied” (Urquart 2013:69). It will provide data to address the research 
question. One-to-one interviews will allow participants to provide detailed 
information of how they work with medicines and what they see as the role of 
other professionals with medicines. Using a semi-structured approach 
facilitates the researcher in asking specific questions, allowing theoretical 
sampling by altering questions following analysis of previous interviews. It 
also allows participants to contribute additional information, enhancing the 
quality and richness of the data. Interviewing face-to-face as opposed to by 
telephone or by Skype was chosen to provide the best chance of getting rich 






3.5.1.6 Questioning in semi-structured interviews 
 
An interview guide was used to list a number of initial themes and questions 
during each interview (Holloway 2005). The purpose of such a guide was to 
use headings loosely identified from the initial literature search to inform the 
early interviews and serve as potential prompts (Corbin and Strauss 2015). 
The initial interview guide, with comments on how this iteratively changed 
during the research process is in Appendix 5.  
This was updated throughout the research process, following analysis of 
previous interviews (Strauss and Corbin 1998). The guide also included 
prompts and general questions which could be used to help participants who 
could not think of what to say. It must be noted however that silence in 
interviews is important, adding to the data. I have had training as a coach 
and am comfortable with silences. The guide also included the introduction to 
the interview. This provided structure and transparency, covering the purpose 
of the interview, the role of the researcher, getting consent, confidentiality, 
duration and the opportunity to withdraw or not answer specific questions. It 
also included some finishing sentences.   
I asked an initial, open question in each interview which was designed to let 
participants speak freely about how they worked with medicines, to help them 
to start thinking about the subject and give them confidence to speak about 
something that they did each day. This was, “I am interested in your personal 
experience of working with medicines in hospital. Tell me about how you 
work with medicines in hospital?” Open questions were asked subsequently 
using “how” and “why” to encourage participants to speak freely. I tried to 
avoid complex and leading questions (Taylor 2005) and noted when I did this 
when listening to interview recordings.   
Piloting an approach is recognised as pragmatic when planning to collect 
data, but is rarely referenced in grounded theory literature.    Nunes et al 
(2011) put forward the proposal that carrying out a pilot study will help the 
researcher to understand the context of the proposed study as well as testing 




decided to pilot my interview for two reasons – to test the interview guide and 
also to practise and reflect on my interviewing skills. This gave me 
confidence for future interviews.  
The study design and ethics approval included the potential to use focus 
groups or documental analysis as well but these were not undertaken.  
 
3.5.1.7 Planning interviews 
 
Planning the interview is important (Wisker 2008, Denscombe 2010). 
Researchers should link with the participant beforehand to give details of the 
interview and agree a convenient time and place. Participants contacted me 
by email to express their interest in participating in the study. I replied, 
attaching an information sheet for interview participants (Appendix 9) and the 
participant consent form (Appendix 10). These are discussed in greater detail 
in Section 3.7. Interviews were planned to take place at least two weeks later 
to allow participants time to read the short paperwork and to withdraw if they 
wished.  
I travelled to the hospitals that the participants worked in, having given them 
the choice to arrange an interview room which was private and protected or 
allow me to do this (Denscombe 2010). In general, rooms were booked away 
from clinical areas but a small number of interviews took place in offices on 
wards. This was not ideal as it could be argued that participants may not be 
fully focused on the interview. My experience was that this was not the case. 
Seating was arranged (usually at a 90 degree angle) to facilitate effective 
communication (Denscombe 2010). Participants were told that the interview 
would take 30 minutes and this timescale was adhered to. It is important to 
ensure a formal approach is adopted and the participant’s time is respected.  
An audio recording, with associated field notes provides an objective and 
accurate record of the interview (Denscombe 2010). Video –recordings can 
be invasive, and whilst they will show non-verbal cues, an audio recording 




I sought the participant’s permission to record interviews on two devices and 
described how I would store the data securely.   
Recordings of interviews were transcribed verbatim by a secretary. This is 
important to preserve the accuracy of the interaction and can be viewed as 
the first stage of data analysis (Kvale 2008). I read through each transcript 
whilst listening back to the recording of the interview and corrected 
typographical errors, misunderstandings and also I made notes on things 
such as inflections and laughter which could add to the quality of the data. I 
re-listened to the recordings of previous interviews whilst I travelled to 
subsequent interviews, as well as updating the interview plan with new 
questions, to ensure I was steeped in the data. 
There are a number of papers and texts which list the advantages and 
disadvantages of the role of the practitioner as researcher, researching either 
in one’s own organization or field of practice. McNair et al (2008) stated that it 
is important for such individuals to recognise the many roles which they bring 
to the interview, for example a possible insider role with respect to the 
participants. McNair et al recommended explaining this to participants at the 
outset to provide clarity. I explained that I was a registered pharmacist at the 
outset of each interview and whilst a researcher, I also had a professional 
obligation to highlight any concerns raised in an interview with the relevant 
Trust professional lead. This would be done, however, following a 
conversation with the participant.  
McNair et al (2008) listed a number of benefits of having a clinician 
researcher. These included being able to use relevant research questions, 
bringing extra knowledge to the analysis and having a dedication to and 
shared understanding of the subject. He highlighted potential downfalls in the 
approach as well. Role boundaries between the researcher and participant 
may become blurred with the researcher potentially not recognising their 
“shared conceptual blindness” with participants. This could affect the rigor of 





3.5.1.8 Sampling in grounded theory interviews 
 
The sample of participants used in a qualitative research study does not 
need to represent the population which is being studied, as in quantitative 
research (King and Horrocks 2010). Creswell (2013) highlighted that in 
grounded theory studies, participants are chosen who have experience of 
and can contribute to theory development.  
Strauss and Corbin described sampling in grounded theory as, “evolving 
during the process” (1998:202) as opposed to being planned from the start. 
The researcher is sampling what is happening as opposed to sampling 
individual practitioners. This is known as theoretical sampling. Creswell 
(2013) explained that theoretical sampling begins with choosing and studying 
a homogeneous sample of participants who contribute to the initial 
development of the theory. Then, a heterogeneous sample can be chosen to, 
“confirm or disconfirm the conditions under which the model holds” 
(2013:155).      
Morse highlighted that a, “targeted research question may guide selection [of 
participants]” (2007:236). My research question led me to sample from 
individuals who were doctors, nurses and pharmacists working in acute 
hospitals in Northern Ireland.  
I had concerns about whether to choose an initial homogeneous sample of 
participants from one profession or whether to choose an experienced 
practitioner from each profession to provide a breadth of initial data. Morse 
(2007) commented that the context of the research is important when making 
decisions about sampling. She referenced carrying out an, “armchair walk-
through” as described by Richards and Morse (2007:236) to help plan a 
sample. I carried out an armchair walk-through at the outset (Appendix 6) 
and decided the following: 
I think I will start by having one-to-one interviews with a 
member of each of the three professions with at least one 
year’s acute hospital ward experience (so that their views are 




As the theory building developed, through using open, axial and selective 
coding, my sampling focused on specific concepts and became more 
purposeful. In open coding, participants are chosen openly as they present 
themselves, as concepts and categories of the theory have not been 
developed as yet. During axial coding, the researcher is looking for 
relationships between categories and sub-categories. They also are looking 
at variation in the data in terms of properties and dimensions. They may look 
for participants who they believe will allow them to test these. This may be a 
challenge for a number of reasons. The researcher may not have access to 
sufficient participants to allow them to choose. Also Strauss and Corbin 
(1998:210) stated that purposeful sampling, as recommended at this stage, 
is, “a deductive process.” The researcher may believe that a particular 
participant will provide further data on a specific category but this may not be 
the case. Finally, in selective coding, more specific sampling should be used 
to help fill gaps, integrate categories and validate previous comments. The 
researcher should engage participants who will help to continue with constant 
comparison and validation of concepts which may contribute to the final 
theory.      
Initially, I interviewed two pharmacists, a specialist nurse and a doctor who 
worked both in an acute hospital and as a general practitioner (GP). They 
were all experienced practitioners (Table 2) and provided, “an overview of the 
entire process” of medicines optimisation in an acute hospital (Morse 
2007:237). As well as meeting my armchair criteria, they were also the first 
four individuals who volunteered to participate in my study. They worked in 
two different acute hospitals. I was concerned that the doctor had a 
combined role, working in a hospital and as a GP. On discussing this with my 
supervisors, I decided to include this individual who had a wealth of acute 
hospital experience and also worked closely with the nurse. I was interested 
in exploring how these individuals worked together, as team-working was 
emerging as an early category. Two of these experienced practitioners (a 
nurse and a pharmacist) compared their way of using medicines to that of 
medical staff. I wanted to see if there was variation in these views and if they 




modified my questions as coding progressed, to allow me to test categories 
with each participant.  
Saturation is described in detail later in Section 3.5.2.4. I could see no new 
concepts at interview 13 but I continued interviewing for a number of 
reasons. Firstly, I was conscious that I had interviewed only three nurses and 
I wanted to explore some emerging concepts with at least one more; I felt my 
first interview with an FY1 doctor (interview 12) did not go as well as I had 
hoped and I wanted to interview at least one more FY1 doctor; finally I 
wanted to be sure that no new concepts would emerge. Subsequently I 
interviewed two more FY1 doctors and a new ward manager.  
The main approach to theoretical sampling in this study was my use of new 
questions. Through coding, analysis and the use of theoretical memos, I 
formulated new questions on areas which I wished to explore in subsequent 
interviews. These tested out what I believed were emerging categories. 
Therefore I modified the interview guide as I progressed through the study. 
Examples of these new additional questions have been added to the end of 
Appendix 5.  
 
3.5.1.9 Study participants  
 
Seventeen individuals (seven doctors, four nurses and six pharmacists) were 
interviewed. Table 2 gives further details of the participants, listed in the 
order that they were interviewed. One of these interviews was a pilot 
interview and I will discuss the reasons for this below and in a memo in 
Appendix 7.  
Participants were based in four of the six Health and Social Care (HSC) 
Trusts in Northern Ireland. These were the: 




 Northern Health and Social Care Trust. 
 Southern Health and Social Care Trust. 
 South Eastern Health and Social Care Trust. 
I interviewed participants in two hospitals in one Trust (the Belfast Health and 
Social Care Trust); therefore five hospitals are mentioned in Table 2.  






















Pharmacist 0 Band 8a 
20 years 
Polly 1 6 
1 
 
Pharmacist 1 Band 7 
5 years 
Rebecca 1 12 
2 
 
Doctor 1 GPSI 
29 years 
Joan 2 8 
3 
 
Pharmacist 2 Band 8a 
26 years 
Karen 2 15 
4 
 
Nurse 1 Band 5 
14 years  
Patricia 2 12 
5 
 
Doctor 2 CT 4 
4 years  
Jayne 3 19 
6 
 
Doctor 3 Registrar 
11 years 
Sally 4 23 
7 
 
Pharmacist 3 Band 8a 
10 years  
Angela 3 18 
8 
 
Nurse 2 Band 6 
3.5 years 
Shirley 4 18 
9 
 
Pharmacist 4 Band 8c 
34 years 
Deirdre 2 15 
10 
 
Pharmacist 5 Band 7 
5 years 
Caroline 4 15 
11 
 
Nurse 3 Band 5 
3.5 years 
Jackie 4 13 
12 
 
Doctor 4 FY1 
4 months 
Fred 1 3 
13 
 
Doctor 5 FY1 
5 months 
Mary 5 15 
14 
 
Doctor 6 Specialty 
Doctor 
10 years 
Frank 1 9 
15 
 
Doctor 7 FY1 
6 months 
Jack 1 10 
16 
 
Nurse 4 Band 6 
10 years  





Interviews were not carried out in the Western Health and Social Care (HSC) 
Trust or the Northern Ireland Ambulance Trust.  The Research and 
Development office in the Western HSC Trust had given approval for the 
study to be carried out there but participants from there were excluded as the 
researcher is the Head of Pharmacy and Medicines Management in the 
Western HSC Trust. This will be explored later in the ethics section (Section 
3.7).  
Non-statistical sampling methods are used when developing a grounded 
theory (Creswell 2013). Although not looking for equal representativeness of 
professions and Trust sites, I did try to interview similar numbers of doctors, 
nurses and pharmacists from each of the four Trusts. I found it particularly 
challenging to find nurses who would be willing to participate. I tried to use a 
“snowballing” approach (Cresswell 2013) to getting more nurses by asking 
participants to suggest others who may be able to contribute to the research.  
This was successful in getting one further nurse involved. However 
individuals from two different clinical teams volunteered and so I believe 
there was an element of informal snowballing happening in these areas. I 
planned to find self-selecting participants at each site by asking permission to 
hang posters in staff areas in acute hospitals, inviting participation. I sent 
coloured posters (Appendix 8) to the Head of Pharmacy and Medicines 
Management of each Trust who were gatekeepers for the study (and named 
as local investigators) in each Trust. I received emails initially from 
pharmacists who I had worked with in the past and who were keen to be 
involved. I had to politely decline these offers to reduce my impact on the 
data. The process of getting participants was slow and I added prompts into 
the system by asking the Medical Director and Director of Nursing from my 
Trust to forward information and posters to their professional colleagues in 
the other four Trusts and follow the contact up at regional meetings. I also 
had to contact the four Trust Heads of Pharmacy and Medicines 
Management again towards the end of the study to get the last few 




I was concerned that some participants would not fully understand the 
specific term, ‘”medicines optimisation”’ but would view “optimising 
medicines”’ solely within the Oxford English Dictionary’s definition of “to 
optimise” which is, “to make the best or most effective use of [a situation or 
resource]” (2018). I checked participants’ understanding of the term at the 
end of later interviews and all but one participant was able to describe its 
general meaning. However despite this, all participants mentioned most 
elements included in the NICE definition. 
  
3.5.1.10 Research journal 
 
Corbin and Strauss (2015) discussed keeping a research journal to aid self-
reflection throughout the research process. I kept a research journal, as a 
separate document to memos, in which I wrote my reflections on how my 
research was progressing. This provided a timeline for the research and 
contributed to the transparency and reflexivity of the work. I described how I 
felt at different stages, writing through my own thoughts to help me to 
determine whether I was making assumptions. This helped me to be more 
aware of my own thoughts and feelings towards the research and helped me 
to progress. A research journal can be used as data.    
 
3.5.2 Data analysis 
 
The data from interviews was coded as described by Strauss and Corbin 
(1998). Coding and analysing data from the outset coupled with checking 
new ideas with those already captured (making constant comparisons) 
defines the grounded theory approach and sets it away from the 
ethnographic approach of gathering a large amount of data and letting it 
speak for itself (Creswell 2013). I have given more detail on how I analysed 
the data, along with examples from the data in Chapter 4. I will outline briefly 




3.5.2.1 Coding methods 
 
Strauss and Corbin (1998) defined three stages of coding. These are:   
 Open coding – breaking the data apart to identify the building blocks of 
theory.    
 Axial coding – linking categories. 
 Selective coding – “building a story” to connect the categories, forming 
theory. 
 
3.5.2.1.1 Open coding 
 
In grounded theory, the theory is grounded in the data but the skills of the 
researcher are required.  To this end it is important to begin by breaking the 
data down into discrete pieces before building it up again. This is known as 
open coding. 
Open coding was carried out line-by-line, using gerunds and some in-vivo 
codes as appropriate. I used constant comparison along with writing 
conceptual memos. The actual process followed is described in detail in 
Section 4.2. 
 
3.5.2.1.2 Axial coding 
 
Strauss and Corbin defined the purpose of axial coding as,” to begin the 
process of reassembling data which were fractured during open coding” 
(1998:124). The goal is to, “systematically develop and relate categories” 




 (Chiovitti and Piran 2003) and also guides the novice researcher. This is 
central to the Strauss and Corbin model of grounded theory and allows the 
researcher to build a dense and rich theory from the data. Strauss and 
Corbin (1998) gave a number of examples of analytical tools and techniques 
which can be used by the researcher. They commented, “we emphasize 
strongly that techniques and procedures, however necessary, are only a 
means to an end. They are not meant to be used rigidly in a step-by-step 
fashion. Rather their intent is to provide researchers with a set of tools that 
enable them to approach analysis with confidence and to enhance their 
creativity that is innate” (1998:14). I have used most of the tools described in 
this text, hopefully, “flexibly and creatively” as opposed to, “in a rote manner” 
as aspired to in Strauss and Corbin (1998:8) and have described these 
below. 
 
 Asking questions of the data 
The researcher can analyse the data in greater depth by asking the 
questions, who, when, where, why, how and with what consequences? 
These questions are asked throughout data analysis.  
 
 Using the Paradigm Model as part of axial coding 
Strauss and Corbin described the Paradigm Model as a scheme used to, 
“sort out and organise the emerging connections [between categories]” 
(1998:128). By using this model, the researcher can analyse and order the 
data, helping to integrate it further into emerging theory and also to help 















The set of circumstances in which the 
phenomena are embedded. 
A conceptual way of grouping the 




Strategies (actions and interactions) 
 
Strategic or routine responses to events 
that arise under these conditions. 







The outcomes of actions and 
interactions. 
What happens as a result of the 
actions/interactions (or not)? 
 
 Developing the category in terms of its properties and 
dimensions 
Strauss and Corbin described properties as, “the general or specific 
characteristics or attributes of a category” with dimensions representing, “the 
location of each property along a continuum” (1998:117). This is another 
analytic approach which allows the researcher to systematically link 





 Coding for process 
Strauss and Corbin (1998) described coding for process as, “purposefully 
looking at action/interaction and noting movement, sequence, and change as 
well as how it evolves (changes or remains the same) in response to 
changes in context or conditions” (1998:167). 
The outputs of these methods were not used as data but the methods were 
used, “as tools to help get a better understanding of the data” (1998:85). 
They provided a framework within which to operate which helped to reduce 
researcher-bias in the analysis. I have demonstrated how I used each of 
these tools in Chapter 4. 
Strauss and Corbin (1998) introduced an additional way of coding called a 
conditional matrix. Subsequent texts have made reference to this (Corbin and 
Strauss 2008, 2015) however other researchers have outlined the difficulties 
with its use in terms of having, “the data, time, or resources” (Creswell 
2013:87). I did not use the matrix also for the aforementioned reasons.     
In summary, I used a range of analytical tools, including asking questions of 
the data, using the Paradigm Model, developing categories in terms of their 
properties and dimensions and coding for process. I did not use the 
conditional matrix for the reasons outlined above. 
 
3.5.2.1.3 Selective coding  
 
Strauss and Corbin defined selective coding as, “the process of integrating 
and refining the theory” (1998:161). Again they defined analytical methods 
such as writing more in-depth theoretical memos, writing the storyline and 
drawing further diagrams, including a final integrative diagram in which links 
are shown between the major concepts in the theory. This integration, using 
selective coding, takes place over time and involves, “organising categories 





Strauss and Corbin (1998) outlined the importance of the core category as 
coming from the data and giving, in essence, a short description of what the 
research is all about. It is able to link and pull together the other categories, 
providing an explanation of the theory, having analytical power. They outlined 
six criteria for choosing a central category. These are listed in Table 4. 
Table 4: Criteria for choosing a central category (Strauss 1987 in Strauss and 
Corbin 1998:147) 
1. It must be central; that is, all other major categories can be related to it. 
2. It must appear frequently in the data. This means that within all or almost all 
cases, there are indicators pointing to that concept. 
3. The explanation that evolves by relating the categories is logical and consistent. 
There is no forcing of the data.  
4. The name or phrase used to describe the central category should be sufficiently 
abstract that it can be used to do research in other substantive areas, leading to 
the development of a more general theory. 
5. As the concept is refined analytically through integration with other concepts, the 
theory grows in depth and explanatory power. 
6. The concept is able to explain variation as well as the main point made by the 
data; that is, when conditions vary, the explanation stills holds, although the way 
in which a phenomenon is expressed might look somewhat different. One also 
should be able to explain contradictory or alternative cases in terms of that 
central idea. 
 
I will demonstrate how I used each of the abovementioned analytical 
methods, including detail on how the core category and theory emerged in 






3.5.2.2 Constant comparisons 
 
Corbin and Strauss stated that, “making constant comparisons refers to the 
act of taking one piece of datum and examining it against another piece of 
datum both within and between documents” (2015:93). By doing this the 
researcher can find out how concepts differ or are similar. Making constant 
comparisons is a core element of developing grounded theory. It is 
embedded into how the researcher analyses the data within and between 
each interview before embarking on a subsequent interview.  
In moving from open coding, through axial to selective coding, three types of 
comparison are used (Strauss and Corbin (1998). These are: 
 Comparison of different incidents to see if there is uniformity in the 
concepts generated. 
 Comparison of concepts with new incidents to get a richer data and 
move towards data saturation. 
 Comparison of, “emergent concepts” to get, “best fit between potential 
concepts and a set of indicators”. 
I used this throughout the research process and will give examples of this in 
Chapter 4. 
 
3.5.2.3 Writing memos 
 
Writing memos also is an essential part of grounded theory methodology and 
has been written about extensively (Strauss and Corbin 1998; Birks and Mills 
2015; Urquart 2013, Charmaz 2014). Strauss and Corbin described memos 
as, “written records of analysis that may vary in type and form” (1998:217).  
Birks and Mills described writing memos as,” the critical lubricant of a 
grounded theory machine” (2015:40). They highlighted a variety of purposes 
for writing memos, including describing your thinking as you gather and 




and providing an audit trail of how  grounded theory was generated, 
enhancing the quality of the research. Each researcher will develop their own 
style of writing memos. I regularly wrote memos as I carried out initial open 
coding relating each memo to a section of an interview using the interview 
number, page and paragraph (#3:p14-01). In these, I highlighted in red 
specific questions which I wanted to pursue in the following interview and 
added these to the interview plan. My memos changed as I progressed 
through the different stages of coding. I described when my thinking changed 
making sure this was grounded in the data.  I explored the development of 
higher-level categories and theory and also concerns which I may have had, 
for example, writing through concerns about rigor and how to ensure this. At 
times, I updated memos as my analysis of the data continued and also 
included quotations from the data to provide easier focus and reference when 
returning to a specific memo. My memos helped me in understanding how I 
had developed specific thinking and provided me with a confidence in the 
process as well as an historical time-line of how the theory had developed. I 
also drew diagrams as part of the process of linking concepts or making them 
clearer (Strauss and Corbin 1998). I have made reference to specific 
examples of my use of memos in Chapter 4.  
 
3.5.2.4          Reaching saturation 
 
Strauss and Corbin spoke of saturation as being when a point is reached 
where additional data collection seems, “counterproductive; the ‘new’ that is 
uncovered does not add that much more to the explanation at this time” 
(1998:136). They add that it may also be the point when the researcher has 
no time or money remaining. The concept of saturation was used by earlier 
authors as a more conclusive point, but Strauss and Corbin commented that 
a researcher can never state that nothing new, however small, can emerge 





Mason (2010) spoke of the potential of producing better analysis from a 
smaller number of well-constructed interviews. Therefore it may be the 
quality as opposed to the quantity of data that is important. All of this has an 
impact on the strength, credibility and generalisability of the study. 
Charmaz (2014) raised the level of discussion of the concept of saturation, 
highlighting that it may be achieved at an earlier stage if repetitive and less 
innovative approaches are used in collecting data. Using “iterative” data 
collection, analysis and theoretical sampling will result in the emergence of, 
“no new properties of the pattern” as opposed to, “seeing the pattern over 
and over again” (Glaser 2001:191). This leads to a rich grounded theory with 
“conceptual density.” Charmaz (2006) expressed concerns that high-level 
analysis may result from working too closely to the grounded theory definition 
of saturation. She encouraged researchers to keep going back to the data, 
recoding it and remaining open to new possibilities to achieve richer theory. 
The implications of this wide debate appear to be that the grounded theorist 
should not depend on a relative concept of saturation when considering when 
to stop collecting data. Rather, they should focus on the quality of the theory 
being produced, through use of effective interview techniques, analysis and 
theoretical sampling. This will produce a thick description of what is 
happening here.     
 
3.6 Enhancing the quality of the data 
 
There is a breadth of literature on how to evaluate the quality of a qualitative 
study, with Corbin and Strauss believing that, “the problem of how to assess 
qualitative research has not yet been resolved” (2015:341). The authors 
commented that quality should be designed into a grounded theory study 
from the outset as opposed to trying to measure it subsequently.  
Whilst terms such as validity and reliability are used to assess quantitative 
studies, other terms such as credibility, dependability, rigor, transferability 




qualitative work (Glaser and Strauss 1967; Holloway 2005; Creswell 2013). 
Criteria have been produced to evaluate the practical elements of a 
qualitative study (Strauss and Corbin 1990; Chiovitti and Piran 2003; Morse 
2007; Creswell 2013), although their inability to also capture the artistic and 
more creative characteristics of qualitative studies have been commented on 
by Charmaz (2006) and Corbin and Strauss (2015). I have used the 
framework devised by Spencer et al (2003) to evaluate this research study 
and a completed framework has been included in Appendix 18.Holloway 
stated that the most frequently used measures of the quality of qualitative 
studies are, “trustworthiness” and “authenticity” (2005:276). These are also 
referred to by Glaser and Strauss (1967), Lincoln and Guba (1985) and 
Morrow (2005). 
Qualitative research must be trustworthy and valid, in other words it must be 
truthful and relevant (Freshwater et at 2010). In order to achieve this, the 
researcher must demonstrate reflexivity, being able to reflect on their role 
within the research, their relationship with the participants and the methods 
which they used to maintain reflexivity throughout the research process 
(Ballinger 2004).  Birks and Mills stated, “it is only through the analysis of 
your subjectivity through the judicious process of reflexivity that you can 
guide your own actions in a more insightful way” (2015:55). I used a number 
of methods including, being open about my background and interests in a 
reflexive statement (Appendix 1); using a defined and structured 
methodology (Strauss and Corbin 1998) to help to reduce subjectivity; 
recording interviews, transcribing them verbatim and using memos. I also 
wrote comments and concerns in a researcher diary. In this, I regularly 
reflected on my thinking and whether I needed to take a step back, how I 
carried out interviews, the questions I used, whether I influenced participants; 
and sharing and discussing recordings and coded transcripts with my 
research supervisors.   
Two types of validity are referred to in the literature (Creswell and Creswell 
2018). Internal validity can be demonstrated by using “thick descriptions” of 
the data to show what is happening and allow others to believe they were 




participants to check that the researcher’s interpretation is valid. The 
researcher must also give a clear description of data collection and analysis 
to help others to determine how the theory was derived, that would allow 
another researcher to carry out the study (also referred to as transparency). 
External validity refers to the generalisability of a study. Corbin and Strauss 
stated that, “generalisability is not the purpose of qualitative research” 
(2015:377), which does not use representative samples. However there 
should be learning from the study and the grounded theory which could be 
used in other areas.   
The grounded theory must be credible or believable, making sense to 
professionals who work in the field as well as to the layperson.  I have 
presented my study to three professional groups (Directors of Pharmacy in 
Scotland, the Medicines Optimisation Research Group at the University of 
Bradford and pharmacists from across Ireland who had just completed a 
clinical leadership course). I also discussed it with two senior clinicians within 
my Trust, a senior pharmacist in Scotland and also I asked a pharmacist with 
knowledge of medicines-related risk to read the thesis and make comments.  
They all stated that they understood the theory and that it made sense. A 
number were surprised at certain findings such as inter-professional 
dependencies and this generated further discussion. I am conscious that 
some of these individuals may have supported my findings blindly but I 
believe that the level and interest in subsequent discussion did not reflect 
this.  
Glaser and Strauss (1967) also spoke of the “applicability” of a theory to 
other areas, with it also being able to support change in wider systems.  
Corbin and Strauss commented on the number of studies which use a 
grounded theory approach, not building specific theory or following a 
“consistent method” (2015:347). A grounded theory study should always use 
constant comparison, develop codes, categories and concepts, define a 
theory with a core category (in diagrammatic form) and use theoretical 
sampling, and possibly saturation. My study has incorporated each of these 




clear about their aim, develop a sense of and respect for the subject and the 
participants and design quality into the study from the outset.  
    
3.7 Ethical issues 
 
King and Horrocks (2010) highlighted the importance of being aware of the 
consequences of producing knowledge through qualitative research. The 
research should be ethically justified. They described the ethical principles of 
respect for persons, beneficence (ensuring participants’ well-being) and 
fairness. 
Willig (2001) listed five basic ethical considerations for qualitative research: 
 Informed consent from participants before the research is started. 
 Not deceiving participants. 
 Ensuring participants feel free to no longer be involved without fear of 
repercussions. 
 Allowing participants to have access to the published outcomes of the 
study. 
 Confidentiality.  
Participants were given an information sheet on the study two weeks before 
they were interviewed. This allowed them to give informed or “knowing” 
consent to being involved as described in King and Horrocks (2010). A copy 
of the information sheet for interview participants in this study is in Appendix 
9 and covers the five points above. King and Horrocks highlighted informed 
consent in qualitative interviewing as being a process, that requires 
continuing renegotiation and allowing participants the opportunity to withdraw 
at any stage. At the start of each interview, participants were asked to read 
through the information sheet again and to initial each point on a participant 
consent form. The form was then signed by the participant and the 
interviewer. A copy of the participant consent form is in Appendix 10.  
Respect for participants is central to the qualitative researcher’s work with 




kept confidential. Interviews were numbered and participants were given 
pseudonyms with codes kept separately and securely. I discussed the use of 
specific quotes with participants and I have paid attention in laying out the 
data to ensuring it is used in a way which does not inadvertently identify a 
participant. Appropriate consideration has been given to the length of time 
that records of interviews are held, with due reference to the Data Protection 
Act 1998, ensuring personal data is kept for no longer than necessary. I 
sought approval to hold data until December 2019 in the research ethics 
submission to each Trust. This was to allow sufficient time to submit this 
thesis and subsequent papers for publication.   
I planned to offer participants the opportunity to read through interview 
transcripts to validate what they had said.  This was to serve two purposes; 
for member checking and also recognising the democratic principle (King and 
Horrocks 2010) that this information belongs to the participant. However, as 
transcripts were verbatim records of the interview, on reflection I decided that 
this would serve no purpose. Participants were told before each interview 
that they could contact me at any time to withdraw any statements which they 
had made. I have a professional obligation to highlight any risks to patient 
safety highlighted through this research and I explained this to participants. 
The outline of these explanations can be accessed in the interview guide in 
Appendix 5.  
This study did not require review by a Research Ethics Committee (REC) 
within the UK Health Departments Research Ethics Service as research was 
limited to involvement of staff as participants (no involvement of patients or 
service users as participants). An on-line Study-Wide document set (IRAS 
Ref: 182436) was submitted for review by the University of Bradford’s internal 
IRAS reviewer. The study received ethics approval to proceed to the NHS for 
consideration and ethical review. Copies of the approval email and 
sponsorship letter are in Appendices 11 and 12. The IRAS application was 
submitted for Health and Social Care (HSC) Research Governance 
permission via the Northern Ireland HSC Research Gateway.    NHS/HSC 
Research and Development (R and D) approval was given by each Trust. 




research governance approval from Belfast,   Northern, South Eastern and 
Southern HSC Trusts are in Appendix 13. As this was a multi-centre study, 
HSC Site Specific Information forms were electronically transferred to the 
Principal Investigators on each of the five potential Trust study sites. The 
Principal Investigators were either the Head of Pharmacy and Medicines 
Management or the Research Pharmacist in that Trust. Local Trust Research 
and Development Research Placement Agreements subsequently were put 
in place.   
Kairuz et al (2007) described the importance of the researcher having high 
ethical standards. I worked in line with the Pharmaceutical Society of 
Northern Ireland’s Code; Professional standards of conduct, ethics and 
performance for pharmacists in Northern Ireland (2016) and the Department 
of Health, Social Services and Personal Safety Northern Ireland’s 
(DHSSPSNI) Research Ethics Framework (2005) and the subsequent UK 
Policy Framework for Health and Social Care Research (NHS Health 




In Chapter 3, I have discussed different research methodologies, giving my 
reasons for choosing a qualitative, grounded theory methodology. Concurrent 
data collection and analysis methods were highlighted. The importance of 
ensuring quality and rigor in a qualitative study was explored. The ethical 









4.0 Data Analysis 
4.1 Introduction 
In Chapter 3, I stated that the aim of this study was to produce a theory which 
explains how doctors, nurses and pharmacists work to optimise the use of 
medicines in acute hospitals in Northern Ireland. I described the methods 
which I have used to collect, analyse and integrate data, using grounded 
theory methodology.  
Grounded theory, as defined by Strauss and Corbin, is, “theory that was 
derived from the data, systematically gathered and analysed through the 
research process” (1998:12). Central to using grounded theory methodology 
is the simultaneous generation and analysis of data (Birks and Mills 2015) 
using the constant comparison method, theoretical sampling and memos as 
outlined in the previous chapter. Analysis and integration of the data starts 
from the outset and develops throughout the data collection process.  
In their later work, Corbin and Strauss, when describing data analysis, 
highlighted the artistic and scientific nature of the work, with the researcher 
being able to, “spin straw into gold” (2008:49). For me, this very creative 
metaphor reflects the rhythmic and continuous working with the often 
disjointed and individual strands of data, letting them run through your 
fingers, intertwining them and through the “spinning” process, creating 
something which is of greater value - the theory.   
In this chapter, I will detail how I used the methodology, giving examples of 
data analysis, constant comparison and using memos throughout which 
explained how the data were integrated into the final theory.  The outcome of 
this process is an integrative diagram giving an overview of the core category 
and the theory (Figure 5). 
I analysed the data in a structured way as described by Strauss and Corbin 
(1998). I have divided up my data analysis to show structure and process in 




However, as highlighted by Strauss and Corbin (1998), open and axial 
coding happened concurrently, helping to build up a dense and rich theory 
from the data. The structured approach to laying out the data is a necessary 
one, demonstrating transparency, and I will try to link the categories and sub-
categories together in my outline as opposed to listing them in isolation. 
 
4.2        Open coding 
 
I coded each line of each interview by hand, writing each code in the margins 
of the interview transcript, using active terms (gerunds). Examples of these 
initial line-by-line codes for three different interviews (a doctor, a pharmacist 
and a nurse) can be seen in Appendix 14. At the beginning, I found it difficult 
to find different language which captured the essence of what was being 
described. This became easier as I immersed myself in the data. I grouped 
the line-by-line codes initially by hand-writing them under emerging headings 
(concepts) in an artist’s pad, making sure to reference their source using the 
interview number and the page number, for example (#1p4). As interviews 
and coding progressed, it became apparent that certain open codes, for 
example, checking and amending discharge letters, were profession-specific, 
whilst others, related to the work of all three professional groups, for 
example, checking with patients. At this stage it was important to capture this 
detail to provide a clear audit trail and aid future analysis. This developed to 
writing codes on coloured Post-it notes and small cards which I could move 
around into different emerging categories as the analysis progressed. The 
Post-it notes were colour-coded with a profession-specific colour, to make it 
clear which profession the code related to.  
At the same time, I wrote memos on what I believed was happening in the 
data, asking questions of the data and identifying new questions to ask new 
participants at a later stage. There are some examples of these in Tables 9 
and 10. I also maintained a researcher journal of my thinking and learning 




Starting from the first interview, I grouped together line-by-line codes which 
had similar meanings and gave them an overarching name which 
encompassed what they had in common. Strauss and Corbin (1998) refer to 
this as conceptualising. Table 5 is an example of grouping initial line-by-line 
codes from early interviews to form the concept, having checking systems.  
Table 5:  Examples of initial line-by-line codes which fed into the concept, having 
checking systems 
 
Initial line-by-line codes 
 
Concept / category 
 
Checking with patients.  
Checking with pharmacists. 
Seeking expert advice. 
[Pharmacists] checking and amending 
discharge letters. 
Telling the patient’s medicines story.  
“Trying to actively engage my brain every 
day.” 
Monitoring patients. 
[Pharmacist] is “keeping us right.”  
Focusing on getting it right. 
Checking out concerns. 
Nurse’s role- checking if unsure. 
Challenging prescribing. 
Managing missed doses. 
Involving patients in discharge. 
Adopting a structured approach.  
Empowering others to question 
prescribing. 











In this way, a list of concepts emerged from the data in the early interviews. 
This list is in Table 6. 
Table 6: A list of initial concepts which emerged from the first four interviews 
 Professional responsibility. 
 Responding to queries. 
 Ensuring accuracy. 
 Prioritising. 
 Ensuring timely administration of medicines. 
 Not in control of own work. 
 Problem-solving. 
 Having checking systems. 
 Managing workflow and time. 
 Risk management – minimising risk. 
 Prescribing habits of doctors. 
 Multi-professional working/ multidisciplinary team working. 
 Prescribing pharmacists and nurses. 
 Communicating openly. 
 Following standards of practice. 
 Structured working. 
 Building open relationships between healthcare professionals. 
 Training - learning on the job. 
 Increasing complexity of medicines. 
 Correcting prescriptions. 
 Having a discharge focus. 
 Pharmacists’ roles on admission. 
 Struggling with complexity. 
 At the forefront of practice/power. 
 Having governance processes in place. 
 Using guidelines. 
 Involving patients – focusing on what the patient needs. 
 Choosing drugs.  
 Making efficient use of time. 
 
Some of these codes and concepts reflected the work of members of just one 





I checked that the concepts did not simply reflect any questions which I 
asked during the interviews and saw that this was not the case. My questions 
were open, for example, “how do you work with medicines?” This can be 
seen in the outline of the interview guide which is in Appendix 5. I used these 
concepts to continue to group the line-by-line codes from subsequent 
interviews. This list of concepts grew longer as new concepts emerged from 
the data.  
Strauss and Corbin (1998) described carrying out microanalysis by grouping 
codes or concepts under, “more abstract higher order concept(s), based on 
its (their) ability to explain what is going on” (1998:113). They described 
these categories as having, “analytic power because they have the potential 




Through the use of constant comparison and memos, a number of early 





















Table 7:  A list of some of the early categories which emerged from the data  
 
 Making the best use of time. 
 Working under pressure. 
 Managing risk. 
 Seeing the whole patient. 
 Having checking systems. 
 Reviewing medicines. 
 Administering medicines. 
 Seeing the whole process. 
 Working in a complex world. 
 Communicating with each other. 
 Effective team working. 
 Valuing multi-professional working. 
 Developing new roles, for example, independent prescribing. 
 Using the evidence base. 
 Learning on the job. 
 Understanding roles and responsibilities. 
 
 
This is not an exhaustive list of all of the categories and further categories 
emerged from subsequent interviews and comparisons. Strauss and Corbin 
(1998) highlighted different ways of naming categories including using a 
name of an earlier concept which is broader than the others, using in vivo 
codes or using a concept from the literature. Initially I used mainly the first 
approach but as categories developed, I used all three and reference will be 
made to this later in the chapter. In general, I made sure that the names of 
the categories were embodied in and had their meanings in the data.   
 
Within the context of the research question, I also tried to organise initial 
open codes under professional role headings, for example, what codes relate 
to the role of the doctor, nurse or pharmacist as well as to specific processes 
associated with these professionals, i.e. prescribing, administering and 
checking medicines. Although this helped me to become more familiar with 
the data, I believed it tended to force it and so I did not pursue it at that early 




data to demonstrate a subsequent category of understanding roles and 
responsibilities which was later integrated into the core category managing 
risk.    
 
I underlined in vivo codes as I coded each transcript. In vivo codes, as 
described by Glaser and Strauss (1967), are taken from the words of the 
participants themselves and are often more eye-catching terms. In this way, I 
was using the language of participants which captured what was happening, 
making the data more real. I have used a number of these in vivo codes in 
later chapters when laying out the theory. 
 
4.3 Axial coding  
 
In Chapter 3, I described axial coding using specific methods defined by 
Strauss and Corbin, “as tools to help get a better understanding of the data” 
(1998:85).  
These included, asking questions of the data, using the Paradigm Model as 
outlined in Section 3.5.2.1.2, developing categories in terms of their 
properties and dimensions and coding for process. These methods provide a 
framework to operate within which helps to reduce researcher bias in the 
analysis. I will now describe how I used each of these. It should be noted that 
the outputs of these methods were not used as data but the approaches 
were tools. 
 
4.3.1 Asking questions of the data 
 
Asking questions such as, who, when, where, why, how and with what 
consequences helped me to understand what was happening and to 
examine the data more fully.  Strauss and Corbin stated that by answering 
these questions, “analysts are able to relate structure with process…which 




(1998:127). I have included an example of asking these questions of the 



















Health care professionals at 
different grades. 





All the time. 
Formally in outpatients/ward 
rounds. 
Informally- knowing there are 
others in the background, 
“having your back.” 
When asking for advice. 
When reviewing patients.  
 
When making decisions. 
When moving things 
forward, for example, 
planning a discharge. 
When others need help. 
When there is someone 
with more appropriate 




On the ward, at the bed side, on 





Getting all jobs done. 
Using skills in the best way. 
Getting things right. 
Reducing risk. 















By being helpful. 
Passing on information – formally 
or informally. 
By answering queries. 





Putting pharmacists and 
technicians onto wards. 
Co—ordination roles, for 
example,   at discharge, 
TDM. 
Knowing how others can 
help. 
Knowing what everybody 
does. 
Being part of the team. 





Staff feel supported – “having 
your back.” 
Work gets done- the system 
keeps going. 
“Watching your back.” 
All the jobs get done – grunt 
work, mundane. 
More efficient working. 
Greater job satisfaction. 
 
Working closer to patients. 
Person with the right skills 
does the job. 
More holistic patient care. 
Reducing or increasing 
double-handling. 
Getting it right. 
Making the best use of 
time. 
 
I also used the tool of asking questions from the data when I wanted to dig 
deeper into what was happening with respect to the prescribing roles of 
doctors, nurses and pharmacists. I had asked Karen (Pharmacist 2), a 




team. She said that she had a more holistic approach. I tested this out with 
the next participant, Patricia (Nurse 1), who was a prescribing nurse and 
wrote the memo in Table 9. 
Table 9: Memo 2.1.17 Prescribing pharmacists and nurses 
 
There is a thread in the early interviews of pharmacists and nurses being 
aware of the pitfalls of prescribing and the consequences of getting it 
wrong - the things that can increase risk, for example, busyness, 
interruptions and then seeing the need to build in self-checks to ensure 
they prescribe accurately. There was a comment about medical staff not 
valuing the prescribing role in the context of the many other important 
things that they do. Is there something here about experienced (nurse 
and pharmacist) practitioners taking on a new, cherished prescribing role 
and knowing how badly it can go wrong? Being trusted with this and 
knowing that it’s important to get it right? Check where does prescribing 
sit among or within the roles of the doctor? 
 
 
My next two interviews were with Jayne (Doctor 2) and Sally (Doctor 3), 
experienced doctors. I asked them about their prescribing roles. I made this 
note immediately after my interview with Jayne: 
Table 10: Memo 29.6.17 Initial thoughts immediately post-interview with Jayne 
(Doctor 2) 
 
Jayne talked a bit about increased compassion, being able to speak more easily 
to patients and getting very positive feedback from senior consultants and the 
passion she has for her job. How it made her a better doctor. We were talking 
about growing in experience and about getting constant feedback that allows you 
to practice optimally. This was a very thoughtful individual and I felt a great 
empathy towards her. As I walked back after the interview I felt conflicted and 
challenged as this was not the doctor’s approach that was being described by 
the earlier interviewees and it made me reflect on how easy it is to lose a level of 
impartiality during the interview process. I wonder how I can capture that and 





The interviews with Jayne and Sally helped open up the analysis and 
contributed to some new concepts and categories including those listed in 
Table 11.  
Table 11: New concepts and categories following interviews with Jayne and Sally 
(Doctor 2 and Doctor 3) 
 
 Making decisions in isolation – needing information. 
 Prescribing can be mundane. 
 Working automatically. 
 Doing routine work. 
 “Part of the daily grind.” 
 Lack of full evidence base. 
 Individualising drug therapy. 
 Reviewing patients and medicines. 
 Managing patients on a “day-to-day” basis. 
 Making life or death decisions. 
 On the job training- role models. 
 Checking with the patient. 
 Carrying out audit. 
 Changing hierarchical structures. 
 Making prescribing errors. 
 Getting the best out of medicines for patients. 
 
 
The detail of the questions that I ask of the data from Jayne and Sally’s 
interviews is in Appendix 15.  
 
4.3.2 Using the Paradigm Model 
 
I applied the Paradigm Model to the categories which had emerged. This 
allowed me to further analyse, order and integrate the data into emerging 




particular helped me to structure the analysis and added rigor. I have 
included an example of the Paradigm Model applied to the category 
managing risk in Table 12. This later became the core category. 
Table 12: Use of the Paradigm Model as applied to the category managing risk 
 
Conditions  
 Importance of patient safety. 
 Increasing numbers of and 
complexity of patients. 
 Increasing numbers of, 
complexity and choice of 
medicines. 





 Not enough time/capacity. 
 Lack of full evidence base. 
 Lack of information to make 
decisions. 
 Training environment – staff have 
different levels of experience. 
 
 
Managing Risk – Properties 
 Managing risk. 
 Professional responsibilities. 
 Individualising drug therapy. 
 Reviewing patients and 
medicines.  




 Prioritising work. 
 No time to check.  
 Focusing on critical medicines. 
 “What we are all about.” 
 “Medicines safety is our thing.” 
 
Strategies 
 Communicating.  
 Getting an accurate medication 
list.  
 Checking prescriptions. 
 Using rules of thumb. 
 
 
 Checking with the patient. 
 Knowing what everybody does. 
 Developing new roles. 
 Knowing the evidence base. 




 Learning the tricks of the trade. 
 Valuing multi-professional 
working. 
 Using checks and balances. 
 Prioritising the important things. 
 Adopting a structured approach. 
 Structuring the day around 
medicines rounds and ward 
rounds. 
 Managing workflow. 
 Managing patients on “a day to 
day basis.” 
 Having medicines available on 
the ward. 
 On the job training – role 
models. 
 Using specific medicines 
(doctors). 
the patient in decisions. 
 Monitoring patients. 
 Encouraging reflective practice. 
 Highlighting errors. 
 Monitoring practice. 
 Auditing. 
 Confirming the list. 
 Reducing medical prescribing errors. 
 Learning from experience, 
experienced decision making. 
 Decision making at the right time, for 
example, multidisciplinary team, 
patient, notes available. 
 
Consequences  
 Getting the best out of 
medicines for patients. 
 Providing safer patient care. 
 Making the best use of time. 
 Targeting high risk patients first. 
 Moving towards medicines 
optimisation. 
 Having the right people doing 
the right jobs. 
 
 
 Reducing errors or making errors. 
 Improving staff morale and job 
satisfaction. 
 Improve patient outcomes. 
 Reducing stress, morbidity and 
mortality. 
 Allowing us to manage the 




One of the challenges for me was determining whether categories were 
conditions, strategies or consequences. I was applying the Model and it 




process, but sometimes these secondary decisions felt unnatural. I was 
relieved when I went back to the text (Strauss and Corbin 1998) and saw that 
I should be coding to help me gain an understanding of what was happening 
and not specifically for conditions and consequences. The authors used the 
following analogy: 
Analysts who rigidify the analytic process are like artists who try 
too hard. Although their creations might be technically correct, 
they fail to capture the essence of the objects represented, 
leaving viewers slightly cheated. Our advice is to let it happen. 
The rigor and vigor will follow (1998:129). 
 
4.3.3 Developing categories in terms of their properties and 
dimensions 
 
I used this approach which allows the researcher to see further linkages and 
patterns in the data to integrate into theory. An example of its application to 






















Working with the complex 
and the routine 
 
Detail 
High                                                       Low 
Complex                                           Simple 
Interesting                                     Mundane 
Unusual                                        Routine 
 
  
Volume of work 
High                                                       Low 
Heavy                                                   Light 




Challenged                                     Relaxed 
Stressed                                         Relaxed 
Overwhelmed                            Well-paced 




Sufficient                                     Insufficient 
Long                                                    Short 
Under pressure                               Relaxed 
 
 
This table shows the properties and dimensions of this category which came 
from the data. The list of properties increased as further interviews were 
carried out and some properties had more than one set of dimensions. This 
allowed me to compare different references in each interview transcript to 
working with the complex and the routine, group them together to help 




This category, working with the complex and the routine, subsequently 
became the causal condition in the theory. It emerged from the earlier 
categories listed in Table 14. 
Table 14: Categories which integrated into the condition working with the complex 
and the routine 
 
• Working in a complex world. 
• Doing routine work. 
• Working under pressure. 
• Needing information. 
• Making prescribing errors. 
• Changing systems (no standardisation). 
• Medicines- a big thing. 
 
Tables 15 and 16 show the properties and dimensions of some of these 
earlier categories, working under pressure and needing information. These 
overlapped with the properties and dimensions of the higher level category 
working with the complex and the routine seen in Table 13. This approach 




















Working under pressure 
 
Volume of work 
High                                          Low 
Heavy                                        Light 
Constant                          Intermittent 
  
Type of work 
Timely                                   Delayed 
Thorough                          Incomplete 
Accurate                            Inaccurate 
Complete                          Incomplete 
Detailed                              High-level 
Complex                                Routine 
  
Having time 
Sufficient                           Insufficient 
Long                                          Short 
  
Feeling 
Challenged                            Relaxed 
Stressed                                Relaxed 
Overwhelmed                   Well-paced 

















Needing information  
 
Quantity 
Sufficient                               Insufficient 




Accurate                                Inaccurate 
Complete                             Incomplete 
Detailed                                High-level 
Up-to-date                            Out-of-date 
Structured                               Scattered 
Summarised                         Voluminous 




Timely                                      Delayed 
Easy                                         Difficult 
At hand                               Not available 
 
4.3.4 Coding for process 
 
Analysing data for process further helps to integrate the data and links 
categories, through connecting process with structure. Process can be 
routine or strategic and can change over time or remain the same. 
Participants described a number of processes including administering 
medicines, checking prescriptions and prescribing medicines. Questions 
asked of the data included, “what is going on here?” as well as, “does this 
change over time or within the dimensions of the sub-categories of the 
condition?” An example of this is the process of reviewing prescriptions 




interested in seeing what was going on here. The following diagram shows 
the sub-categories of the category reviewing prescriptions regularly.  
  
 
Figure 1: Sub-categories of the category reviewing prescriptions regularly – what is 
happening here? 
Looking at the properties and dimensions of this early category, it became 
clear that this was a process which doctors, nurses and pharmacists were 
part of and which changed within the context of the condition working with the 
complex and the routine. Later in the analysis, the category reviewing 
prescriptions regularly became an action strategy and then was further 
integrated into the action strategy using checks and balances.  
I also used coding for process to look at how and when medical staff 
prescribed medicines. Prescribing was described as a doctor’s main role with 
medicines, and from the data, the role very obviously changes with the level, 
experience and increasing knowledge of the doctor. Prescribing is part of the 
sub-category understanding roles and responsibilities which was integrated 
into the core category managing risk. Figure 2 shows the progressive nature 
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 Building confidence. 
 Increasing experience. 
 Increasing knowledge. 
 Increasing responsibility.    
 Increasing complexity. 
 Needing information. 
 
Figure 2: The progressive nature and process of the medical prescribing process 
This figure shows movement, sequence and change in the medical 
prescribing process as the sub-categories of the condition change, for 
example, increasing or decreasing complexity or needing more or less 
information.  This is outlined in further detail in Chapter 5.4.2, managing risk.   
 
4.4 Selective coding 
 
Strauss and Corbin defined selective coding as, “the process of integrating 
and refining the theory” (1998:161). In this section, I will describe how I did 
this, including descriptions and examples of the analytical methods which I 
used, for example, writing more in-depth theoretical memos, writing the 
storyline and drawing further diagrams, including a final integrative diagram 
in which links between the major concepts in the theory are illustrated. I will 
FY1 






• Knowing the 
basics. 











also describe how I used this approach to decide upon the core category and 
integrate and refine the theory. 
 
4.4.1 Using selective coding to decide upon the core category 
 
Strauss and Corbin (1998) outlined the importance of the core category as 
coming from the data and giving, in essence, a short description of what the 
research is all about. It takes time to arrive at this stage.  
 
In their later book, Corbin and Strauss (2008) wrote about the importance of 
taking time to think and, “allow sensitivity to grow and evolution of thought to 
take place” (2008:245). At this stage in my research, I took some time away 
from my job to carry out the selective coding process, to revisit the data, write 
memos, read and think. I familiarised myself again with the original codes, 
making sure that they were included in the analysis. I wrote further theoretical 
memos and continued to develop links between and integrate categories. I 
revisited some of the analytical methods which I had used previously, for 
example, using the Paradigm Model and I discussed my work with my 
research supervisors. From applying the criteria outlined in Table 4, and also 
from being immersed in the data, managing risk was emerging as the core 
category.  
 
However my instinct was that there was something more and so I continued 
to write theoretical memos, revisit my codes and categories and make diary 
entries as I went through the data again. Line-by-line codes were typed into 
an Excel spreadsheet to facilitate easier reading and to make sure that no 
codes had been missed. This process also helped me to revisit the raw data 
on a regular basis and contributed to ensuring that the audit process was 
clear, improving the rigor of the work. 
 
Strauss and Corbin (1998) outlined a number of analytic methods to help with 
integration and determining the core category. I used the following analytic 




as part of selective coding, when focusing on integrating the data and 
seeking clarity about what was happening: 
 
 Writing the story line - what is happening here? 
 Using diagrams. 
 Reviewing and adding to memos. 
 
4.4.1.1 Writing the story line - what is happening here? 
 
I used writing the story line from early in the research to summarise what was 
happening initially and to clarify my thinking. I also used it (from early stages) 
to make sure that I was using the data and not my personal bias and 
thoughts when analysing the data. However I found writing the storyline most 
helpful in the latter stages of integrating the data, when I needed to get a 
grasp of the data when I felt overwhelmed by it. An example of a later 
storyline from 3 April 2018 is in Appendix 16.    
4.4.1.2 Using diagrams  
 
Different types of diagrams for example integrative or process diagrams help 
the researcher to think more abstractly about the data. I used both types of 
diagrams at all stages of data coding and analysis, especially when looking 
at how processes linked with structure, the relationships between categories 
and integrating categories. I have included examples of two of these 
diagrams below.  
Figure 3 shows systems and processes of what happened with medicines at 
each stage of the patient’s journey.  
All of the processes are surrounded by: 
 Informed decision making. 
 Training and learning on the job. 
 Medicines optimisation diagram- is the patient at the centre? 
 Different professional roles. 







Figure 3:  A flow chart showing the systems and processes of what happens with 




Figure 4: The systems and processes of administering medicines (sub-categories of 
this early category).  
Front Door 
• Patient is assessed by an experienced doctor. 
• Doctor clarifies medicines. 
• Doctor holds or stops medicines. 
• Doctor prescribes new medicines for current condition. 
Ward 
• Ward rounds - decisions. 
• FY1 writes or updates the Kardex- FY1 is not on the ward round. 
• FY1 gets queries about medicines - FY1 is easily accessed. 
• Daily patient review - middle grade doctor- includes medicines. 
• input from other healthcare professionals. 
• Nurse knows how patients are - swallow, bleeding, pain - advises on decision-making. 
• Pharmacist input- advise on decision-making, sign-posts doctors, informs nurses. 
• Doctors and pharmacists liaise with specialists for example microbiologists, diabetic nurse 
specialists who can prescribe themselves. 
• Physio- drugs for one outcome 
Discharge 
• Planning for discharge - why just for this? 
• Doctors and nurses liaise with the pharmacist. 
• Focus on blister packs and appropriate medicines. 
• Phamacist checks the discharge prescription. 
• Pharmacist writes the discharge prescription sometimes. 











Getting it Right 


















4.4.1.3 Reviewing and adding to memos 
 
I reviewed and added additional thoughts and comments to memos. This 
helped me to tease out more ideas, carry out further integration and ensure 
there was a logical flow in the developing theory.  
 
4.4.2 Analysis by professional group 
I was interested in developing a theory to explain how different healthcare 
professionals worked to use medicines effectively in acute hospitals (Section 
1.1). A very early code was, having roles and responsibilities, and this, along 
with the research question, prompted me to ask a specific question about 
what the participant’s and others’ roles and responsibilities were with respect 
to medicines. As I interviewed participants and coded the data, it became 
apparent that certain codes related solely to one profession whereas others 
related either to 2-3 professions or were systems-related. I wanted to make 
sure that I captured this detail to ensure validity of the analysis and provide 
an audit trail. Through axial and selective coding, I linked and integrated 
codes derived from all participants. Some of these higher level categories 
remained profession-specific. In light of the research question, I noted any 
codes or categories that provided more in-depth information on the role of 
each professional group with medicines. This came from all participants as 
opposed to one professional sub-set of the sample. There were differing 
views of, for example, a nurse or pharmacist with respect to the role of a 
doctor with medicines and, in comparison, a doctor’s view of their own role 
(see Tables 9 and 10). I tested out these roles in my questions to new 
participants from any profession to build a rich picture of what was happening 
here. There were also roles and responsibilities that almost all participants 
agreed were mainly profession-specific. This led me to group together some 
of the codes and concepts that related to the work of each professional 




I built upon this in describing the core category, managing risk (Section 5.4). 
The aim of the research was to identify how doctors, nurses and pharmacists 
worked to optimise medicines and therefore I laid out the data on each 
professional group’s role in managing risk associated with medicines, using 
participants’ quotations. I then compared and contrasted these in the text.  
It should be noted that this data came from an analysis of the data from each 
individual participant in the study using grounded theory methodology and 
not from individual professional (sub-group) analysis. The data on each 
professional may have been richer and more robust if I had analysed it by 
individual professional group, although I would have needed to increase the 
numbers of participants to achieve saturation in each group.      
 
4.4.3 Turning to the literature for a unifying concept  
 
I still had an open mind with respect to the core category, although managing 
risk seemed to meet Strauss’s criteria listed in Table 4. I was reading the 
literature to develop my knowledge of the methodology further and I came 
across the term, “adapting to a changing world” with respect to staff working 
with dying patients in a number of palliative care wards in America (Glaser 
and Strauss 2015 reprint). This immediately resonated with the data for me. 
Strauss and Corbin described researchers, “turning to the literature to look 
for a unifying concept which might fit their data” (1998:155). They went on to 
say that they did not do this as it may only provide a term which is a partial fit 
to the data and also may impair the researcher’s creativity and development 
of the knowledge of the subject area. I had not turned to the literature to seek 
a unifying concept but at this point, “adapting to a changing world” seemed to 
be just that.  I thought that this phrase gave a better description of what was 
happening than managing risk. However I did not like the way that I had 
come across the term and felt that I was forcing the data. This feeling was 
supported by Strauss and Corbin’s reluctance to use the approach and also 




There were categories which, on being revisited, could fall under this 
heading. I began to look at the codes (line-by-line and in vivo) to see if I had 
missed this and asked what is leading up to, “adapting to a changing world?” 
I analysed this potential category in terms of properties and dimensions 
derived from the data and attempted to incorporate it into a Paradigm Model. 
I discussed it with my supervisors. I let it sit and continued to analyse and 
integrate the data. In the end, “adapting to a changing world” was not a key 
category or a term which I used in the final integrative diagram for all of the 
reasons outlined above.   
I continued to work on developing the storyline, looking at memos and 
constantly comparing the data from different interviews. One of the questions 
I was asking of the data was, “why do healthcare professionals speak so 
much about checking what they do?” Participants had referred to the initial 
prescription being incorrect or not having confidence in the accuracy of the 
prescription. I asked, “what is happening here? What reasons did the 
participants give for a prescription not being right?” The answers from the 
data to these questions are in Table 17. 
Table 17: What reasons did the participants give for a prescription not being right? 
 
 Lack of knowledge about the medicine. 
 Inexperience. 
 Lack of good information about the patient. 
 Lack of good information about the medicines they are on. 
 Insufficient information to make a decision. 
 Lack of care – just made a mistake. 
 Not knowing the system. 
 The wrong person writing the prescription.  
 
In reading through the transcripts and initial open codes of the doctors’ 
interviews, I saw that each doctor spoke clearly about focusing on getting 




spoke about feeling vulnerable when prescribing due to a lack of knowledge 
and how they managed this (their balances). By re-naming, managing risk 
as, using checks and balances, the core category seemed more whole. 
As I was writing the chapters on the conditions and the core category, using 
checks and balances, I had problems in describing the core category as the 
data I was using was already integrated into the action strategies. Using 
checks and balances began to feel more like an action strategy than the core 
category. Also, it did not meet the criteria for choosing a central category as 
described by Strauss (Table 4). I went back to looking at managing risk as 
the core category. 
 
I presented my findings to the University of Bradford’s Medicines 
Optimisation Research Group (MORG) at this time. This group is made up of 
academic staff from a range of disciplines and PhD students. We discussed a 
number of key points including the core category. I laid out the data and 
background to managing risk and using checks and balances. The group had 
confidence in my analysis that managing risk was the core category, which 
was positively supported by data presentation.  
 
4.5  The core category  
 
Managing risk is the core category. All other categories relate to it and it was 
mentioned by all participants. It is described by participants as being inherent 
in what doctors, nurses and pharmacists do when they work with medicines. 
Each healthcare professional has their own checks and balances, based very 
often on their perception of risk and their experience with medicines and 
patients. The overall system in which medicines are used has a raft of formal 
and informal, in-built risk management strategies through interdependent 
working as well as guidelines, procedures and professional standards. I will 
describe these, with reference to the data, in subsequent chapters.   
Managing risk as the core category fits Strauss’s (1987 in Strauss and Corbin 




pharmacists involved in the use of medicines in acute hospitals in Northern 
Ireland. The data shows that involving patients, families and carers is part of 
this process which is central to medicines optimisation.  
 
4.6 The final integration 
 
Having decided upon the core category, I revisited the other categories, still 
using selective coding, to continue to build the theory with respect to 
conditions, strategies and consequences, ensuring that it flowed. 
 
I described the development of the causal condition working with the complex 
and the routine earlier in this chapter. The strategies which emerged from the 
data were using checks and balances, making the best use of resources and 
working together, with integration of the latter two strategies into the single 
strategy, working together. These are described with examples of supporting 
data in the following two chapters.   I found it difficult to determine the 
consequences of the theory. I have included a memo which shows my 
thinking on determining the consequence(s) in Appendix 17. This became 
ensuring each patient gets the right medicines.  
The following integrative diagram gives an overview of the theory as it relates 





























Ensuring each patient gets the right medicines 
 
 
Figure 5:  An integrative diagram giving an overview of the core category – 




4.7        Summary 
 
In Chapter 4, I have given detail of how I analysed the data in a step-wise 
fashion, using the tools outlined by Strauss and Corbin (1998) and ensuring 
transparency of process. A theory emerged, grounded in the data. This is 
shown in an integrative diagram in Figure 5, which gives an overview of the 




















In Chapter 4, I described how the grounded theory was derived from the 
participants and data analysis. At the end of that chapter, I illustrated the 
grounded theory in an integrative diagram (Figure 5) which showed its 
structure and the inter-relationships between the categories (Strauss and 
Corbin 1990 in Creswell 2013). 
Strauss and Corbin wrote about laying out the theory. They stated that in 
writing up findings from a grounded theory study, researchers should, “work 
out a main outline that will fully incorporate all important components of that 
story” (1998:251). In this chapter (Chapter 5), I will lay out the theory, initially 
providing a summary overview of the grounded theory.  I will go on to 
describe the causal condition, working with the complex and the routine 
which leads up to the phenomenon (core category), managing risk. I will also 
illustrate the core category, managing risk, as related to the roles and 
responsibilities of doctors, nurses and pharmacists in managing risk 
associated with using medicines in acute hospitals in Northern Ireland. 
In Chapter 6, I will outline the different strategies used when managing risk 
as defined by participants. These are using checks and balances and 
working together.  I will also describe the consequence of managing risk 
which is ensuring each patient gets the right medicines.   
 
5.2 A summary overview of the grounded theory 
 
The causal condition, working with the complex and the routine, emerged 
from the data. The complex related to the number and range of medicines 
used, having sick patients with multiple co-morbidities and the challenges 
and additional workload associated with this. It also described the 




routine was referred to mainly by medical staff who described the daily work 
with prescriptions as being mundane (“grunt work”) but important to get right. 
They spoke of constantly having to engage and focus when prescribing.   A 
lot of this work was seen by medical staff as being of lower risk and so it was 
carried out by less experienced doctors in training. Errors occurred in both 
complex and routine scenarios. Participants described working under 
pressure and needing accurate and timely information to make good 
decisions. Sometimes there were no specific guidelines available on using a 
medicine in a particular group of patients or the professional needed to ask 
questions before they were able to complete tasks, for example, prescribe, 
administer, clinically check or dispense a medicine. Participants spoke of 
striving to do a good job and ensuring patient safety. They spoke about 
learning about medicines on the job with many of the medical staff who 
prescribed medicines being in training posts. Participants suggested that the 
database outlining each patient’s medicines list (the electronic care record) 
was not always up-to-date and mistakes could be made in particular at the 
point when a patient was admitted to hospital. All of these issues which made 
up the causal condition led up to the core category, managing risk.   
All participants spoke of managing risk as they worked with medicines, both 
as individual practitioners and together with other members of the 
multidisciplinary team. Patient safety was named as being most important to 
all and each participant spoke of striving each day to do their best. However 
there was a range of things which did not support them in doing this including 
a lack of time, not being able to access the right information on medicines 
when needed, not having the experience to prescribe medicines and having 
to constantly ask questions to make sure a prescription was correct, or 
understand why a drug had been prescribed. Pharmacists and nurses spoke 
of how they had learnt not to take a prescription at face value.  
Participants developed different strategies for managing risk. There were 
both individual and system-related strategies and they were usually 
influenced by the professional group which the individual belonged to, their 
level of experience and knowledge, as well as a personal assessment of how 




working together. Nurses and pharmacists spoke of taking on new roles, for 
example, prescribing, having dedicated “medicines nurses” on the ward and 
filling in gaps in prescriptions to help the healthcare system to flow. The role 
of the ward-based clinical pharmacist was highlighted by everyone as being 
an important check in the system. The overall system seemed to be 
constantly adapting in managing risk. Individual professional groups modified 
the way they worked, with examples of focusing specifically on higher risk 
situations; giving critical medicines on time, carrying out therapeutic drug 
monitoring and reconciling medicines on admission and discharge. Decisions 
could be made with the best information available at the time and because 
everyone knew this may not be up-to-date or accurate, additional checks 
were built in at every stage around the use of medicines. Many staff 
described being supported by their colleagues in all professions. Medical 
staff relied on there being certain checks in the system to allow them to 
address their workload, for example, knowing that a pharmacist and nurse 
would both be checking what they had prescribed before it reached the 
patient. 
There were consequences or outcomes associated with the strategies which 
the participants used or which were built into the system. These were 
incorporated into one consequence, ensuring each patient gets the right 
medicines. However strategies were not always successful, patients did not 
always get the right medicines and the design of different parts of the system 
did not always support participants in making the best use of resources when 
using medicines.  This sometimes resulted in medication errors, with 
professionals feeling that they were not doing as good a job as they would 
like to and feeling tired and stressed. Each person spoke of making decisions 
about medicines in the context of each individual patient, with the beginnings 
of a change in approach to involving patients and carers in the decision-
making process. This was part of a change in power structures, away from 
the traditional medical hierarchical model towards truer multi-professional 




In developing the theory I have made some analogies; one with an orchestra 
which is playing a symphony and the other a visual comparison of the 
medicines management system looking like the RISE sculpture (the largest 
piece of artwork in Belfast). These are presented in Tables 18 and 19. 
Table 18: Analogy of an orchestra 
 
Using a musical analogy, the theory compares to an orchestra playing a symphony 
in harmony. To do this well, each musician has to listen to each other, take their cue 
from each other and the conductor. The symphony can be interpreted differently by 
different conductors even within the composer’s marked directions. Musicians need 
to be able to read the music, know how to play the instrument and to read and 
adjust their playing in line with changes in dynamics and speed. Some of the 
musicians, for example, the first violins, usually only play the melody. Some have to 
fill in and complete the harmony, for example, the violas could have a nervousness 
of playing the occasional tune. In optimising medicines, there may not be one 
conductor and perhaps that is what is needed to help in managing risk or reduce the 
risk in the system.  
 
 
Table 19: RISE sculpture (Belfast) 
 
Visually I see the system of optimising medicines as a huge ball with the different 
individuals involved and strands of strategies linking together around the outside to 
maintain an intact surface. Together all of these strands form a complete ball 
(similar to the RISE sculpture in Belfast) but each is fragile as are the links and the 
overall structure could collapse. The questions for me are, “do we want to make this 
ball a more stable structure?” and, “what do all healthcare professionals need to do 










In Chapter 4, I described how I analysed the data using the Strauss and 
Corbin (1998) approach to grounded theory. I outlined the phenomenon in an 
integrative diagram (Figure 5), showing the relationships between the core 
category managing risk, its causal condition, the strategic and routine actions 
and interactions (strategies) which arise under that condition and the 
outcomes or consequences of these. 
Strauss and Corbin described the causal condition as, “forming the structure 
or set of circumstances in which phenomena are embedded” (1998:128). The 
core category, or phenomenon, is managing risk. Healthcare professionals 
described managing risk within the context of working with the complex and 
the routine (causal condition). In this section, I will now present the causal 
condition, working with the complex and the routine using supporting data 
(participant quotations). 
 
5.3.2 Working with the complex and the routine (causal condition)  
 
The condition, working with the complex and the routine, is made up of four 
elements. Some of these had also been listed as separate conditions at an 
earlier stage of the analysis but through integration, it became clear that they 
all make up parts of this one overarching condition. 
These elements are: 
 Working in a complex system. 
 Doing routine work (with medicines). 
 Working under pressure. 




Participants described working in a complex system due to the range of 
medicines available for use, their side-effects and the potential for multiple 
drug interactions, the multiple co-morbidities of patients in acute hospitals as 
well as the busyness of the overall healthcare system. Pharmacists and 
doctors are using an increasing number of medicines, many of which had 
serious side effects and interactions with other medicines. Rebecca 
(Pharmacist 1) spoke of the changes which she has seen in the increased 
availability of new drugs since qualifying in 2012: 
None of the NOACs were out [in 2012]. So you had no 
apixaban, edoxaban or dabigatran - you were just going down 
the warfarin line, aspirin, enoxaparin. So there is a lot more 
availability of medicines to prescribe but with that comes, I 
would say, a lot more uncertainty. Doctors aren’t just as sure 
because how do you choose between apixaban and 
rivaroxaban...an awful lot more uncertainty with the side-effects. 
So you are getting more enquiries about can this drug cause 
this, is this patient suffering from this? (P1p7).  
Sally (Doctor 3) spoke about the need to understand how to use new drugs:    
Particularly with the introduction I think with the NOACs. Lots of 
problems! New drugs, new concepts (D3p3). 
Jayne (Doctor 2) commented: 
There are so many drugs out there and so many doses and so 
many caveats too. If this person has liver impairment or renal 
failure or they are pregnant, then you can’t give it or you need 
to adjust the dose (D2p4). 
Later Jayne spoke of her concerns about polypharmacy: 
If you are on lots and lots of medications, then there is no way 
of really knowing - if you are on a drug and you develop a 




have a drug that can help with that symptom as well.” So it just 
keeps adding up and up (D2p7).  
Doctors and pharmacists described using more medicines to prevent as well 
as treat disease and the importance of rationalising these. An example of this 
is stopping a preventative drug such as a statin when a patient is reaching 
the end of life, to help to reduce the unnecessary complexity of 
polypharmacy.  
Most doctors and pharmacists spoke about the increasing age and the level 
of acuity of the illness of patients in acute hospital beds. Sally (Doctor 3) said 
that patient complexity and age were key influences on her prescribing 
decisions: 
I think patient complexity. For me, age is a big thing and when I 
am reviewing drugs, for example, I think risk versus benefit 
(D3p2). 
Rebecca (Pharmacist 1) spoke of her work as being patient-driven and 
having variation due to the fast throughput of patients. She talked about the 
quick turnover of guidelines and at times, feeling overwhelmed by work. 
Jackie (Nurse 3) described how having a lot of patients, some on critical 
medicines, meant that the frequency and duration of medicines 
administration rounds had increased. She described what she did on 
medicines administration rounds: 
They [patients] are on a lot of different medicines but they are 
all very different and then at lunchtime we will be doing orals 
and iv medications because we have  a lot of people on 
antibiotics and iv furosemide and a lot of different tablets and 
injections as well (N3p3). 
Caroline (Pharmacist 5) described the complexity of using antibiotics with a 
narrow therapeutic index. She spoke of the advice she would give to doctors 





It is trying to get an idea into the doctors’ heads that the 
concern is that we don’t want this level to be too high because 
we are worried about the patient’s kidneys or their ears or 
whatever it may be (P5p14).  
Karen (Pharmacist 2) described the following changes: 
There is more medication available, we are keeping sick 
patients alive longer, so there are people living with a lot more 
co-morbidities than maybe they would have before. So the ones 
[patients] that we are managing in hospital are probably people 
who wouldn’t have survived in the past. The straightforward 
patients don’t come into hospital any more (P2p16).  
She also spoke about the complex process of administering medicines in 
hospital: 
So you know how complicated it is now and even in terms of 
administration, lots of different [intravenous administration] lines 
that our patients have in and some of the antibiotics can’t go 
through mid-line, some of them can. So even for nurses, 
knowing what they need to ask can be complicated (P2p14). 
Doctors, nurses and pharmacists described having a number of patients who 
used compliance aids and who needed help in taking their medicines. This 
added to the complexity of organising their discharge. 
All healthcare professionals interviewed made reference to correcting and 
learning from medication errors. Deirdre (Pharmacist 4) asked whether 
increasing complexity has increased the level of risk in the system:   
..getting the pharmacists, doctors and nurses to do reflective 
reports on why things went wrong and how they can change 
their practice to ensure it doesn’t happen again. That is so 
valuable and you start to wonder were things always going 




the complexity of things that have increased the number of 
times things go wrong (P4p7). 
The data showed that a lot of time and focus was given to doing routine work 
with medicines, for example, writing Kardexes and discharge letters.  All 
participants made some reference to having to do routine work with 
medicines which filled the gaps in prescriptions and helped the system to 
flow; however, doing routine work was specifically spoken of by doctors. 
Some of this work, from the medical perspective, was looked upon as being 
of relatively low risk and was assigned to Foundation Year 1 (FY1) doctors. 
Such work was also described as being mundane. Sally (Doctor 3) 
commented: 
Linking-in medication appropriateness and blister packs and all 
that - medication is a big part of the daily grind (D3p2).  
Later, she commented: 
[Prescribing] can easily become a mind- numbing process 
where you engage no thought. That is bad practice and I am, 
on the ward rounds, I am telling the juniors, “always check the 
Kardex” (D3p7).   
Jack (Doctor 7) described his role as doing what the Foundation Year 2 
doctors (FY2s) do not have time to do because they are doing the medical 
planning. His role involved: 
Sort of you carve out the administration stuff with the grunt 
work, prescribing medical care, fluids, bloods etcetera, that say 
haven’t been gotten round to by the SHOs [FY2s] or the 
phlebotomists. It is sort of the loose ends when we come along 
and tie them up (D7p4).  
He was unclear about his prescribing role: 
In terms of actually a prescribing role, it is very unclear. I never 




more just I tend to say yes because it is a learning experience, 
everything is, so yes is usually a better answer, I find (D7p3). 
He continued to describe the types of drugs which he was confident to 
prescribe for example, most routine antibiotics, and of having a threshold of 
where he called for help which was subjective and depended on how sick the 
patient was.   
When asked if there were specific roles for different grades of doctors, Sally 
(Doctor 3) commented that she usually writes the initial Kardex at the point 
when the patient is admitted to the Emergency Department, however FY1s 
wrote Kardexes on the ward: 
On the wards, generally the F1s would be writing the Kardexes. 
That task is often left to them. I think other times the nursing 
staff, if they have a query with the medications, they will go to 
the F1 first, even though the F1 will not have been on the ward 
round (D3p2). 
In the midst of the busyness, doctors in particular described, “needing to 
engage the brain”. This was an in vivo code used by Jayne (Doctor 2) when 
she described the importance of focusing on prescribing medicines:  
At a basic level, we are responsible for prescribing medicines, 
so we have to be extremely careful with what you are writing 
down. It can be very monotonous. It is just something you do 
without thinking, for example, prescribe paracetamol, but with 
more experience as a doctor, I found that you really need to 
engage your brain when you are thinking about medicines 
(D2p1). 
She described how challenging prescribing was and used the analogy of 
being a good driver: 
I would say it is like being a good driver. You can go on 
autopilot and just not engage your brain and that’s how 




in in front of you or you are looking to change lane and 
someone has just flown up beside you. If you are fully engaged 
with what you are doing, every time you drive then you are 
going to be much safer (D2p9). 
So the mundanity, routine nature and lack of stimulation involved in working 
with medicines also seemed to contribute to the need for doctors, nurses and 
pharmacists to have to focus on managing risk, as identified as the core 
category. Doctors, in particular, strongly highlighted the potential for making 
errors if they did not focus on what they were doing.  
With increasing complexity and volume of work, each professional group 
made reference to carrying out a number of important tasks to keep the 
system moving forward and constantly having to prioritise. They described 
working under pressure as a result of not having enough time to carry out 
tasks, not having enough staff and the increasing throughput of sick patients 
who needed care.  
Shirley (Nurse 2) described the increasing pressures on nursing practice: 
Between being busier, short staffed, more patients, trying to get 
all the tablets at the set times and also interruptions. You are 
not meant to be interrupted when doing the medicines but it still 
happens (N2p8). 
Jack (Doctor 7) was asked if his practice changes when he is busy. He 
described living in the real world: 
It is not as we were trained in that you are one guy or girl with 
one patient and you have to take a full examination etcetera. 
That is a very distant memory it seems now. That aspect of it 
changes dramatically under pressure and everyone is rushed 
and shortcuts are taken inevitably. You take shortcuts when you 
can and when it is safe to do so (D7p5). 





Your training is so far removed from what it is like today to deal 
with a real sick person, especially as they become more and 
more complicated (D1p12). 
Doctors described not being very well trained on how to prescribe. The 
doctors who did most of the prescribing were doctors in training posts. Mary 
(Doctor 5) commented: 
You go off in medicine and you have never prescribed a 
medication at all but yet you’ve got a Kardex in front of you and 
you have to prescribe and put your name to something 
(D5p21). 
She described being concerned about having little time to go home and learn 
more about some of the things she had come across during the day due to 
busy shift patterns. Her usual practice was to make lists of things to look up 
at home:  
I have only had one day off since starting here a few weeks 
ago, so that is something I want to read up on as I don’t like it 
and it makes me feel very uncomfortable to prescribe 
something I have no knowledge on (D5p24). 
Jayne (Doctor 2) described working with medicines as being a, “big thing,” 
which involved making life and death decisions. With this, along with the 
increasing complexity and volume of work, comes a need for doctors, nurses 
and pharmacists to access sufficient, accurate information easily to support 
them in making good decisions.  Such decisions included prescribing the 
right medicine for a patient (all three professions), deciding that a medicine 
was safe to administer (predominantly nurses) and deciding whether to query 
the accuracy or appropriateness of a prescription (predominantly pharmacists 
as well as nurses).  
All participants spoke about times when they did not have accurate 
information. Jack (Doctor 7) mentioned accessing potentially inaccurate 




Actually very often now the drug history, because we rely on 
ECR so much from that which is a poor data setting and a poor 
list of medications anyway, we don’t really do drug histories any 
more…but the thing is, the ECR GP meds form is not strong 
enough to replace it (D7p8).  
Nurses and pharmacists also spoke about using ECR routinely and 
described its benefits and pitfalls. Shirley (Nurse 2) said: 
So they [doctors] usually get most of their information off ECR 
and this unfortunately can be quite rushed. So there would be 
mistakes, normally in the first day there could quite often be 
mistakes. ECR maybe hasn’t been updated, so if the patient 
tells us that they don’t take that anymore then we would always 
hold back and check it out with the pharmacist (N2p8). 
So introducing technological solutions contributes to changes in basic 
practice, such as taking a medication history, and new ways of working. 
Being aware of the strengths, with knowledge of the weaknesses, in any new 
system is important in ensuring any risk associated with change can be 
managed.  
Sally (Doctor 3) spoke about having to make a decision at a point in time and 
the importance of being able to access the right information easily, for 
example, prescribing an unfamiliar drug when on a ward round and not being 
able to access the British National Formulary (BNF). The consequences of 
this were that the drug would be prescribed with the intention of coming back 
later to check it. It was acknowledged that this could cause problems for 
someone else down the line if the doctor did not get back to see the patient 
and check that the prescription was accurate, due to workload. She said:  
I think mistakes with unfamiliar drugs are very easy to make, very 
easy to make. It is fantastic having the online BNF. I do miss 
having a BNF at the bedside / on the trolley; when your phone 
cannot get a signal. People think, I will just prescribe this now but I 




see. It would generate a lot of work for somebody else and would 
stop someone from going home that day. So I do miss the paper 
BNF (D3p4). 
In comparison, Caroline (Pharmacist 5) spoke about doctors sometimes 
taking the opposite approach and not prescribing the drugs which they were 
uncertain about when a patient was admitted. This could mean that 
medicines were missed and also required follow-up, usually by a pharmacist. 
Junior doctors (FY1s) also spoke about being expected to carry out lots of 
different roles, including prescribing or re-writing medicines when they did not 
have a lot of information about the patient and/or the medicine. Jack (Doctor 
7) was interviewed in the middle of a busy shift, having worked all weekend. 
He described living in the real world: 
…once you’ve seen the patient and making management plans, 
you do everything within your power…I don’t think anyone 
should be prescribing things without having a really good grip 
on the patient, especially not having seen them. Doing that is a 
great mistake I think and so I don’t do that [prescribe] without 
having seen them …but time pressures make it very difficult 
(D7p5). 
He continued to describe the pressure of the prescription not being written 
until he saw the patient:  
If you say you are going to come and see them and the nurse is 
a bit standoffish, then the person that suffers at the end of all 
that, apart from the nurse getting frustrated and then you 
getting frustrated, is the patient sitting there with the 
temperature (D7p5). 
When asked how he would design a better system to manage medicines in 
hospital, Jack (Doctor 7) said he would like an electronic Kardex which the 





I think a lot of the issues that there are with medicines are 
people who are unsure when they come in what medications 
they are on, whether they are taking their medications or not 
and then when you come to discharge, you are discharging 
them based on what you think they were on beforehand and if 
you get it wrong at the start, it is very difficult going back 
(D7p17). 
He described this as being a particular concern with warfarin in older people 
who had had unplanned admissions.  
Mary (Doctor 5) had a role in re-writing Kardexes: 
Obviously when you are re-writing them we wouldn’t have the 
time to actually go to the patient and clarify things and make 
sure these are definitely right – so there is that safety aspect 
that is probably missed (D5 p5). 
Mary used a range of methods to support her decision-making, including 
looking to see if the pharmacist has signed for checking the prescription and 
prescribing with the comfort of knowing that someone else had written the 
original prescription. 
Mary described being expected to sign prescriptions for items which she was 
not fully knowledgeable about: 
They have a pile of them [prescriptions] and they say, “would 
you mind signing these?” and I’m like,” what is this on my first 
day?” and they say, “it is just a quick signature”….I was saying, 
“I don’t know, this isn’t something I am familiar with,” but yes 
they were persistent so I did fold (D5p25). 
When describing re-writing medicines which had previously been prescribed 
by another doctor she said: 
I have joked about writing cheques with it because they could 
have anything in front of me and I know I have to sign it so I 




Mainly pharmacists spoke about being unhappy to make decisions when they 
were not in possession of all the facts. Karen (Pharmacist 2) spoke about 
making fully-informed decisions, especially when prescribing: 
Sometimes I will make a decision. I don’t necessarily have to 
speak to a doctor but I think on the ward you are very much 
seen as part of the multidisciplinary team and the consultant is 
still the person with his name above the patient’s bed. So I 
wouldn’t want to put myself in the position of changing 
something maybe if I didn’t have all the information and him 
having to question that at a later stage (P2p3). 
Nurses spoke of holding off on administering a medicine if they were unsure 
if the prescription was correct. When asked what her most important learning 
was relating to medicines, Shirley (Nurse 2) said: 
Not to trust the Kardex. If there is a gut feeling that it is not right 
or you are not 100% sure, then always check it out (N2p6).  
She described seeking information initially from a pharmacist and then 
approaching the doctor.  
In describing her own prescribing practice, Angela (Pharmacist 3) said that 
her ideal world would be getting more information from patients to help make 
better, informed decisions: 
You have no time to actually properly chat with someone and see 
what they want to do or just sometimes making decisions and 
going with it because there is just no time to do it any other way 
(P3p17).  
Only the senior medical staff spoke about having to make prescribing 
decisions in situations where no evidence-base existed.  Sally (Doctor 3) said 
that this was a relatively common occurrence at her level of practice 
(Specialist Registrar) and described following her instincts:  
Like increasingly, one of my gripes is the fall in a patient on a 




right and centre.  Do they really need to be on it? There are no 
real guidelines for that. Different people do different things. 
There is no real evidence, like the blind leading the blind. The 
harm of stopping a NOAC is a massive stroke. The harm of not 
stopping a NOAC is a massive bleed but we need to have a feel 
for those kinds of figures. So we may just hope and pray and 
take our chances (D3p6). 
Some participants also described having too much information which took 
time to assess to help make decisions, with Deirdre (Pharmacist 4) 
commenting: 
The amount of work involved in getting the medication right on 
admission - medicines reconciliation takes a lot longer even 
though we have got emails and the ECR GP medication form to 
print out. The access to all that extra information means we 
have to go that bit further to make sure everything is right. So 
the amount of time that it takes a pharmacist to check the 
different sources and get the right medicine prescribed when 
they are in hospital, checking the Kardexes are right and 
communicating with the doctors when things aren’t right and 






5.3.3  Summary 
 
In this section, I have described the condition, working with the complex and 
the routine in terms of its four elements; working in a complex system, doing 
routine work [with medicines], working under pressure and needing 
information.  Participants spoke about treating patients in hospital who are 
sicker than those they had treated in the past. They also highlighted being 
able to use a greater range of medicines with potentially increased benefits 
but also potentially greater risks for patients. Alongside this is the volume of 
routine tasks involving medicines which need to be completed. Participants 
mentioned feeling overwhelmed at work and working under pressure, not 
having enough time or having to care for a patient with complex needs. They 
also described not always having access to the right information (either 
inaccurate or unavailable) to support their decision-making. All of these 
elements can increase the possibility of medication errors occurring. Doctors, 
nurses and pharmacists all spoke about having a professional responsibility 
to provide safe care for patients. In order to do this, healthcare professionals 
are managing risk in the system to keep patients and staff safe. In Section 
5.4, I will describe the core category, managing risk.  
 




In Section 5.3 I outlined the conditions which led up to the core category. 
Bluff (2005:156), states that, “the core category or storyline needs to be 
evident and demonstrate how it links all the data.” In this section, I will 
explain the core category, managing risk, with reference to the data. I also 
will outline the roles of doctors, nurses and pharmacists in using medicines 




5.4.2  Managing risk (core category) 
 
The category managing risk was an early in vivo code and it also was a code 
which I used when carrying out line-by-line coding. 
Participants were managing risk to ensure patients are treated well. They 
described managing both individual patient risk as well as risk in the whole 
system.  
Participants’ approaches to using medicines sat within the context of 
recognising and continually managing the risk in the medicines process each 
day. Frank (Doctor 6) described this as: 
Managing day-to-day risk with the inpatients that I am largely 
involved in - a Kardex gets reviewed every day, administration 
gets reviewed every day and missed drugs and so forth. The 
nurse would be very good at highlighting if somebody has not 
been able to take medication and our pharmacist checks each 
admission, will check that all the routine drugs have been 
prescribed, that the additional drugs have been prescribed or 
certainly double-check with either myself or one of the 
consultants why something has been omitted or changed 
(D6p11). 
In this quotation, Frank outlines a continuous and dynamic process of 
managing risk which involves all three professional groups carrying out 
specific tasks each day. In carrying out these roles, all participants are 
acknowledging the risk of being involved in a medication error which has the 
potential to harm patients.  It was inferred from the data that such errors 
usually did not reach the patient due to the system having built-in checks. 
The phenomenon is having all three professional groups, continually and 
actively, carrying out specific tasks each day to manage risk in the medicines 





When carrying out my analysis, I asked the question, “why do healthcare 
professionals manage risk when using medicines?” and I have listed some of 
the reasons which came from the data in Table 20. 
 
Table 20: Why do healthcare professionals manage risk when using medicines? 
 
Why do healthcare professionals 
manage risk when using medicines? 
 
Not having all the information. 
Because risk is everywhere. 
Medicines are a risky business. 
We have inexperienced staff. 
Different levels of risk. 
Prioritising high risks only. 
Not fully owing tasks. 
Knowing someone else has your back. 
Complexity and acuity. 
“Doing the grunt work.” 
Learning on the job. 
Dancing to the beat of a different drum. 
Knowing there are safety nets. 
Lots of players. 
Interdependencies. 
Needing to make the best use of time. 
Needing to provide safe patient care. 







Most of these phrases are integrated into and elaborated on more fully in this 
section as data.   
The need to manage risk came from working with the complex and the 
routine. There seemed to be uncertainty in the appropriate use of medicines. 
Jackie (Nurse 3) asked questions when she wasn’t sure about the accuracy 
of a prescription: 
It is my role to question something if I wasn’t sure about it, then 
I would have to go and ask somebody else before I would give 
it (N3p8). 
Doctors and pharmacists also spoke of asking questions and seeking clarity 
about prescriptions. When using medicines, there needs to be a high level of 
certainty to make sure that well-informed decisions are made. This is 
because the outcome of making an error with a medicine can be fatal. It is 
interesting to see how this fact impacts on how doctors, nurses and 
pharmacists work with medicines and what their roles are.   
There were a number of references to certain consultants managing risk by 
using particular medicines which they had more experience in using. 
Different healthcare professionals illustrated this, for example, Rebecca 
(Pharmacist 1) commented: 
There is a lot more for people to prescribe and in that then I can 
definitely see preferences with consultants, what they prefer to 
prescribe.  Like our cardiologists, one loves ticagrelor, the other 
hates it because of the bleeding risk, would only go for a 
loading dose of clopidogrel. So there is an awful lot more 
variety in prescribing and in that then there is an awful lot more 
uncertainty with the side effects (P1p7). 
This was reiterated by Jayne (Doctor 2), who said: 
 I have actually found that with the more senior doctors in the 
hospital as well, if you go to one, they would suggest one drug 




something different. For each of them, that’s their number one 
choice for it and they have their own reasons for choosing that 
(D2p6). 
This variation in prescribing between consultants also can introduce risk into 
the system which is minimised through the clinical team inherently knowing 
and managing each consultant’s preferences. 
Each healthcare professional interviewed described a range of systems and 
processes which governed the use of medicines in their day-to-day practice. I 
will outline these in more detail in the action strategies as they describe how 
individuals manage risk. The sheer number of processes and rules could be 
seen as signposting that using medicines is a risky process. (This was also 
commented on when I presented my initial findings to the University of 
Bradford Medicines Optimisation Research Group. I was asked if we are 
conditioned to fear medicines-related processes because of the volume of 
systems controls in place which possibly implies that they must be risky 
processes). 
On my way to interviewing Cathy (Nurse 4), I heard a retired senior 
healthcare manager speaking on BBC Radio Ulster about the outcomes of 
the Inquiry into Hyponatraemia-related Deaths in Northern Ireland which had 
just been published that day (Crawley and Compton 2018). John Compton 
commented that healthcare is all about managing risk. In this context, I asked 
Cathy if she agreed with the comment. She looked uncomfortable but her 
response was more positive than her body language. She agreed with the 
statement but developed the conversation to include protecting nurses as 
well as patients: 
We are always managing risk. I suppose yes, some of it is all 
about managing risk and I think everyone is so afraid and so it 
is always about making sure that we have protected ourselves 





A number of participants made reference to giving critical medicines on time. 
There seemed to have been a recent effort in each of the hospitals which I 
visited, to educate clinical staff on what critical medicines were and the 
importance of administering them on time. Jack (Doctor 7) mentioned that 
critical medicines may often be highlighted on prescriptions with a marker 
pen, for example, anti-epileptics, drugs to treat Parkinson’s disease. He said: 
I think that the nursing staff had a list of which patients had 
critical medications that needed to be administered on time 
(D7p13). 
This comment highlights two points; firstly that a risk-based approach was 
being taken to ensure the timely administration of medicines but secondly 
that there was a need for such an approach (possibly because the current 
system for administering medicines could not guarantee that critical 
medicines would be given on time). This links with the causal condition, 
working with the complex and the routine. 
I had asked each participant what each of their roles and responsibilities 
were as a doctor, nurse or pharmacist as well as the roles and 
responsibilities of the other two professional groups. Most comments 
included roles which mentioned medication safety and fell under the category 
managing risk. When working with the complex and the routine, it is 
important that each person understands their own role and the role of others. 
I have summarised the data in Table 21. The role(s) referred to by almost all 
participants is in bold type.  The responsibilities are listed in the order of how 










Table 21:  Participants’ views of the roles and responsibilities of doctors, nurses and 








Administering intravenous drugs 
which nurses can’t administer.  
Filling the gaps – junior doctors.   
Medication safety. 
Ensure the prescription is 
correct, has a start date, 
signed and accurate times.  
Patient care.  




Signing off requisitions.  
Prescribing. 
Ensure the patient gets all 
the medication they are 
prescribed.  
To administer the right 
medicine, the right dose, by 
the right route at the right 
time for critical medicines. 
Medication safety.  
Patients.  
Keeping themselves right.  




Getting medicines ordered from 
pharmacy [technicians]. 
Discharge focus. 
Highlighting problems to doctors. 
Answering queries. 
Reassuring nurses.  
Getting changes made. 
Tying up loose ends. 
Signposting doctors. 
Managing medicines risk. 





The aim of the research was to identify how doctors, nurses and pharmacists 
worked to optimise medicines. Managing risk has evolved from the data as 
the core category. Therefore in this section, I will lay out the data on each 
individual profession’s role in managing risk associated with medicines and 
then I will compare and contrast these.  
Prescribing was named by everyone as being the doctor’s main role with 
medicines. Sally (Doctor 3) described it as a dynamic process, in which there 
needed to be regular checks and focused decision- making. She talked about 
her professional responsibility in personal terms: 
The first responsibility is patient safety - I think that overrides 
everything, including your personal pride! (D3p6). 
Sally added: 
I think as the medic, the buck stops with you in terms of 
prescribing, what you are prescribing, why you are prescribing it 
and any guidance that you might give. For example, if I start 
somebody on a drug that has impaired renal function, then I 
have the responsibility to contact the GP and say, “please 
check this prescription after seven days.” So I think there is that 
particular responsibility forced on the clinician (D3p6).  
Joan (Doctor 1) spoke of her professional and personal responsibility to do 
the right thing for a patient overriding everything else:  
You are constantly trained to work very hard, to put your filters 
on and to get it right for the person, for the patient (D1p14). 
Jayne (Doctor 2) recounted how her approach to prescribing has changed 
with experience: 
When I first started as an F1, I think that was at the level of, “oh 
my goodness, am I allowed to prescribe paracetamol? I actually 
have to sign this?” You have palpitations, then you become 




experience I have come to recognise that is my responsibility 
again (D2p6). 
When asked about a doctor’s responsibility, Caroline (Pharmacist 5) said: 
I suppose doctors are responsible for prescribing and they are 
responsible for the overall care of that patient. The decisions 
they make, although we may prompt them to change things, 
they are still responsible for what they are prescribing. I think 
most of them are aware of that. They will challenge you if you 
have asked them something that they are maybe not sure about 
(P5p7). 
Jack (Doctor 7) commented on having to get to know what his role with 
medicines actually was: 
That was something that was the hardest bit about starting back 
in August, knowing where the parameters of our role and our 
remit are. That has become clearer now but there are still grey 
areas, particularly more in the out-of-hours setting (D7p3). 
I asked Deirdre (Pharmacist 4) how a new doctor would know what his role 
was with medicines. She replied: 
Surely is that not part of their training? Before they become F1 
doctors, they go through the training programme and the 
pharmacists are involved in that training programme. They do 
various Direct Observational Clinical Practices; and that is to 
help keep the doctors safe and explain to them their role 
regarding medicines (P4p15). 
Participants spoke about new doctors starting work on wards every few 
months, having to learn what medicines are used routinely. The pharmacists 
and nurses were identified as being the static professionals on the ward who 
supported and sign-posted new medical staff and who mainly choreographed 




accurate prescriptions and I will discuss this in Chapter 6 when outlining the 
strategies used for managing risk.    
All participants highlighted the nurse’s main medicines-related role as 
administering medicines. The nurses spoke about how they used this 
process in managing risk. One doctor’s (Jayne Doctor 2) comment on the 
nurse’s role was representative of what all medical staff said: 
The nursing staff, they are the ones who are giving the 
medicines to the patient so they know what the patient is 
refusing or what they will actually take for you. They can guide 
you on the consistency of medication where they can say,” well 
actually I gave them this tablet and they weren’t really taking it. I 
think we should maybe switch to a liquid form.” Even in that 
case it highlights that their swallow isn’t as good as it used to be 
so I find that very helpful(D2p3).   
Doctors in particular recognised that nurses are good at safety checks, with 
Sally (Doctor 3) mentioning:  
I have prescribed stuff and they [nurses] have said, “are you 
sure it’s that drug?” (D3p4). 
Frank (Doctor 6) commented that nurses were the primary care providers 
and their knowledge of each patient helped to inform treatment choices.  
Deirdre (Pharmacist 4) commented:  
They [nurses] are very much involved with administration of 
medicines but again prescribing is important to them too. They 
need to make sure the doctor is prescribing correctly as well. It 
shouldn’t just be the pharmacist’s job. If nurses see errors in 
prescribing, they should identify them to the doctors and get 
them corrected and also make sure the patient understands 
why they are being prescribed a certain medicine and how to 





There were also a number of references made, predominantly by nurses and 
pharmacists, to nurses acting as go-betweens and signposting doctors 
towards prescribing the right medicines. 
Shirley (Nurse 2) highlighted the nurse’s responsibility as making sure 
everything was right: 
Allergies are the big one and dosage because obviously 
everyone can make mistakes. It is important for us to make 
sure we have it right but it is important to make sure it is 
documented right as well. Also making sure the timing is correct 
especially for critical medications, such as Parkinson’s 
medication etcetera. It is our responsibility to make sure that 
our patient gets their medicines on time (N2p7). 
Patricia (Nurse 1) spoke of the nurse’s responsibility in broader terms: 
As a nurse, our responsibility is your duty of care to your patient 
and our Code that we follow. We also have a duty of care to the 
Trust as well that we work for and we have to respect and go 
through the guidelines and adhere to them (N1p7). 
Caroline (Pharmacist 5) commented on the inherent professional 
responsibility of nurses to satisfy themselves that a prescription is accurate: 
Nurses are responsible for making sure the patient gets all the 
medication that they are prescribed. They do have responsibility 
for medicines safety, the same way everybody on the ward does 
I think. So even though it is prescribed, it could well be 
prescribed and even signed off from pharmacy and it is still their 
[the nurse’s] responsibility, if they have a concern, to raise it 
(P5p11). 
Nurses spoke of the medicines administration round as a central and 
powerful process on the ward which needed time and focus. It is the process 
which is used to make sure patients get the right medicines on time, playing 




was a problem with medicines rounds being constantly interrupted either by 
others or if the nurse had to go and find a medicine to administer. The 
medicines round had a dual role because during the round, as well as 
administering medicines, the nurse also will check how each patient is 
feeling, for example, if they have any symptoms, what support they may need 
in taking their medicines and how much they know about their medicines. 
The nurse is asking herself questions about whether it is appropriate to give 
the drug and seeking clarification as needed.  
The nurse must meet professional standards when administering medicines 
and participants spoke of nurses withholding a medicine until they checked 
out whether it was appropriate to administer it. Medicines administration is 
identified as a special and dedicated task that nurses need to be protected to 
carry out accurately. I have shown the specific roles of nurses relating to the 
medicines administration process as described by participants in Figure 6.  
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I initially found it challenging to identify what participants said the 
pharmacist’s specific role was. This may partly have been because I am a 
pharmacist. The role was seen predominantly as checking prescriptions, 
ensuring medicines safety and filling in the gaps, either because 
prescriptions were incomplete or inaccurate or because additional input was 
needed to make sure a patient received the right drug. Pharmacists were 
also prescribers.  
Introducing a clinical pharmacist to work on the ward was highlighted by all 
participants as being very important in managing risk associated with using 
medicines. Jack (Doctor 7) commented: 
 It does seem like the pharmacist checking through things like 
discharges, although it is not written in stone, it is just the fact 
that they are there: it is absolutely fundamental I think. There 
would be a lot more that could go wrong if they weren’t there 
(D7p6). 
Pharmacists, in particular, seemed to delve deeper into a patient’s 
medication history, their social circumstances and also why certain 
prescribing decisions had been made. They appeared to work from an initial 
position of not accepting things at face value, working things out from first 
principles as if each patient’s care needed to be investigated and the correct 
solution found.  
When defining the pharmacist’s role with medicines, Shirley (Nurse 2) said: 
Correctly identifying that the patient is on them, that there are 
no allergies, that their weight is appropriate for the dosage and 
then for discharge. The pharmacist would take a big role in 
discharge, ensuring they are going home on the right stuff, if 
they are on a blister pack [compliance aid] with changes, they 





Deirdre (Pharmacist 4) described the pharmacist’s role in a similar way: 
Well, the main responsibility [of the pharmacist] is making sure 
that the patient is getting the right medication for the right 
reason and the way they do that is to get medicines 
reconciliation right on admission and have time during the 
patient’s stay to check prescribing. Also, advising doctors on 
what could potentially be stopped and reviewed….so it is about 
raising awareness (P4p11). 
Angela (Pharmacist 3), a prescribing pharmacist, commented on how her 
role and level of responsibility had changed over time:  
[From being] a [band] 6, it [my role] has definitely changed 
because now I am writing medication on discharge. I definitely 
review patients now more than what I would and I know the 
juniors [junior pharmacists] don’t, as it is a lot about matching 
lists when you start out. So you have your ECR and you are just 
obsessed about matching a list whereas I think we need to move 
more towards, ”is the list actually ok, it may match but do they 
need to be on it?” I don’t think that is done enough but I would do 
that now when I am doing the medicines reconciliation. I will 
review and see if things are appropriate for the patient and then 
stop them if they’re not. We are discussing with the medical staff, 
so it has changed a lot that way for me just as you gain 
experience and know what to look out for (P3p6).   
When asked how she prescribed in her practice, Angela added: 
I mostly prescribe on admission when you are doing the 
medicines reconciliation and there are things missing or they 
are written up at the wrong dose or wrong frequency, I would 
change that at the start. Inpatient-wise, I would stop Sando Ks 
and things that are just left open with no stop dates I would look 
at. Discharge again, if you are changing, maybe stopping, their 




heavily be at admission. So if you get it right then, there is not 
too much to change at discharge (P3p5). 
A number of participants had highlighted the benefits of pharmacists being 
able to prescribe and resolve prescription queries within the context of 
working as a member of the clinical team. 
Caroline (Pharmacist 5) commented that the pharmacist’s role was all about 
medicines safety:  
I suppose medicines safety is our big thing. So we are day- to- 
day reviewing Kardexes and making sure when there is an 
admission that there is medicines reconciliation. So that’s 
tallying up what they were on before they came in and that sort 
of thing (P5p3). 
Caroline spoke of how the pharmacist highlighted concerns to the medical 
team, often after prescribing decisions had already been made:  
We are just highlighting things to the medical team and saying, 
“have you thought about the potential that this might be a 
problem?” So it is things like that (P5p5). 
The pharmacist’s important role in managing risk at the point of discharge, 
making sure a patient’s discharge prescription is accurate and dispensed in a 
timely way, was mentioned by the majority of participants. Karen (Pharmacist 
2) described a multi-faceted role:  
Optimising treatments for patients going home and then doing 
the nitty gritty of the discharge letter and the interface between 
hospital and primary care - needing to speak to community 
pharmacists, GPs, carers and nursing homes  (P2p7). 
This is an example of the problem-solving role of the pharmacist, filling in the 
gaps and helping the system to flow and move forward. Karen went on to 
comment on the pharmacist’s wider role of counselling patients on how to 
take their medicines. This contributed to managing risk but was not 




The measureable things are the interventions that we do, in 
terms of stopping and starting medicines, and that’s what you 
keep your statistics for. Whereas sometimes we lose track about 
this other [counselling] role that with the knowledge we have, that 
we can bring to people and we almost take it as common sense 
but it’s not common sense. It is only common sense to us 
because that is what we do (P2p10).  
When asked if the pharmacist’s role was what they had expected it to be, 
Mary (Doctor 5) said that she  thought that pharmacists would be dispensing 
in the pharmacy as opposed to checking Kardexes at ward level. She 
described the pharmacist’s role as counselling the patient (a role which 
doctors also had) and: 
Very much checking up on us to make sure we are doing the 
right thing (D5p15). 
Sally (Doctor 3) spoke of the wide and all-seeing role of the pharmacist 
enthusiastically: 
They are great at coming in and knowing what is missing, what 
should be done or what needs adjusted for the GFR and things 
like that. I think pharmacists have some compendium, some 
magical database that we cannot see. They are absolutely 
fantastic at discharge planning. The F1 will do the letter, they 
[pharmacists] will go over the drugs and check every single 
drug and highlight anything that has been left out and we notice 
a difference when they are not here, in terms of getting our 
patients’ drugs up in a timely fashion. It is just chaos when they 
are not here. So I think the role of the pharmacist has really 
changed. It makes a massive difference having them based on 





Some doctors and pharmacists suggested that the pharmacist should be 
present routinely when the patient is admitted, to ensure the medicines are 
right at that stage. Often pharmacists would come along up to 24 hours later 
and retrospectively correct prescriptions whereas a better and safer 
approach would have been to carry out the medicines reconciliation and 
prescribe drugs in real time. Angela (Pharmacist 3) highlighted this: 
It would probably be ideal if a pharmacist was there at the start 
to write up all the medicines and then that way you would get 
rid of that risk with the medical staff prescribing. Then they 
[doctors] might be deskilled if they aren’t prescribing anything 
on the Kardex (P3p5). 
When comparing the responsibilities of all three professionals, Shirley (Nurse 
2) commented within the context of how mistakes were often made on the 
first day when a patient was admitted to hospital: 
Well, the doctor’s [responsible] because they prescribed it, they 
are in the wrong as such. It is our [nurses’] responsibility to 
recognise when things would be wrong and then our 
pharmacists would be the ones that would correct it then 
(N2p8). 
Angela (Pharmacist 3) listed the medicines-related roles of all three 
professionals: 
Nurses’ would be administration. Doctors’, well they have to be 
able to prescribe it properly to begin with. The pharmacists are 
really checking and changing when things go wrong (P3p5). 
Karen (Pharmacist 2) commented on roles being blurred now with a 
development to other professionals listening to and acting on the advice of 
the pharmacist, thereby recognising the pharmacist’s role with medicines: 
I think the roles with medicines are all quite blurred now, in that 




pharmacist] have any input about medication, they [doctors] are 
right open to hearing about it and if I said even to a staff grade, 
“that’s not what we normally do”, they would change that. So I 
think the professions are recognising the [pharmacists’] 
expertise and doctors have given, maybe they haven’t held on 
to, control of medicines (P2p17). 
When managing risk, each professional group appeared to adopt a different 
approach. 
Polly (Pharmacist 0) spoke about everyone who worked in healthcare 
wanting patients to have the medicine which is right for them, given at the 
right time. She went on to say that doctors, nurses and pharmacists each 
brought something unique to the use of medicines from their professional 
approach: 
Each comes with the part that their own profession kind of 
brings,  medical staff more in relation to prescribing, nurses 
more in relation to administration and pharmacists, while 
looking out clinically, will also have a supply head on because 
they can never get away from that and will also have a 
medicines information view as well – is it appropriate? 
Pharmacists will ask, “can we actually get it?”! (P0p4). 
She went on to describe how each different professional group had different 
needs and focus with respect to working with medicines:  
Medical staff will want much more of the evidence around that 
decision, to be making an informed decision, whereas nursing 
staff will also want that to some extent but will also have a  
view, “that’s what’s being prescribed, that’s what I am being 
directed to give, I need to just know is that safe to give?” As a 
nurse,…. I am more concerned about what it is going to mean 
for the patient. If I have a patient in front of me and they are 
asking, ”how is it going to make me feel?”, they [nurses] are 




kind of information that they need. Or if they are discharging the 
patient home – “are we going to have any issues to sort out for 
district nursing?” I see it as there is a common ground – like a 
Venn diagram – the circles are the three professionals with the 
patient in the middle – each brings their own slant to it (P0p5). 
 
Figure 7: Venn diagram – the questions which doctors, nurses and pharmacists ask 
when using medicines. 
The questions shown in the Venn diagram in Figure 7 were also raised by 
other participants. 
Polly added: 
When you [pharmacists] see that whole picture of the patient 
coming in [to hospital], these are the medicines they are on, are 
there any they should be on?  You [pharmacists] do bring 
different skills to that situation …., in discussions you are aware 
that you bring something different to the situation and it is hard 
to put your finger on it (P0p6). 
The more experienced pharmacists and nurses spoke about working in line 
with their professional Codes of Practice. In listening to these individuals in 
particular, they explained that their professions looked at medicines 
Doctors: - what is the 
evidence-base? 
Making decisions in real 
time. 
Nurses: - is it safe 
to give? 
What does it mean 
for the patient? 
Pharmacists: - is it 
clinically 
appropriate for the 
patient as a whole? 




differently to especially medical staff. Patricia (Nurse 1) highlighted the 
nurse’s view:  
We take a holistic approach to patient care (N1p3).  
Karen (Pharmacist 2) reflected on how a physiotherapist who was a new 
prescriber used medicines: 
They [physiotherapists] use medicines differently and I don’t 
know if that is because physio is more practical. So they are 
using medicines to generate sputum and correct 
breathlessness, more a means to an end, I suppose, to allow 
them to do their job properly; whereas medicines are our 
[pharmacists’] job, maybe? The physio is very different as they 
are very practical but wanting to use medication then to help his 
role. Whereas I think for us [pharmacists], we are all about 
medicines (P2p9). 
From both of these quotations and comments from other participants, it felt 
as if pharmacists and nurses thought more widely and fully about all the 
factors needed to use medicines safely.  
Doctors and pharmacists in particular, spoke of making decisions by 
assessing the relative risk of the tasks which they had to carry out.  
Polly (Pharmacist 0) summed up the pharmacist’s approach in saying: 
Pharmacists are more risk- aware. This develops early on in 
their professional life. They have the foresight not to take things 
at face value. They manage on a day- and-daily basis, 
continually looking out for risk, mitigating against it and trying to 
prevent it (P0p4). 
This was reinforced by Caroline (Pharmacist 5), who explained how she liked 
having a second pharmacist on the ward-based team to check with because 




It’s not necessarily from a safety point of view, but pharmacists 
can be quite black and white, so what are the rules on this, 
where are the guidelines? And the doctors will sometimes make 
decisions and it is a clinical decision based on the patient they 
have in front of them. It [the clinical decision] might not 
necessarily 100% follow what the BNF says or what the 
guideline says but that guideline maybe doesn’t suit the patient 
they have in front of them. It is good to have another pharmacist 
there to say, “this is sort of off- guideline, but do you think it is 
ok, do you think it is still safe?”  … and we can rationalise why 
maybe the doctors haven’t gone with just the guideline 
information (P5p20). 
Medical staff made complex decisions by taking all of the information about 
the patient on-board and looking at the evidence-base.  Polly (Pharmacist 0) 
commented that right from a very early stage, doctors very quickly have to 
become used to being on the spot, being asked questions and having to 
justify their decisions. She saw a difference between the approach and 
confidence of student doctors, nurses and pharmacists: 
Nursing students, maybe because of their time on [clinical] 
placements, they do seem willing to speak up when they see 
something not right. I see this when we do inter-professional 
educational sessions with nursing, pharmacy and medical 
students in their final year. You do see the confidence more 
with the medical and nursing students- it has improved with 
pharmacy but it’s taking a while. They have less clinical 
exposure (P0p12). 
So differences are seen between the different professions from an early 
stage. This may be due to a variety of reasons including the training methods 
used and the level of clinical exposure during training.   
When managing risk, doctors spoke of  integrating medicines review into the 
daily patient review, making decisions in the here and now and moving on to 




pharmacists spoke about filling the gaps, querying prescriptions, especially at 
discharge and sorting out the implications and impact of doctors’ prescribing 
decisions.  
Fred (Doctor 4) highlighted the difference between nurses and doctors’ ways 
of doing things which they didn’t know much about. Nurses were cautious 
about doing something that they have a problem with, making a note to cover 
their backs which they believed was appropriate. On the other hand, he said 
that junior doctors were: 
Putting our name to very many drugs that maybe we don’t know 
much about and we are just putting them [the patient] on 
because the previous Kardex has but it does have implications 
down the road potentially if something does go wrong, for 




Managing risk is central to how doctors, nurses and pharmacists work with 
medicines in acute hospital wards. I have extrapolated some of the reasons 
why a risk management approach is adopted and outlined the roles and 
responsibilities of doctors, nurses and pharmacists in managing the risk 
associated with medicines. I have also discussed the different approaches 
taken by each professional group when managing risk. Focusing on the work 
of three different professional groups has helped to address the aim of the 
study. 
Patient safety was highlighted by all participants as being central to the way 
they worked. In ensuring patient safety, each participant adopted a range of 
risk management strategies, depending on their profession, their role and 
level of experience and seniority. I will go on to define the different strategies 





6.0 Laying out the theory - strategies and consequences  
 
6.1  Introduction  
 
In Chapter 5, I described the condition working with the complex and the 
routine that leads up to the core category managing risk.  Strauss and Corbin 
mentioned that, “our concern, as analysts is…with conditions of various types 
and the way in which they crisscross to create events leading to 
actions/interactions (strategies)” (1998:133).  
Two main (action) strategies emerged from the data and they are integrated 
into the theory as outlined in Figure 5. They are: 
• Using checks and balances. 
• Working together. 
In this chapter, I will lay out the data in relation to these strategies, as well as 
the data in relation to the consequence, ensuring each patient gets the right 
medicines. 
  
6.2 Using checks and balances (strategy) 
 
6.2.1 Introduction 
The term using checks and balances was an early in vivo code and I had 
identified it as the core category at one stage of the analysis. 
It relates to: 
 Each professional’s personal, internal checks and balances when 
using medicines. 
 The checks and balances built into the whole system of using 




Using checks and balances became a rich strategy into which a number of 
earlier sub-strategies have been integrated as a result of ongoing analyses. 
These sub-strategies were:- reviewing prescriptions regularly, making good 
decisions, checking information with patients and carers, structuring each 
day’s work, prioritising tasks, being able to access information, making the 
best use of time, introducing new ways of working and developing new roles. 
All of these sub-strategies were used by individuals as well as being part of 
the system of using medicines. Such integration is central to the development 
of a robust grounded theory (Strauss and Corbin 1998). 
 
6.2.2 Personal checks and balances 
Each participant made reference to checking as part of their day-to-day 
practice with medicines. These checks took on different forms, for example, 
checking stock levels of medicines, checking a patient’s allergies, checking 
with a colleague and also checking their own work. Checking was particularly 
central to the role of the pharmacist and the nurse.  
Participants’ individual approaches to using medicines included making risk-
based judgements in their work - the balances. This was specifically spoken 
about by doctors and pharmacists. FY1 doctors worked mainly within their 
personal limits when prescribing. They took, “safe short-cuts” (D7p7). More 
senior doctors helped patients to balance risk with choice of medicine (Doctor 
6). Pharmacists balanced their time when prioritising, “the top thing” to be 
done (P3p4).  
Each person interviewed mentioned using their own personal checks and 
balances within the context of understanding that medicines errors could 
have serious consequences, making sure that they did a good job and 
ensuring each patient gets the right medicines. It was clear that checks may 
not have been carried out on every occasion that they could have been and 
that balances were not effective each and every time, leading sometimes to 
medication errors. Professionals’ insight into this lack of consistency drove 




The doctors spoke mainly about how they prescribed. The middle grade and 
senior doctors spoke of being thoughtful about their prescribing and taking 
care with the decisions they made.  
They mentioned having, “in-built alarms” and being guided by nurses, 
pharmacists and other medical staff when making prescribing decisions. 
Jayne (Doctor 2) commented: 
Something triggering in your mind like,” I have to check about 
this one, there is something, I have to be careful. I’m not sure 
what it interacts with or what I need to be careful of but I need 
to look it up”. Things like that where you have signposts in your 
head, where you think,” ok, you may not know exactly what it is 
that’s wrong about this but you need to check” (D2p2).  
Different levels of doctors explained ways of using checks and balances 
when making decisions. FY1 doctors prescribed a limited number of 
medicines which had usually been prescribed before. They tried to make a 
risk-based judgement that the medicine was low-risk and within their 
competency to prescribe, for example, a laxative. More senior doctors spoke 
about using mechanisms to make decisions about more complex medicines, 
for example, discussing treatment options at a regional multidisciplinary 
team.  They talked about understanding guidelines, either from first principles 
or in the context of a particular patient, and being able to make well-informed 
decisions using this information, taking a balanced approach. They spoke 
about how they learnt from all the members of the multi-professional team. 
They involved patients in their decision- making, often asking what drug had 
worked well for them in the past.  
Jayne (Doctor 2) spoke of how she checked before she prescribed a 
medicine: 
At a basic level, we are responsible for prescribing medicines, 
so we have to be extremely careful with what you are writing 
down. It can be very monotonous; it is something you do 




more experience of working as a doctor, I found that you need 
to really engage your brain when you are thinking about 
medicines because these are the things that are going to kill 
people. Anything is toxic in a high enough dose. So I have 
come to learn that you have to check the BNF if you are not 
sure or ask your friendly neighbourhood pharmacist if you have 
any questions (D2p1). 
Mary (Doctor 5) talked through the checks and balances which she uses 
when prescribing a medicine which she is not very familiar with. These 
included looking to see if it has been prescribed before, prescribing what her 
senior has told her to prescribe, checking if the patient has had it before and 
looking to see if a pharmacist has checked the prescription. Having each of 
those things would support her in prescribing the medicine. She spoke of 
having a line over which she does not cross, insisting that a senior colleague 
signs a prescription for a high risk drug:  
It is not something I would do without consulting someone. If I 
wasn’t sure and there were no obvious guidelines and the 
pharmacist wasn’t around, I would discuss with the SHO or 
above to clarify first of all why they need it and then obviously 
the correct dosage. I wouldn’t jump into something to be honest 
if I didn’t know what I was prescribing (D5p11). 
Frank (Doctor 6) set aside time away from the busy ward to prescribe 
complex therapies. He recognised that this was a higher-risk task and he 
altered his personal approach to manage that risk. 
The nurses interviewed had a different practice to the doctors when using 
checks and balances. They were the only profession which integrated the 
use of safety checklists such as the Five Rights (Smetzer 2007) and the, 
“more than three” rule (no reference) into their practice. Shirley (Nurse 2) 




Yes, well we will have the name and the dosage of the 
medicine and then from knowledge you should know that 
doesn’t look right and then you would query it. You were always 
taught a maximum of three, anything over three and you 
question it. So we would always know if something was 5mg 
and they came in 2.5mg tablets, then two tablets of that is okay. 
But if you were giving any more than three then other than 
steroids, you would question that (N2p5). 
Nurses also spoke about checking that a prescription was accurate before 
administering a medicine, knowing their medicines, seeking advice if they 
were unsure and checking a patient’s details.  
The pharmacists identified using structured checking processes as well, 
including medicines reconciliation when patients crossed interfaces between 
wards and between primary and secondary care.  Angela (Pharmacist 3) 
spoke of making decisions and not having time to check with a patient that 
they are the best decisions: 
Sometimes making decisions and just going with it because 
there is just no time to do it any other way (P3p17). 
Lack of time was mentioned especially by doctors and pharmacists as 
something which forced them to make balanced, risk- assessed decisions. 
 
6.2.3 System-related checks and balances 
As well as highlighting their own personal checks and balances, each 
participant made reference to using checks and balances in the system 
which they worked in. Some described formal processes such as audit and 
incident reporting. Structured working practices such as ward rounds also 
supported participants in carrying out tasks. Participants also assessed the 
relative risk of medicines-related tasks.  . The presence of individual, 




also mentioned as being a less formal check and balance in the system. 
These are all described more fully below.  
Most of the medical staff described auditing the use of medicines, for 
example, carrying out antimicrobial or pill-burden audits. These experiences 
seemed to influence their subsequent prescribing practice. Jayne (Doctor 2) 
had mentioned how carrying out medicines audits had made her a more 
thoughtful prescriber: 
In the last year I took part in an antimicrobial audit and from that 
I have been a lot more careful about the antibiotics that I am 
prescribing and patients I have looked after with C diff – it really 
focuses your mind and you think,” do they actually need to be 
on this antibiotic or are they on the correct antibiotic, can we 
focus it down?”(D2p2). 
She gave a recent example of reviewing an antibiotic prescription and how 
she felt the system in her current ward had not been effective: 
I looked at a patient’s chart. They actually had what looked like 
an AKI so I looked through their Kardex and they were on 
trimethoprim for a UTI and whoever had written it had quite 
rightly written,”3 days” but then it had just been continued on. 
So we were on day 6 by the time I caught it. And I wondered 
what the relationship was between the nurses and the doctors 
in this hospital as in the previous hospital, particularly with us 
doing that audit, it empowered everybody to question whether a 
patient needed to be on an antibiotic (D2p2).  
So formally auditing practice not only raised awareness but gave permission 
to nurses and doctors to ask challenging questions. This example also 
underlines the importance of questioning what is happening and 
professionals working together in using checks and balances. 
When patients did not get the right medicines, some participants highlighted 
errors relating to medicines being reported through Trust incident reporting 




It would be learning from mistakes and learning from what we 
have already been told. One big one here would be the IV 
paracetamol and the weight restrictions. So we would make 
sure all our patients are weighed when they come in where 
possible (N2p4). 
When working with the complex and the routine, nurses and pharmacists in 
particular described structuring the way that they worked to manage risk. 
They spoke of approaching each day’s work with medicines in a specific way. 
Jackie (Nurse 3) structured her day around the medicines round. When 
asked how medicines fitted into all the other work that happens on the ward 
she said:  
We would start our day out with the medicines and that would 
be the first. After you have them [patients] sitting up for their 
breakfast, we do our medicines first to make sure that they 
were comfortable and we can find out if there is anything else 
they need. It is a good way, when you are doing the medicines, 
to see if they feel sore or in pain etcetera (N3p4). 
Karen (Pharmacist 2) explained how she worked at ward level: 
The first time the consultant sees them [newly admitted 
patients], they [the consultant] will do a post- take ward round 
and they will put a plan for what they think is wrong with the 
patient and what their plan would be. So I would go back to that 
once I’ve done the medicines reconciliation to check that we 
have implemented that plan and that it is appropriate for that 
patient, based on all the other factors that you would take into 
consideration. So you would make sure that the Kardex is right 
and they are being prescribed everything and that it is the 
correct dose and the correct route and all those other things 





Rebecca was able to solve problems in a structured way on the 
multidisciplinary ward round because all the resources she needed were 
there:  
We have started going on the ward rounds in the mornings 
which is great and then we go to the 11 o’clock discharge 
meeting with the consultant; so on that round it is very, very 
good, for you are highlighting problems and you are actually 
able to solve the problem when you are there because you 
have two medics, nursing staff and you have the patient in front 
of you, so that’s stopping the problem going any further. So I 
find that very, very beneficial (P1p4). 
She compared this to working in areas where she didn’t attend the ward 
round: 
Certainly on the other wards where you don’t do a ward round, 
you can really see the difference, in that everything comes at 
once in a big cluster and everybody, the nursing staff, can get 
quite flustered at times because there is so much work. 
Whereas, if you had the ward round in the morning and you are 
prioritising your workload as you go along, seeing the patients, 
seeing what needs done, it is much easier. I believe it is much 
safer doing it that way (P1p5). 
There were a number of other systems which provided checks and balances.  
Mary (Doctor 5) sought local prescribing advice when she started working on 
a new ward, wanting to know the common prescribing tips which were 
particular to that area of practice: 
I ask just for wee hints of different things and different 
adaptations to medications maybe compared to what you would 





Fred (Doctor 4) heard nurses confirming each patient’s name and date of 
birth when administering medicines. He believed that this was an obvious 
thing to do but was surprised that it continued as when you are present every 
day, you know who the patient is. He finished his point by saying: 
The first time it happened, we had just been with the lady on the 
ward round and prescribed it and I thought it almost seems a bit 
unnecessary but if it happens every time it really does stop the 
wrong person getting the wrong medications (D4p12).  
Shirley (Nurse 2) had said that everybody looked out for each other. I asked 
her if double checking systems were effective. She said that they were not 
always effective as sometimes staff can take their eye off the ball or lose 
concentration: 
If you get lackadaisical or if you get familiar, it can be just a 
case of you are glancing. You need to remind yourself at times 
to really sit down and do the 1-2-3-4 different stages to ensure 
that it is correct because people can get very lackadaisical in 
checking and double checking (N2p15). 
Deirdre (Pharmacist 4) spoke about providing written checklists to help 
doctors and nurses on wards which were not visited by a pharmacist to 
streamline medicines requests: 
What we have done is provided a guidance, directions on what 
to do before sending the script to pharmacy, like a checklist, 
and that has helped. Wards without clinical [pharmacist] cover 
were cross because scripts were back and forwards trying to 
get them fixed up. So we have tried to guide them on how to 
make sure, streamline it and go through the checklist so that 
the script isn’t delayed unnecessarily (P4p10). 
Deirdre also described changing the template of prescriptions to help direct 




Checks and balances are designed into the hospital medicines management 
system by all healthcare professionals also by taking a risk-assessed 
approach to carrying out specific tasks. Doctors stratified the risks associated 
with prescribing by allocating appropriate levels of prescribing to different 
grades of doctors to allow them to learn on the job within a relative risk-
assessed framework. Each doctor spoke about their prescribing role and that 
of other doctors. In analysing this data, it appeared that the doctors in my 
study carried out levels of prescribing tasks allocated as part of a conscious 
or subconscious practice framework in operation within Trusts. I integrated 
the different levels of prescribing tasks, with the associated practice outlined 
by participants, as well as participants’ descriptions of what they thought 
about prescribing at their current level, into Table 22. This table allowed me 
to delineate a prescribing process spoken about by participants in my study 
which contributed to my understanding and analysis of how they thought 
about prescribing. All of the doctors mentioned how their approach to 
reviewing prescriptions changed with experience.   
 
Table 22:  A developing process of making prescribing decisions throughout a 
doctor’s hospital career 
 










Foundation Year 1 
(FY1)  
 











Spend more time in the 
specialty. 




















Foundation Year 2 
(FY2) /  CT4) 
 
Prescribing drugs on 
admission. 
 
You know the 
basics. 
 
What about involving the 
patient in prescribing 
decisions? 
 
Driving a car analogy. 
Gut feeling. 
Unconscious competence. 
Engaging your brain. 
Can be mundane. 






doing the general 
run of the mill 
stuff. 
  
Seeing prescribing in 
the wider context of 










in the absence of 
evidence. 
Trying to back up 
complex 
decisions – going 







 Taking an informed 
pragmatic approach. 
Local MDT.  
 Weighing up the 
potential risks. 




 “Guidelines are just 
guidelines.” 
Writing local and 
regional 
guidelines. 
 Choosing particular 
drugs based on 
experience of using 







I checked the content of this table through discussion with subsequent 
medical participants. It appeared that this “framework” had not been made 
explicit to the other healthcare professionals involved in using medicines or 
initially to junior doctors.  
In surgery, a different approach was taken, with the FY1 prescribing the 
drugs on admission. When asked why, Mary (Doctor 5) thought: 
It is just because the patients come in well to us so they [the 
Consultants] are happy for us [the FY1] to clerk them in 
whereas in medicine not so much (D5p5). 
So prescribing in surgery possibly is seen as a task of lower risk compared to 
carrying out the surgery. Also, fewer changes are made to medicines during 
a patient’s stay on a surgical ward.  
Each professional group outlined how their approach to reviewing 
prescriptions and using medicines changed as they gained experience. This 
particularly seemed to be the case with the doctors interviewed.  
Jayne (Doctor 2) said that her prescribing changed with experience:  
I was chatting to some friends and we all agreed that in the 
beginning you knew very little and then with experience on the 
job you felt like, “I know a wee bit, this is good. I feel like I am 
getting on well.” Then in second year you think, “I know 
everything now, I am great. I understand everything, I 
understand the physiology of everything - there is nothing more 
I can learn.” Then as you get further on and you gain more 
experience, you suddenly think, “oh my goodness, I know 
absolutely nothing, but you knew more than you knew the year 






When asked if the way he made decisions had changed during his career, 
Frank (Doctor 6) said that it had as circumstances changed and as his 
responsibility had increased.  
When asked if the way she used medicines had changed with experience, 
Shirley (Nurse 2) replied:  
The principles are all the same, your checks are all the same 
but confidence comes a lot easier the longer you’ve been 
working with them (N2p6). 
She went on to describe having a gut feeling:  
For example, IV antibiotics etcetera, if you don’t think they [the 
patient] should be on that or they have a penicillin allergy and it 
is something that you are not 100% sure if there is penicillin in it 
or not, then go and check it out. There has been the odd time 
where it has been missed (N2p6).  
Having a gut feeling was also commented on by medical staff as part of their 
checks and balances. 
Jackie (Nurse 3) talked about the pharmacist’s routine role in medicines 
reconciliation, which had been mentioned by pharmacists in particular as an 
important check in the system:  
They [pharmacists] will do it [medicines reconciliation] the next 
morning and they will update us [nurses] on what medicines 
need altered, if they need doses changed so that we can let the 
doctors know (N3p8). 
Using nurses as a go-between was not practice on the ward where Angela 
(Pharmacist 3) worked. She described needing to move from simply 
reconciling to fully reviewing medicines: 
Whereas I think we [pharmacists] need to move more towards, 




of medicines on admission] but do they need to be on it?” I 
don’t think that is done enough but I would do that now when I 
am doing the medication reconciliation. I will review and see if 
things are appropriate for the patient and then stop them if 
they’re not. We are discussing with the medical staff so it has 
changed a lot that way for me just as you gain experience and 
know what to look out for (P3p7). 
Jackie (Nurse 3) described the checks and balances which she saw doctors 
using when prescribing for new patients: 
I suppose they would be looking at the ECR as well and 
checking off their list as that is their main base for finding out. 
Sometimes they will go and ask the families because the 
families know best what they’ve been getting and they will work 
closely with the pharmacists to see if there is anything missing 
from the Kardexes (N3p8). 
Participants (doctors, nurses and pharmacists) referenced the benefits of 
having higher banded staff available routinely at ward level to answer 
questions, act as role models and provide support. They also spoke of the  
benefits of having a fixed pharmacist with specialist knowledge based on a 
ward with respect to continuity, establishing relationships with clinical staff, 
understanding consultants’ preferences, being part of an established team 
which seems to work seamlessly together (have each other’s back) and 
being able to operate at a particular level of practice.  
 
Rebecca (Pharmacist 1) commented: 
The consultants do find it quite hard us [pharmacists] being 
rotational – having three new faces every six months. That is 
very hard for medical staff because they learn to trust that 
person. They learn to know they can go to somebody they know 
with this - I could ask them this. They know that if they go to 
Medicines Information they will get back to me, or no I don’t 




to do this after. Then the patient’s care suffers because the 
answer isn’t got as quickly, the medicines aren’t changed as 
quickly so the patient isn’t priority number one (P1p14). 
Angela (Pharmacist 3) also highlighted concerns about junior pharmacists 
rotating through clinical areas too quickly, not helping them to consolidate 
their knowledge. Both Rebecca and Angela however understood the 
importance of training new pharmacists in each clinical area and this way of 
working mirrored how junior doctors were trained. Pharmacists in a different 
hospital had a multi-layered approach with a more senior and more junior 
pharmacist on the ward. This provided service continuity as well as a role-
model. 
The nurse seemed to be the glue on an acute ward, the steady presence - 
doing the medicines round and knowing all the patients, their symptoms 
today, what social support they have and whether they can take their 
medicines. They were spoken of by everyone as being the go-to person for 
the other healthcare professionals and they provided input on choice of drug 
based on their wider knowledge of patients. All of the doctors realised that 
nurses highlighted things which doctors may not perceive, such as a patient 
being drowsier than the doctor thought or having problems with swallowing. 
In addition to this, Sally (Doctor 3) defined the nursing role in using checks 
and balances: 
The nurses are very, very good and even analgesia and 
additional analgesia but also safety checks. So I have 
prescribed stuff and they said, “no actually, I think that’s the 
wrong spelling or are you sure it’s that drug?” So they play a 
key role (D3p4). 
Nurses linked with the pharmacy team regarding medicines availability and 
checked when something did not look right. 
Reviewing medicines regularly was mentioned as being an important action 
(in relation to using checks and balances) by all participants. The term could 




so, in order to capture its multi-professional nature, I have used the term, 
reviewing prescriptions regularly.  
For doctors, this was usually carried out as part of a wider review of the 
patient and was mostly the role of a more senior doctor. However as junior 
doctors (FY1s) described being asked to write and re-write prescriptions as 
well, I have used the term to cover reviewing all prescribing, including nurse 
and pharmacist prescribing.  
Sally (Doctor 3) spoke of how she made prescribing decisions: 
When reviewing patients, looking at what they are on, is it 
relevant, is it needed and how do I modify it in tune with their 
observations or their wellbeing that day? Sometimes on the 
ward it would involve assisting F1s if there are patients unable 
to swallow, whether there are alternatives or if the patients are 
having seizures and their magnesium is low, how do we convert 
the oral medication to IV medication? (D3p2). 
This description was similar to that given by other senior doctors. Jayne 
(Doctor 2) commented: 
As I’ve gotten more experience, I feel more confident, for 
example, if patients are reaching the end of life, taking the bull 
by the horns and thinking, “right, do they need to be on their 
statin? Is it going to be prolonging their life? No they are going 
to be passing away soon so take that off.” Whereas in the past I 
wouldn’t have felt that it was up to me to do that. I would’ve felt 
that was too big a job (D2p8).  
Nurses reviewed prescriptions each time they administered a medicine or 
discussed medicines with patients. Pharmacists reviewed prescriptions each 
day, having a particular focus on reconciling medicines on admission and 
when helping to prepare the discharge prescription. This involved checking 
for accuracy and appropriateness as well as filling in any gaps in a 
prescription. This was carried out either by a pharmacist prescriber or by 




Nurses and pharmacists also spoke about taking wider information into 
consideration when making decisions about a patient’s medicines.  This was 
an additional check and balance in their practice, grounding decisions within 
a wider continuum of patient care. Some spoke about this with zeal.  When 
asked what influenced the way she worked with medicines, Patricia (Nurse 1) 
mentioned evidence and clinical guidelines but also everything around the 
patient:   
Again if not 100% sure, I will ask the multidisciplinary aspect of 
it, to see is it going to suit the patient? Is it going to suit with the 
relatives? Is there going to have to be District Nursing involved? 
Is there going to have to be other disciplines pulled in to help? 
Whatever is going to help the patient with the best outcomes; 
say for us it is to reduce HbA1c, but that is not always the goal. 
We have to have a quality of life as well as what we are 
recommending. It is a holistic assessment that I would use 
(N1p3).  
When asked how her approach to prescribing differed to that of other 
professionals, Karen (Pharmacist 2) outlined: 
I think as pharmacists we probably, maybe this is not fair but, 
we think about the whole patient, not just think this is what’s 
wrong with that person, this is what we need to treat it…maybe 
we see what else they are on as well whereas I think they 
[doctors] don’t. They tend to just see one condition and 
prescribe for it (P2p5). 
Participants from each professional group highlighted the importance of 
paying attention to the detail when reviewing prescriptions. They looked at 
the implications of prescribing each drug for individual patients.   
Fred (Doctor 4) highlighted the value of having a plan in place for medicines 
before the patient is discharged. This would help to inform the FY1 about 
what to prescribe when writing the discharge letter. Sally (Doctor 3) taught 




Cathy (Nurse 4), talked about the importance of nurses paying attention to 
detail: 
It is our responsibility to ensure we are giving the right 
medication, the right dose by the right route and that the 
prescription is right. That we are not just scanning it over either 
and just giving the drug, that everything in that prescription box 
is correct and anything that is not correct then we need to be 
flagging it up (N4p6). 
A further systemic check and balance used by all participants was being able 
to access and use accurate information. This was particularly important when 
working with the complex and the routine. Throughout the interviews, 
participants frequently talked about looking for information, seeking 
clarification, signposting others and asking for advice when reviewing 
prescriptions. When doing this, they used a range of information sources to 
help them to review prescriptions when they were prescribing, administering 
or checking them. These included asking patients and carers, using 
guidelines, other texts and training as well as asking professional colleagues. 
I have given examples of how participants used each of these three sources 
below.   
All healthcare professionals spoke about asking patients about the medicines 
they were taking as an additional check and balance when prescribing or 
administering medicines. They also commented on many hospitalised 
patients being older, often with dementia, and not being able to discuss their 
medicines. In such situations, a family member or carer would be 
approached. 
Jackie (Nurse 3) said:  
The patient, they are the centre of it. So sometimes we would 
get families up and they know inside out what their relative 
takes and sometimes the patient does themselves, just 
depending on their background and what they are like. They 




taking medicines and it is not changed on ECR because 
obviously the GP doesn’t know because they [patients] change 
it themselves (N3p16). 
Mary (Doctor 5) was permitted to clerk-in patients in surgery but not in 
medicine. She saw the advantage of doing this when it came to prescribing 
medicines: 
It is nice in surgery then to actually confirm with the patients 
and go through the list of medications so that you know that you 
are signing something that is actually correct, rather than 
signing something that someone else has deemed to be correct 
(D5p6). 
A number of more experienced doctors said that sometimes they would ask 
patients what had worked well for them in the past before prescribing a drug. 
Jayne (Doctor 2) commented:  
Then if they’ve had an allergy and it is on their ECR but then 
the patient says they’ve never had an allergy to penicillin and 
they’ve had Tazocin in the past. So generally talking to the 
patients themselves and asking what sorts of things have 
happened them in the past with medication; is there anything 
that they actively avoid and why and what happened to them? 
(D2p4). 
A further check and balance was each professional keeping their personal 
knowledge of medicines up-to-date by learning on-the-job, using formal or 
informal mechanisms. All participants talked about constantly learning on-
the-job and learning from errors. In this way they were continually managing 
risk. They acknowledged getting their base-line learning when they were 
undergraduates. Pharmacists in particular referenced participating in formal 





Nurses mentioned reading patient information leaflets in medication boxes 
(package inserts), the BNF or having ward-based teaching sessions from 
pharmacists. Shirley (Nurse 2) said: 
As a student, you were encouraged to read up on them 
[medicines], between the leaflets in the boxes and your BNF. 
The more you work with them, the more knowledge you gain 
and again we have a good relationship with the pharmacist that 
we will ask what this is for (N2p5). 
Karen (Pharmacist 2) highlighted that there was a lot expected of nurses 
when it came to medicines and commented on how nurses learned in 
comparison to pharmacists: 
I don’t know that, certainly initially, that they [nurses] have the 
training; it probably comes only with experience. I don’t know 
that when they do ward rounds, medicines rounds by 
themselves, they never get the opportunity to see how 
somebody else works. We tend to as pharmacists, at some 
stage, get to work alongside other people, whereas they 
[(nurses]) are very much, “you’re a qualified nurse, go and do it 
now.” I do empathise with them and you see them struggling 
(P2p14). 
Caroline (Pharmacist 5) described the benefit to her practice of enrolling on 
formal, practice-based, postgraduate courses which had content which 
related to what she would do on a day-to-day basis as a pharmacist on the 
ward. She also described learning from how other pharmacy colleagues 
practised: 
When I started here I was just shadowing other pharmacists 
and it was brilliant, just for even, again it is not necessarily the 
clinical things, but just practically is that how you would 
approach that and it just helps to see different ways of 
working……you can pick the best bits from everybody’s ways of 




Nearly all participants used guidelines to different extents as a check in their 
practice. Guidelines seemed to be central to the approach of middle grade 
medical staff:  
Jayne said: 
I think my own personal experience comes into play as well but 
I am very guideline- driven. I think I am a bit OCD about 
guidelines and I get frustrated when I can’t find them (D2p4). 
Sally (Doctor 3) spoke about what influenced her prescribing: 
I think it is a combination of things. There are the obvious facts 
and the guidelines but I think part of being a good doctor is 
being able to personalise the drugs to the patient, for example, 
statins if you are a diabetic, 88 year old patient who cannot 
swallow. So I think there is a bit of common sense and 
guidelines are for guidance (D3p3). 
Joan (Doctor 1) described her prescribing practice in hospital outpatient 
clinics. She said that she uses a lot of guidelines when making decisions: 
Partly that is appraisal- driven and partly that you are just trying 
to see where everything fits (D1p4).  
Later, however, Joan spoke of preferring to learn from attending training 
sessions as opposed to using guidelines: 
You can choose the things you are worried about and go to the 
lectures on it and find out what people are doing and talk to 
them. The guidelines are fair enough but they are always so 
outdated by the time they print them, something new could 
have happened and that’s not even in it. So guidelines are 





Frank (Doctor 6) described going back to first principles to read the original 
research on the use of a medicine or the treatment of a disease to help in the 
design of local drug protocols. Having this deeper knowledge helped him to 
make better decisions when faced with a complex problem and to be able to 
justify a decision he would be responsible for. 
Nursing staff in particular described following guidelines and standards quite 
rigidly. Patricia’s (Nurse 1) prescribing practice involved working within 
guidelines, with off - label or non-routine prescribing being the territory of 
experienced consultants: 
Just by means of assessment, obviously we have our rules and 
regulations and our guidelines and what we can do. If it is 
above me, for instance if it is some medication or insulin that 
maybe I’m not familiar with, then I would then go to our 
Consultant or someone who is more experienced (N1p3). 
When asked what informed her prescribing decisions, Angela (Pharmacist 3) 
replied that she changed her prescribing practice when guidelines changed:  
For example, when it came out about lidocaine being used so 
much for unlicensed indications. So I will now actually look up 
that now and stop it when I can. So when guidance comes out, 
it does change your practice. Or at the start for stroke, you used 
to always get simvastatin 40mg whereas atorvastatin got a bit 
cheaper and it is much better and Trust guidance changed 
(P3p8). 
Participants described making the best use of resources as being important 
in ensuring each patient gets the right medicine.  I have used the word 
“resources” as a collective term for time, staff, expertise and money and will 
outline what participants said about each below. With respect to making the 
best use of resources in general, participants spoke about redesigning and 
streamlining the way medicines management systems worked; trying to get 
tasks done quickly to improve the flow of patients through the hospital; 




the circumstances. These were extra checks and balances which they 
adopted in their practice. 
All the healthcare professionals who were interviewed made reference to 
time in a number of different contexts. Making the best use of time and 
prioritising work were early codes and categories which were integrated into 
the strategy, using checks and balances.  Doctors and pharmacists in 
particular described prioritising what they did. Rebecca (Pharmacist 1) 
prioritised her workload in a number of ways. Firstly in terms of prioritising 
patients with particular illnesses which required a critical medicine and then 
making sure the right drug has been prescribed or stopped: 
I personally always prioritise my patients and their medicines in 
terms of, so you have your guidelines, you have your patients 
who would be on their critical medicines, so your Epilim, your 
epilepsy patients, your Parkinson’s patients, your dementia 
patients, your patients who are nil-by-mouth and have to, as I 
said, be changed to oral and also those patients who are new 
presentations such as strokes. So you are focusing on ensuring 
they have their aspirin or if they have had a haemorrhagic 
stroke that they don’t get their thinners and that there is no 
enoxaparin (P1p3). 
She also prioritised specific tasks to ensure that the patient’s care is 
managed as safely as possible: 
Or else, whenever you are in the acute medical setting, 
prioritising medicines in terms of who has been in, who needs a 
drug history and who has to be out the quickest to free up a 
bed. That sounds terrible but in that different setting then my 
approach would be very much that you get your drug histories 
done to ensure that the patient is safe, that their discharge 
[prescription] is correct, that it goes quickly through pharmacy 




Angela (Pharmacist 3) spoke about prioritising her work:  
We have an SOP for prioritisation but I just know how to 
prioritise. Discharges are always the top priority. I know I won’t 
prioritise a discharge if there is a Parkinson’s patient or 
something more urgent or somebody seizing or they need their 
anti-epileptics sorted out. I will do that before I do a discharge 
even though they are number one. Discharges come first then 
after I finish the discharges it will be a medicines’ reconciliation 
and I will put them in order of priority. So this morning, I had 
seven to do so I will put them in order on the clip board. It 
means if I don’t get to do a couple then it will be the lowest 
priority ones to try and minimise risk. Then there are the in-
patient reviews that would come last, but again depending on if 
someone is on Sando-K and there is no stop date, I will 
prioritise that. I will make sure that is done in the day whereas if 
there was someone on magnesium with no stop date, I could do 
that tomorrow. I just know what the most important jobs would 
be (P3p12). 
In outlining what has changed in hospital practice, Patricia (Nurse 1) spoke of 
having increasing time pressures, keeping patients alive longer and using 
more complex medicines. She said: 
The straightforward patients don’t come into hospital anymore 
(N1p5). 
When asked what she would do to design the perfect medicines optimisation 
system, Angela (Pharmacist 3) commented: 
I would like more pharmacists probably. You don’t have time. 
Time is a massive issue for medicines optimisation, for 
example, patient choice. You don’t have time when you have 
ten discharges in a ward to go and talk to a patient about their 
medicines and how they are doing with them and can they take 




would be great but in an acute hospital when you are very busy 
unfortunately you don’t have time to fully do that (P3p11). 
She added: 
More incident forms being done to improve patient safety and 
for learning. There are not huge amounts of time for anyone to 
do that and I know that it is very time-consuming and you have 
a lot of other things to do, but sometimes it isn’t prioritised as 
the top thing (P3p12). 
Karen (Pharmacist 2) mentioned that pharmacy is good at juggling lots of 
balls and this has contributed to them taking on more roles. 
When speaking about administering medicines, Shirley (Nurse 2 said): 
It would be brilliant to find a way that makes it straightforward – 
no interruptions, just plain easy, straightforward. Here you go, 
take your tablets. Something similar to blister packs already 
made up on the ward would be nice but obviously I understand 
that we need to make sure we know what we are giving 
(N2p13). 
Deirdre (Pharmacist 4) described pharmacists doing what they needed to do 
to keep patients safe, going the extra mile. She spoke of the additional time 
which pharmacists, who had taken on new clinical roles, needed to make 
sure that medicines were right. This was partly due to having access to a lot 
of additional information which they looked at before reconciling medicines. 
She said: 
The amount of time it takes a pharmacist to check the different 
sources and get the right medication prescribed for the patients 
while they are in hospital. Checking the Kardexes are right and 
communicating to the doctors when things aren’t right and 





The design of different parts of the system for using medicines did not always 
support participants in making the best use of resources.  The consequences 
of this would include medication errors (some resulting in patient harm), 
professionals feeling that they were not doing as good a job as they would 
like to, stress and exhaustion. There seemed to be a comfort taken by 
medical staff from using checks and balances in the system to allow them to 
address their workload -  knowing that a pharmacist and nurse would both be 
checking what they had prescribed before it reached the patient. Whilst it was 
good to have these checks in the system, they should not replace paying 
attention to detail and focusing on prescribing accurately. 
The need to use finances effectively was mentioned by some participants. 
Deirdre (Pharmacist 4) when asked if healthcare professionals inadvertently 
put up barriers to the way medicines are used said: 
Yes we throw up barriers around selection [of expensive 
medicines]. We throw up barriers because we want to make 
sure we get value for money. We have product standardisation 
and we decide this is what we are going to allow and we work 
on formularies to kind of restrict down the prescribing in a 
sensible way. We are doing that in order to save money to be 
able to pay for the newer, more expensive things that could 
potentially save lives. Those are barriers to access, but they are 
necessary (P4p25).  
Angela (Pharmacist 3) said: 
Money is probably a big thing as well - budget constraints. Day-
to-day it doesn’t really affect me on the ward. I will change 
things if I know it will be cost-effective but to me personally, if it 
is doing the patient good, I can’t say I don’t care about money, it 
is not high on my list of things really…if I can save money I will. 
For instance, liquids are really overused for peg patients. Day-
to-day I am not hugely overburdened by cost restraints. It would 
be the ward manager probably that has that problem once she 




However, apart from a reference made by Joan (Doctor 1) to prescribing 
restrictions in primary care, the other participants did not refer to financial 
matters.   
Deirdre (Pharmacist 4) spoke of how she can see pharmacy staff beginning 
to get stressed and get things out of proportion. She spoke about trying to 
pre-empt or avert a crisis by intervening and reassuring staff that they can 
only do so much. She went on to describe how stress manifested itself in 
doctors and nurses: 
[Stress manifests itself] in a similar way [in doctors and nurses]. 
Sometimes a job that should be straightforward becomes not 
straightforward. Staff just need a little help and support. You 
see a lot more mistakes happening when staff are stressed 
(P4p9). 
She went on to outline new ways of working that she had introduced to ease 
pressure in the system with respect to medicines. Often these new ways of 
working brought additional checks and balances into the system. 
Each interviewee made reference to new ways of working, to changes being 
made to practice associated with how medicines were managed in their area. 
Many of these involved the introduction of a new (or current) member of the 
staff who would take on a new role or responsibility. The most appropriate 
professional would carry out specific roles. This was viewed as an 
improvement which made the process of using medicines more streamlined 
and the ward team’s working lives easier. This freed up time to focus on 
other tasks and helped in managing risk in the system. 
These changes included introducing: 
 Ward-based clinical pharmacists and technicians. 




 Nurses who focused solely on administering medicines. 
  Specialist nurses and pharmacists in acute hospitals – inpatients and 
outpatients. 
These changes contributed to changing the medical hierarchical model of 
working, increasing the recognition of the benefits of nurses’ and 
pharmacists’ roles, enhancing multi-professional working and in general, 
making the system more robust.  
Most participants spoke of having a clinical pharmacist and pharmacy 
technician based on the ward on which they worked. For some, this had been 
practice for a number of years and for others, this was something relatively 
new which they were still marvelling in. The approach was described as 
integrated medicines management (IMM) and these roles introduced a 
variety of checks and balances onto the ward. 
Cathy (Nurse 4) talked about how the integrated medicines management 
system allowed nurses to change from administering medicines from a trolley 
to administering a patient’s own drugs from the patient’s bedside locker and 
seeing this as a safer approach: 
You have time to interact with your patient as well and you get 
to know what medicines are specific for them (N4p4).  
She added: 
I think there is less risk of, you know what nursing is like, you 
get interruptions quite a lot, you could easily be picking up the 
wrong thing in the trolley whereas in their cupboard it is specific 
for them [the patient] and I think it is a lot safer system (N4p4). 
Sally (Doctor 3) summarised what most of the nurses and doctors expressed: 
So pharmacists are a key part of acute medicine and we miss 
them when they are not there. They are great at coming in and 
knowing what is missing, what should be done and what should 




Doctors and nurses spoke proudly about their pharmacist who acted as their 
advocate in pharmacy, speeding up the supply of medicines.  
Deirdre (Pharmacist 4) spoke of staff working differently compared to when 
she first qualified: 
Roles have changed now. Years ago it was the doctors that 
prescribed and the pharmacists and nurses worked quite 
separately. Now the nurses can prescribe and the pharmacists 
can prescribe too, so there is much more sharing of roles 
(P4p9). 
Pharmacists were able to build on their clinical role at ward level by 
continuing to develop new ways of working. Caroline (Pharmacist 5) 
described how she has picked up on therapeutic drug monitoring as being 
important on her ward and has developed the pharmacist’s role in that. She 
described it as something which doctors maybe didn’t view in the same way 
that pharmacists did, not placing the same importance on it. She described 
building on her undergraduate learning on the subject and using this in 
practice. She said: 
We would find a lot, for example, a gentamicin level and it 
would come back high and we would say, but what time was it 
taken? Is it taken at the right time and we are maybe the ones 
that prompt that conversation to look at rather than just saying 
its high so let’s hold the next dose. I suppose I’ve kind of 
developed our role in that, that we are the ones that tend to 
manage that a lot and the junior doctors will come to us then to 
ask, “what will we do with this next dose, do we need another 
level?” (P5p13). 
The role of independent pharmacist and nurse prescribers was highlighted by 
a number of participants, some of whom were independent prescribers. It 
was interesting that the initial nurses who volunteered to participate in the 
study were prescribers and I had to proactively seek non-prescribing nurses. 




as a fourth pharmacist who was training to prescribe. All of the independent 
prescribers spoke of the benefits to patient care and managing risk of being 
able to prescribe. These included: 
 Making it easier to change inappropriate or incorrect prescriptions. 
 Resolving concerns in a more timely way. 
 Being able to provide complete, joined-up care for patients. 
 Being able to work more closely with patients. 
 Feeling more fulfilled in their professional role. 
They also described their prescribing practice within the overall work of the 
multidisciplinary team as opposed to working as lone prescribers in isolation. 
Patricia (Nurse 1) spoke of her prescribing role with enthusiasm. She 
prescribed only drugs to treat diabetes and worked closely within guidelines:  
There are loads of medications out there but I work within my 
guidelines obviously and what best suits the patient and what is 
going to have the better outcome (N1p3). 
When explaining how, as a prescriber, she interacted with the other members 
of her MDT, Patricia spoke about the weekly two-hour meetings where 
positive experiences and potential problems with drugs were discussed. 
Being able to prescribe gave this specialist nurse a feeling that she is 
working at a higher level for her patients and team. She described it being so 
much easier and making better use of time:  
I know I can go in and say, well I would recommend and be 
alright to prescribe it and know that it will be followed through 
and it is your recommendation and I am positive that this is 
going to work and this is the right way forward and this is what 




Rebecca (Pharmacist 1) spoke of the benefits of pharmacists being able to 
prescribe for patients and for the overall system: 
Yes it definitely is beneficial if a pharmacist could make the 
changes there and then. I think it would also cause a lot less 
errors, be a lot safer for patients. They would have better all-
round care and I do also think their discharges would be an 
awful lot quicker because you’re not worrying about getting 
Kardex changes, doing a whole big drug history, you’re not 
ending up doing a wee tiny med rec[onciliation]at discharge and 
you are sorting the problem there and then (P1p12). 
Polly (Pharmacist 0) commented: 
Non-medical prescribing has shifted things slightly. It’s still 
evolving and it will be interesting to see what happens over time 
especially with complacency. Medical staff, not immediately, but 
maybe within 1-2 years, get a bit tired with the monotony of 
prescribing. Carelessness can come in, there is always 
someone else coming in checking my script, “I’ll just get it done 
quickly and will just wait for the phone call”.  I wonder if that will 
come in with the NMPs where initially they may be very, very 
cautious in terms of prescribing, paying meticulous attention to 
detail, if that will wane as well as it becomes routine over time 
(P0p7). 
She commented on a difference she has seen between nurse and 
pharmacist prescribers: 
I also wonder, I’ve seen some nursing staff who have less of an 
air of caution than I see in pharmacists taking on that same 
role. They say, “that means I can prescribe anything” and we 
[pharmacists] have to say, “no, just within your clinical sphere, 
your scope of practice”. Pharmacists tend to be very tentative 
prescribers and build their confidence. Nurses, some of them 




Nurse and pharmacist prescribers spoke of the benefits of being able to 
prescribe and sort things out quickly and efficiently. This was supported by 
some of the doctors (Sally and Mary). 
The pharmacist prescribers who participated in the study each had at least 
ten years post-registration experience and had each worked on a particular 
ward for a number of years and felt part of the ward team.  
Karen (Pharmacist 2) said that she can: 
amend discharge letters and Kardexes within my competencies, 
so a lot of things I would discuss with the doctors at whatever 
grade I felt was appropriate…..Sometimes I will make a 
decision, I don’t necessarily have to speak to a doctor but I 
think on the ward you are very much seen as part of the 
multidisciplinary team and the consultant is still the person with 
the name above the patient’s bed (P2p3). 
She said that she was a cautious prescriber and again saw the benefits of 
her being able to prescribe in improving medicines safety, proactively 
changing prescriptions as opposed to leaving a note to get a medicine 
changed and making changes at the right time.   
Rebecca (Pharmacist 1) outlined her current training as an independent 
pharmacist prescriber. However she expressed a need for pharmacy leaders 
to define what the pharmacist’s prescribing role was, with reference to the 
legislation and also to provide clarity for pharmacy and non-pharmacy staff. 
The extent of pharmacist prescribing roles varied across Northern Ireland 
and Rebecca believed that this was confusing especially for medical staff that 
moved between hospitals. 
The more senior doctors who were interviewed spoke of the development of 
pharmacist prescribers, seeing the benefits in safety and doing things at the 




The nurses highlighted having a named medicines nurse on the ward that 
focused on administering medicines as being another check and balance. 
This role recognised the importance of the medicines task, provided 
continuity by having one nurse as the person to speak to  about medicines 
issues, for example, waiting for a drug blood level result to come back and, it 
was hoped, reduce interruptions on medicines administration rounds.  
Shirley (Nurse 2) spoke about the nurse who is administering the medicines 
wearing a tabard with a sign saying, “do not interrupt.” This empowered more 
inexperienced staff to focus on administering medicines. She said: 
There are people that will turn round and say, “sorry I am doing 
medicines, I can’t be interrupted”. Obviously junior staff, it takes 
a wee bit more for them to stick up for themselves. Then you 
would see them locking up trolleys- it’s all about being able to 
say, “no I can’t do this right now” (N2p9).  
Patricia (Nurse 1) described the new nursing approach to administering 
medicines: 
I would say definitely [it has changed]. Before when you were 
doing medicines people would have come up and said, 
“Where’s this? Where’s that? Can you get me that? Can you do 
this?” Now specifically we have got nurses and their main role 
that day, that morning, and job is to give the medication out. So 
they are focused on that and that only (N1p10). 
Some participants spoke about nurses and pharmacists who had developed 
specialist clinical roles. With respect to how she worked with new Specialist 
Nurses, Joan (Doctor 1) spoke of changed practices: 
Because they are all Nurse Specialists, they are all highly 
trained. They are able to feed back and say, “no, can we try this 





Deirdre (Pharmacist 4) mentioned Consultant Pharmacist roles in working 
with older people. She described pharmacy Medicines Optimisation in Older 
People (MOOP) teams which were developing to help with supporting and 
monitoring medicines use in older people to help keep patients out of 




All participants described using checks and balances when working with 
medicines. These helped in managing risk. They included internal, personal 
checks and balances but more usually having wider systems checks. Each 
professional group described the importance of reviewing prescriptions 
regularly. This was a key, routine check in the system and errors occurred, 
for example, missed doses when this did not happen. Other checks and 
balances in the system included,  making good decisions, checking 
information with patients and carers, structuring each day’s work, prioritising 
tasks, being able to access information, making the best use of time, 
introducing new ways of working and developing new roles. These were 
integrated into practice.  
 




In this section I will provide an overview of the strategy working together 
using supporting data. The term working together as opposed to working as a 
team has been used as the data shows that, when working with medicines, 
doctors, nurses and pharmacists individually bring a unique perspective and 
carry out a specific role, as well as contributing to the benefits of the work of 
the multidisciplinary team. In Chapter 5, I laid out the data on the individual 




managing risk. In this next section, I will build on this by exploring how 
participants described working in a team, their multi-professional 
interdependencies and finally, the data on how they communicated with each 
other.  
 
6.3.2   Working together 
 
A range of healthcare professionals work on acute hospital wards and this 
study focused on doctors, nurses and pharmacists. Physiotherapists, 
dieticians, speech therapists, social workers and pharmacy technicians were 
also mentioned by participants but their roles do not fall within the scope of 
this research.  
Most participants made reference to how working together as a member of 
the multidisciplinary team (MDT) on the ward was a strategy for managing 
risk. Nurses, in particular, spoke of how everyone worked together and 
supported each other to do a good job. Pharmacists were keen to confirm 
that they were well-accepted members of the ward multidisciplinary team but 
also members of the pharmacy team as well. Doctors spoke of team-working 
and listening to the views of the MDT, but did not specifically refer to 
themselves as being a member of the team. 
I interviewed four individuals who worked together on the same ward; Shirley 
(Nurse 2), Jackie (Nurse 3), Caroline (Pharmacist 5) and Sally (Doctor 3). 
They were able to speak about working together from that perspective, 
although the fact that they worked together was only referred to by the 
nurses. Shirley spoke of everyone as, “having each other’s backs” (N2p7). 
She also knew at the start of a shift whether a day was going to run smoothly 
or not depending on what team members were on duty.   
When asked how powerful she felt in being able to make change or highlight 
things, Jackie (Nurse 3) said that she felt confident asking doctors if 





I think it is just a good rapport that we all built up together and 
everybody has been here now for maybe over a year, the same 
team. It has been quite good and then when the doctors change 
over, because the nurses and pharmacists have all been here a 
while, they can build up and give the doctors some support 
when they are just new into the setting (N3p8). 
All of the pharmacists interviewed spoke about being a member of two 
different teams; the ward-based multidisciplinary team and the pharmacy 
team. They had competing loyalties but even though they were pharmacists 
to their core, they felt, most of all, part of the ward-based team. Karen 
(Pharmacist 2) described a tension between being the pharmacy person on 
the ward and being that clinical, ward-based person that is going to benefit 
the patient in the bed at that time. She spoke of wearing two hats: 
You are very aware you are the face of pharmacy and you’ve 
still got that enforcement role. So there are the legal aspects 
you need to keep right and you still have the cost savings and 
you don’t want them to over-order or order the wrong things. 
Then you are trying to promote the other side of the safe use 
and prescribing and do your clinical role as well (P2p12). 
When asked what she thought other members of the multi-professional team 
viewed her role to be, Angela said: 
Probably just giving out tablets and putting them in a bag. Some 
of them have a better understanding than others. Some of them 
know you do a medicines’ reconciliation which is important. 
There is one nurse in particular that would come to me and ask 
me if I have done a medicines’ reconciliation before she even 
does her medicines in the morning because she knows there 
can be mistakes made. Others have a very poor understanding. 
If you are told there is a discharge and they say in the same 
breath, “what time will that be?” There is clearly no 
understanding of what you do. Or you have to check what they 




home team? Is it complex in some sort of way that you can’t 
instantly answer what time it is going to be ready at (P3p13). 
All of the pharmacists said that it took time to become part of the ward team, 
with Rebecca (Pharmacist 1) believing that pharmacists should have longer 
rotations on each ward to build relationships. When asked what working with 
the team looked like, Angela (Pharmacist 3) said: 
Just being there really, being available on the ward, talking to 
people, being approachable. Like I said, with the consultants, I 
think it takes a while to get there with pharmacy. It takes a while 
to develop those relationships. The consultants will come to me 
and chat to me, all of them will. The nurses come in for things, 
the dietician, and social workers will come to chat about how we 
are getting someone home with their Medi-dose. I think it is just 
important to be there, be friendly enough that people will come 
and ask you things and respect what you are saying (P3p6). 
Sally (Doctor 3) also recognised that her relationships with the pharmacists 
developed over time:  
First I think often in initial encounters, they [pharmacists] are in 
correction mode and highlight things. If you are not used to 
having a pharmacist looking over you, the initial reaction is 
defensive. Then as you work with them day-by-day, the 
relationship evolves (D3p4). 
So, the role of the pharmacist on the ward team is valued by all professionals 
but is a role which is developed over time.  
Medication incident forms are completed when an error occurs. These forms 
are used to identify learning and trends. They can be completed by any 
member of staff with the ideal being that they are completed by the person 
who made the error. When talking about completing incident forms about 
errors which other team members had made, Angela (Pharmacist 3) was 




No matter what relationships you build with the team, you have 
to think of the patient first. If it is going to ruffle a few feathers, 
well it has to be done but you just have to do it in the right way 
so as to keep the good relationships with the team (P3p10). 
Some pharmacists spoke of being on multidisciplinary ward rounds with the 
consultant, junior doctors, nurses and other team members as well as the 
patient and the benefits of being able to discuss and make decisions there 
and then, as opposed to after the fact. Other pharmacists described being 
members of the multidisciplinary team but walked around after the medical 
team had completed their ward round, picking up concerns. They then had to 
approach individual medical staff to resolve problems after the ward round. 
These two different ways of working often reflected the busyness of the ward, 
the experience of and the competing pressures on the pharmacist who may 
have had to work a dispensary shift and so were not on the ward all the time. 
Jayne (Doctor 2) was cognisant of her lack of knowledge of medicines and 
needing the support and advice of the multidisciplinary team (MDT): 
That is what has led me to feel that I do need the MDT to help 
me because I know there is so much of medicine that I don’t 
know and particularly with regards to medication. I just know 
how little knowledge I have in comparison to how much there is. 
That’s why I am so much more willing to have other people 
because they have their own specialty, their own knowledge, 
their own expertise and if you put it all together then we are all 
going to be much better off (D2p7).  
She spoke about how her experience of working in a multidisciplinary team 
has changed her professional practice. She had learned the importance of 
listening to other healthcare professionals, valuing their input and 





Frank (Doctor 6) commented on how he used a formal multidisciplinary team 
(MDT) approach to manage risk both locally within their hospital and 
regionally, as part of regional MDT meetings. The local team re-introduced a 
new, high-risk treatment into their hospital. This involved the whole team 
meeting up to review and write a new protocol, providing profession-specific 
training and walking through each stage of the process.  
All junior doctors (FY1s), with one exception, felt that they were made 
welcome in each team they joined. The implication of the negative case was 
that the unwelcoming team was the team of doctors (surgeons) as opposed 
to the multidisciplinary team on the ward. Junior doctors felt well-supported 
by their seniors during working hours but less supported out-of-hours.  Whilst 
they did not attend consultant ward rounds, FY1s felt able to ask questions of 
all healthcare professionals and that they were encouraged to do so. They 
did not allude to being a member of any particular team. FY1s all described 
seeking support and advice from nurses and pharmacists as well but did not 
describe this within a team context. Jack (Doctor 7) commented: 
I actually quite like moving around teams. I think it’s nice and 
it’s nice to get to know who people are on all different teams. 
We are familiar with the nursing staff because we do out-of-
hours but more so medical teams. It is nice to get to know the 
new people and so far they have all been super and very 
welcoming and integrated straightaway (D7p3). 
When asked how the system adapted if there was a weaker member of a 
team, Mary (Doctor 5) described an experience of knowing of a weaker 
colleague and said that if she had to work on the same ward with them  that 
she would double-check things with the nurses and check what the individual 
was doing. She would make sure the nurses were comfortable with the 
individual’s practice and if not, tell them to come to her or a senior colleague. 
Pharmacists and doctors in particular described being supported and seeking 
additional information on medicines from specialist colleagues from within 
their own profession, with doctors also getting information from a pharmacist. 




and then doctors. Two pharmacists and one doctor worked with colleagues 
on a regional basis, for example, producing guidelines as a member of an 
older people’s pharmacist peer network or making decisions as a member of 
a regional multidisciplinary team.  
However, as well as feeling supported, some participants raised concerns 
about having to protect themselves when working together. Cathy (Nurse 4) 
spoke of needing to document concerns which she had raised: 
For us, we are looking at the Kardex every day to make sure we 
have flagged that [a missed drug] up. If we have flagged that up 
and no one has taken any notice, then we have protected 
ourselves and unfortunately it is all about protecting (N4p11). 
Rebecca (Pharmacist 1), made reference to there being a blame culture 
where she worked: 
I think that we have a very big blame culture. I think that nursing 
staff are a lot more cautious of what they do and what they are 
doing with medicines than maybe what they did at the start 
whenever I started in the Trust (P1p6). 
However these were the only references which participants made to needing 
to protect themselves when errors were made.   
A number of participants from each profession also described the change in 
relationships from a medical hierarchical model to more collaborative working 
where everyone’s opinion was valued equally. Karen (Pharmacist 2) 
recounted her experience of these changes:  
I don’t know if it is just culturally that those barriers have got 
broken down and the doctor is maybe not seen as the big 
doctor or the person in charge. They are still in charge and they 
still have the responsibility but I think they realise and 
appreciate that there will be a better outcome for the patient if 
they do accept everybody’s input and even in terms of listening 




In relation to her experience of working as part of a multidisciplinary team, 
providing care to older people, Jayne (Doctor 2) commented:   
We were all [the multidisciplinary team] sitting around and all 
bringing issues about what the patient went through, each 
patient on the ward. That impressed on me that in the past it 
would have been the doctor’s word is law, this is what we are 
doing. If things don’t happen it is not because the doctors did 
something or didn’t do something. It is more when you have 
that MDT and you see exactly how much they do and how it 
influences the patient’s progress through hospital. It has really 
taught me to listen to what other people say (D2p2). 
Other doctors highlighted the importance of involving the nurses in decisions 
about medicines administration and involving pharmacists in decisions about 
complex drug choices in particular. Patricia (Nurse 1) commented on this 
changed approach:  
Gone are the days now that we are moving from the hierarchy 
of you are just the nurse and I am the doctor. They will respect 
and ask, ”well, you are the one that is administering this so you 
are the one who is more familiar with this – what do we need to 
do?” (N1p26). 
Representatives from all three professions described working with and 
supporting healthcare professionals at different levels of their career. Junior 
doctors felt well-supported by senior medical staff as well as by nurses and 
pharmacists. Shirley commented (Nurse 2) on the nurse’s role in this:  
With doctors, especially junior doctors, just coming fresh on, it 






In listening to especially nurses and pharmacists, it is apparent that there are 
interdependencies between their work and that of the other team members. 
These can be viewed as cogs. 
 
Figure 8: Multidisciplinary interdependencies when working with medicines on an 
acute ward 
Nurses described having a responsibility for making sure they are 
administering the right drug to the right patient and to do this, they must 
make sure that the prescription is right.  Shirley (Nurse 2) highlighted this: 
It is important for us to make sure that we have it right but it is 
important to make sure that it is documented right as well. Also 
making sure the timing is right for critical medications – it is our 
responsibility to make sure the patient gets it on time (N2p7). 
Equally, pharmacists needed to check that the prescription was correct in 
order to dispense or supply medicines, as well as it being part of their 
professional, ward-based clinical role. Therefore the system is designed so 
that nurses and pharmacists cannot carry out their roles without the doctor, 
or prescriber, having completed their role accurately.   




















Healthcare professionals are aware that they need to be constantly checking 
that the prescription is right as part of their independent professional roles. 
Therefore medical staff will always know that others are checking their 
prescribing and this gives a sense of the risk being managed and somewhat 
reduced because of this. Some comments from Sally (Doctor 3) and Angela 
(Pharmacist 3) on this were: 
 They [the pharmacists] have our backs (D3p5).  
They [doctors] know they have a back-up there but it can 
sometimes be dangerous because they do have the attitude 
sometimes, “oh well sure pharmacy, somebody will be checking 
it anyway” (P3p7). 
Doctors spoke of having a lot to do and making sure they did each thing well. 
They seemed to be able to assess the relative risk of each task and prioritise 
work accordingly. This way of working however, could impact on the work of 
nurses and pharmacists who had to tie up loose ends and who could not 
progress with some of their own work before making sure a prescription was 
correct. 
As part of working together, communicating with other healthcare 
professionals and with patients and their carers was mentioned by all 
participants. Participants regularly asked colleagues from all three 
professions for advice on medicines, especially when making decisions about 
things they were not familiar with or when seeking clarification.  
Most participants asked pharmacists for information on the use of medicines, 
usually to build on basic information which they already had read in reference 
books such as the BNF. This was also the case for pharmacists who asked 
for information on particular drugs from other pharmacists who had 
experience of their use or who worked in a particular specialty. This 
additional, deeper knowledge of the drug in-use was respected and sought 
after. Pharmacists referred to doctors and nurses when they wanted to 
understand more fully the clinical or social context in which medicines were 




The diabetic nurses and those sorts of teams that come to the 
ward can be really invaluable when you are thinking about 
medications and what we are going to do with them and to have 
a specialty coming in, that’s brilliant. Palliative care teams and 
all those teams coming in are great for advice (P5p15). 
Nurses asked pharmacists for reassurance on the use of a particular 
medicine when deciding whether to administer it. Patricia (Nurse 1) 
commented on a pharmacist’s role in supporting her conversation with a 
patient:  
I go on to a ward and sometimes it is better to ask the 
pharmacist about your patient than the doctor.  I’m not being 
disrespectful to the doctor but the pharmacist will know what 
they are on and they will know the details like they eat their 
dinner at this time. They know the patient, they speak with the 
patient, they review them and it is amazing. There is more 
clinical time there. Even pharmacists we work with have one-to-
ones with patients. It is amazing and I love it because then it is 
like a consultation on their own, and then I could say,” would 
you mind coming in?” and, “do you think this is okay?” and, “will 
that go with that?” (N1p19). 
Sally (Doctor 3) asked other specialists, for example microbiologists or renal 
physicians, for advice on prescribing a drug she would not use routinely. This 
allowed her to manage the higher risk of making a prescribing error with an 
unfamiliar drug.   
All junior doctors interviewed spoke of the ease with which other professional 
colleagues (doctors, nurses and pharmacists) answered their questions and 
helped them to make prescribing decisions.  
Nurses and pharmacists described communicating with and signposting 
doctors towards making decisions on what was usual prescribing practice on 




The medical team obviously has the ultimate decision on 
medications but for us we will happily go and suggest things to 
the medical teams especially for the likes of our COPD patients, 
at end- of- life, could we add in more Oromorph/Oxynorm for 
the relief of breathlessness? That is just from experience that 
we have had and we would be saying [to new doctors], “look 
this is what works for our patients” or the likes of even 
suggesting syringe drivers (N4p10). 
The most common way of communicating on acute wards was by word of 
mouth, although participants also wrote comments on Kardexes or made lists 
of tasks in communication books. Jackie (Nurse 3) explained:    
A lot of the communication would be verbal. Then they [doctors] 
will write on the Kardex if they want any medications held and 
they will write for it to be reviewed then. Generally it is quite 
clear. It has improved a lot (N3p11). 
Caroline (Pharmacist 5) added: 
So you will see some of our doctors writing when they are 
prescribing even an anti-epileptic, they will write in there,” 
critical medicine - give on time” (P5p23). 
When asked how a doctor decides whether to pass on information verbally or 
in writing, Jackie said: 
I don’t know if it depends maybe on the individual. It is hard to 
speak for the doctors because I think it depends on what way 
they find it easier to work for themselves. Nine times out of ten 
they do both, just to make sure that nothing is missed …. if the 




Deirdre (Pharmacist 4) however said that everybody would document what 
they had done: 
Doctors would document in the patient’s notes, if they’ve 
counselled or advised a patient, why they need to take 
something and likewise with a nurse. She would document in 
her nursing notes if counselled or added something extra to 
help a patient, and likewise a pharmacist (P4p14). 
Cathy (Nurse 4) described the importance of knowing what was going on with 
medicines and being able to answer queries on the consultant ward round. 
She gave an example of when a medicine is held for a few days, for 
example, a diuretic. The prescriber will put the code ‘8’ into the administration 
box on the Kardex:  
I have a patient whose furosemide was 8ed over the weekend. I 
knew that, I relayed it to staff and then this morning on the ward 
round, the new consultant wanted to know. I was able to relay 
the information and she was able to review that (N4p5). 
Sometimes that medicine will continue to be held until someone proactively 
rescinds the order and patients may not get their drug until the next 
medicines review. Cathy continued: 
Sometimes doctors will ‘8’ medications and they are not always 
reviewed on a daily basis. That’s where the patient could be 
missing an important drug for days on end. So it is very 
important and it is our responsibility to be flagging that up on 
ward rounds (N4p6). 
Mary (Doctor 5) highlighted her practice of keeping nurses in the loop with 
ward round decisions and making sure instructions are clear: 
I would go up to them and say, “Would you mind, we are 
starting this new tablet, is that ok?” And then just go through it 




Similarly Mary would communicate with pharmacists: 
I would just say to one of them, “I’ve done this discharge. Would 
you mind checking the medications for me?” or, “I think this is a 
blister pack. Would you mind chasing the medicines for me, 
organising that?” (D5p17).   
Ward-rounds or daily multi-professional white board meetings were also 
highlighted as effective and efficient ways of finding out what was happening. 
Karen (Pharmacist 2) explained: 
The ward sister and the rest of the team would run through 
each of the patients in about ten or fifteen minutes (P2p4). 
Caroline (Pharmacist 5) described how she made notes on the Kardex to 
prompt doctors:  
We note things on the Kardex as well if they are not necessarily 
urgent but they may require reviews, say if someone needs to 
review a discharge. So I know that a doctor will see that, if I 
write on it. If the doctor is doing a discharge letter, that will 
prompt them to come and ask me if they are not sure what it 
means or ask a senior or review it and make a decision 
themselves for whatever it might be (P5p6). 
All pharmacists mentioned having to decide what level of doctor to query a 
prescription with. Caroline (Pharmacist 5) commented:  
I suppose the big thing for us, which is a big learning thing for 
me here it is picking what grade of doctor you are going to 
approach for the query (P5p6). 
Most pharmacists spoke to higher-graded medical staff and would escalate 
queries to consultants if they were uncomfortable with an answer from a 
lower-graded doctor. It was recognised by participants from each 
professional group that the most accessible doctor could be the one with 




Polly (Pharmacist 0) spoke about the importance of knowing how to 
approach different medical staff, especially if you did not know him or her: 
It can vary enormously depending on whether you have a 
working relationship with the doctor or if you have not met 
before. You can take more shortcuts in communication if you 
know them. You know how they think and how to communicate 
to get the outcomes you want to get (P0p3). 
She spoke of a scenario she had been part of a few months earlier where her 
query had not been acted upon. On reflection, she realised that adopting a 
different approach may have helped: 
It was about a patient and the choice of drug. Very quickly in 
the conversation [with the doctor], I realised it was not so much 
about that patient, the issue for the prescriber was being forced 
to use guidelines. If I had approached the conversation and 
hadn’t mentioned this is what’s in the guidelines, I’d have got a 
different response. So it’s learning all of those kinds of things 
and getting to know the different influences that other people 
have in making decisions (P0p4).  
So, building relationships is important to supporting healthcare professionals 
working together constructively and managing risk.  
Jackie (Nurse 3) described the dynamics of doctors, nurses and pharmacists 
communicating with each other on her ward. She spoke of the nurse as 
sometimes being involved in conversations between pharmacists and doctors 
about medicines, acting as a go-between: 
We all work pretty well together, so if the pharmacist picks up 
on anything, they let us know or they even let the doctors know 
and we will all work together. There is good communication 
because if there is something the pharmacist feels needs 
changed when they are doing their medication review, they will 
let me or the doctor know, and then they would tell me if they’ve 




Jackie was the person who administered most of the medicines on the ward 
during her shift. She also seemed to be the central person who passed on 
information on medicines between shifts and other colleagues. In that 
context, she gave an example about waiting for drug level results: 
So they would let me know because sometimes the doctors 
would go home at 5pm and then the [drug] level is not due back 
until a wee bit later than that. Then they would let me know 
what I was looking for so that when it does come back, I know if 
I am able to give it [the drug] or not. Then I can let the doctors 
on the long day know what the pharmacist and doctor had said 
before that (N3p11). 
In all of these scenarios, there was no mention of having a written protocol 
for how information on medicines was passed on between professionals and 
between shifts. All participants commented that the doctors, nurses and 
pharmacists on the ward communicated well, with a small number saying that 
in the past, communication could have been poor, for example about drugs 
being withheld, but now, with medicines being reviewed more regularly, this 
has improved.   
Caroline (Pharmacist 5) said that pharmacists are communicating with 
nurses all the time, mainly relating to the patient’s home circumstances, as 
the nurses tended to know the patients best. She continued: 
So we do a lot of communicating about who manages a 
patient’s medications with the nurses. So you know, is it the 
sister or daughter or somebody there that we can ask? We 
would also prompt the nurses on a lot of thing. They would 
come to you with things that maybe we haven’t seen on a 
Kardex or they would come to you, “does this look ok or is it 
usually prescribed this way?” So we do a lot of reassurance 





Electronic communication of changes to medicines was described by 
Deirdre (Pharmacist 4) as being a current, potential barrier to effective 
communication:  
I think the main barrier would be the electronic communication 
of changes to medications. You can see in the future a potential 
for everything to be fully joined up but we are not there yet. 
People are trying to improve and make changes but then they 
don’t get communicated to the right people. So patients can 
sometimes end up being on duplicate medication or staying on 
things longer than they should because something hasn’t been 
communicated to the right person; or it has been communicated 





The input of different professionals working together, each having different 
levels of knowledge, experience and training, is a strategy for managing risk 
when working with medicines. Working in a team, building relationships over 
time and knowing how to approach each other helped with this. Cognisance 
is taken of new staff who join established teams and learn new ways of 
working as they rotate between specialties. Nurses and pharmacists rely on 
the prescription being accurate before they can carry out their role of 
administering, dispensing or clinically checking a prescription. There is no 
reciprocated interdependency for doctors when prescribing initially. Doctors 
know that a nurse and/or a pharmacist will be checking what they have 
prescribed and whilst that gives them a level of reassurance, it gives nurses 
and pharmacists an extra job to do to make sure the prescription is right or 
complete. Getting advice from different professional colleagues was also 
mentioned. This was highlighted as a change from the traditional medical 









Strauss and Corbin spoke of consequences as follows: 
Whenever there is action/interaction or lack of it taken in 
response to an issue.., there are ranges of consequences, 
some of which may be intended, others not (1998:134).  
Consequences can be further described in terms of their properties and I 
have tried to do this to ensure a richer and fuller explanation of what is 
happening here. 
 
6.4.2 Ensuring each patient gets the right medicines 
 
All doctors, nurses and pharmacists spoke about the consequence of 
managing risk when working with medicines as ensuring each patient gets 
the right medicines.  
It is important to note that whilst the consequences are written as positive 
statements, strategies for managing risk were not always successful. 
Therefore there is a continuum of consequences, defined further by their 
properties and dimensions, for example, ensuring or not ensuring that each 
patient gets the right medicines. 
Participants did not give many examples of specific medication incidents but 
they were actively managing risk, with an inherent assumption that there was 
risk in the medicines management system. There were also unintended 
consequences of managing risk and I will make reference to both of these in 




The term each patient is used because all healthcare professionals involved 
in this study described making decisions in the context of an individual 
patient, using the best information available and looking into the potential 
implications for that patient as a result of a decision made at a specific point 
in time. Optimising medicines means putting the patient at the centre of 
decisions about medicines to achieve certain outcomes. Whilst this was not 
described overtly as being a strategy adopted fully by all healthcare 
professionals, the participants did describe practice moving in this direction.   
Patricia (Nurse 1) spoke about how she prescribed in her specialist role: 
Looking at my patient, looking at what their requirements and 
needs are, then I would base my decision on that (N1p3). 
Ensuring each patient gets the right medicines involves stopping 
inappropriate medicines (de-prescribing), as well as starting new medicines 
and this happened as a result of proactive prescription review. Joan (Doctor 
1) spoke of how she worked with medicines: 
It’s one-to-one, it’s what you do on a day-to-day basis, it is 
evidence of efficacy and then the problems you encounter with 
it and still then you have got your guidelines and your feedback 
from all your colleagues. It takes a heck of a lot to keep going at 
everything and I am doing it ok (D1p12). 
Not managing risk effectively resulted in errors being made, for example, 
patients having an inaccurate prescription or being administered or supplied 
the wrong medicine. Participants described this happening particularly when 
they were using a medicine which they were unfamiliar with, when they did 
not focus on their work or when they had insufficient time to complete a task 
fully. This was not ensuring each patient gets the right medicines.   
All the participants wanted to do a good job and use medicines accurately, 
safely and appropriately to get positive treatment outcomes for patients. They 
spoke of working within guidelines and their professional Code of Practice 
and also having a level of job satisfaction to ensure each patient gets the 




Participants highlighted a number of possibly unintended consequences of 
managing risk. In Chapter 6, I described how professionals had developed 
new roles. This resulted in more collaborative working among healthcare 
professionals as well as between healthcare professionals and patients. This 
contributes to ensuring each patient gets the right medicines. It has fostered 
increasing joint decision-making and the development of a medicines 
optimisation approach. It also has resulted in new legislation and the 
beginnings of a shift in power relationships within healthcare.  
Patients were also involved in ensuring that they got the right medicines. This 
was more than affirming that they were on the right medicines as mentioned 
in Section 6.2 on using checks and balances. Patients also made agreed and 
informed decisions about their medicines to ensure concordance.  Joan 
(Doctor 1) commented: 
I think more and more patients are getting more knowledgeable 
and powerful and it is really great when they do sit down and 
say, “Can we look at that list?” And I think yes, let’s look at that 
list – why, why, why? (D1p15).  
Jackie (Nurse 3) added: 
Then they [doctors] ask the patient what works for them at 
home? (N3p7). 
Frank (Doctor 6) spoke about involving patients in treatment decisions: 
We do have a subset of those patients that would be young or 
think that they would like to follow a slightly alternative 
approach to their treatment and it does tend to be young 
patients. They think it through and it can be challenging being 
supportive of their conclusions, or trying to challenge them 





Angela (Pharmacist 3) had seen a change in her own practice from having a 
paternalistic approach to starting a new medicine, to including the patient 
more in making that decision: 
So I have changed a lot in that way, where I would ask the 
patient and talk it through with them and see if they are happy 
for something to change or trial them maybe without their 
quinine or whatever that may be (P3p8). 
Mary (Doctor 5) was the only negative case. She described a paternalistic 
approach still being taken in her clinical area when starting new medicines:  
It is very much, “we are just starting this tablet”; it is not, “we 
think this tablet might benefit you, what do you think?” (D5p29). 
She went on: 
It is not a discussion, it is kind of this is what you’ve got, unless 
we know it is an awkward patient …then we would be a bit 
more cautious of what we do and what we document (D5p29). 
I did not question what the participant meant by, “an awkward patient” and 
should have followed this up within the interview. Mary came back after the 
ward round to explain new medicines to patients almost covertly and hoping 
that they had no questions which needed to be fed back to the team. 
Frank (Doctor 6) spoke about how patients tended to be quite involved with 
their medicines often because they had to understand how to take 
complicated medicines regimens as an outpatient. These patients got 
support from a specialist nurse as well as written information on their new 
drugs and compliance support.  
These changes have also contributed to individuals, both healthcare 






Deirdre (Pharmacist 4) spoke about healthcare professionals being more 
aware of the history of medication errors occurring with associated 
consequences. She said that junior doctors in particular are more aware of 
this and that had resulted in them practising differently to junior doctors in the 
past: 
I think they are much more open to asking questions and asking 
for help. Also involving the nurses and pharmacists more and 
not being lone workers. When I first qualified there were a lot of 
doctors that you would’ve had difficulty trying to convince that 
they weren’t prescribing correctly or that they could do 
something slightly differently. I think it is easier now (P4p17). 




The consequence of managing risk is ensuring each patient gets the right 
medicines, or reducing the risk that they might not get the right medicines.  
This consequence has a patient-focus, with the data indicating that 
healthcare professionals are aware and sensitive towards the need to involve 
patients in making decisions about medicines and self-reporting doing so. All 
participants reported striving towards this goal and articulated the methods 













Holloway and Walker stated that, “the discussion focuses on the findings 
directly derived from the data and is not based on speculation or unfounded 
inferences” (2000:144).    
Creswell commented that in the final discussion section of a thesis, the 
researcher should, “discuss the relationship of the theory to other existing 
knowledge and the implications of the theory for future research and practice” 
(2013:229).  Urquart highlighted that the analytical generalisability of a 
grounded theory can be improved by, “relating it to other theories in the 
literature” (2013:169).   
Whilst many authors have outlined the purpose of the discussion chapter in a 
grounded theory doctoral thesis, few have proposed a specific structure. The 
discussion of the grounded theory can be interwoven into the data analysis 
section of a thesis; however I have chosen to present the discussion as a 
separate chapter. This is to allow a greater focus on discussing the theory in 
relation to the current literature identified following the emergence of the 
theory. 
Holloway and Walker (2000) provided an outline approach to the discussion 
chapter, underlining the importance of following the structure used when 
presenting the data, discussing individual findings as well as the research as 
a whole. I have used a modified version of Holloway and Walker’s approach, 
being mindful also of the need to answer the initial research questions.   The 
chapter includes: a statement of the aim and initial research questions; an 
overarching reflection on the findings and their interpretation; the relationship 
of the findings to the previous literature, structured in line with the integrative 
diagram (Figure 5); a summary of findings, including new findings, 
implications for practice; implications for future research; the strengths and 
limitations of the study including a personal reflection on how I could improve 




I will also analyse the merit of the grounded theory – its strengths and 
weaknesses. In doing this, I have used a framework for assessing research 
evidence in qualitative studies, produced by the Government’s Chief Social 
Researcher’s Office (Spencer et al 2003) (Appendix 18).  
 
7.2 Aim and initial research questions 
The aim of this study was to produce a theory which explains how doctors, 
nurses and pharmacists work to optimise the use of medicines in acute 
hospital settings in Northern Ireland. A theory has been produced and it is 
outlined in the integrative diagram (Figure 5).  
My initial research questions included: 
• Do healthcare professionals work to optimise the use of medicines? 
• What is each healthcare professional’s contribution to working in a 
team to optimise medicines use?  
• Why do they work in this way? 
• How do individual healthcare professionals define their role with 
medicines? 
The answers to these questions will be addressed in this chapter.  
 
7.3 A reflection on the findings and their interpretation 
This study has produced a grounded theory which explains how doctors, 
nurses and pharmacists work to optimise the use of medicines in acute 
hospital settings in Northern Ireland. I will compare and contrast the findings 
with the literature in Section 7.4. However in this section, I will provide a 




The grounded theory presented in this thesis addresses a gap in the 
literature in two key ways. First, as a theory, grounded in the data, it provides 
a multi-factorial explanation of how doctors, nurses and pharmacists optimise 
medicines in acute hospitals as opposed to solely considering inter-
professional collaboration and communication.  Second, it does so within the 
Northern Ireland context and so can be used to inform the current 
transformation in the health and social care agenda in the Province.  
The study shows that there are differences between how each healthcare 
professional approaches and values the use of medicines. The influence of 
new non-medical prescribers on hierarchies, professional pride, inter-
professional relationships and being able to make changes to prescriptions in 
real time showed how the practice, especially of pharmacists and nurses, has 
developed in acute hospitals in Northern Ireland.  
My data demonstrated a high level of inter-professional dependency in the 
system. Both the most junior (FY1) and more senior doctors made decisions 
knowing that there were safe systems in place to catch any errors. This 
knowledge supported them when carrying out multiple tasks whilst working 
under pressure. Doctors’ reliance on nurses and pharmacists to act as safety 
nets in catching prescribing errors is well-documented in the literature 
(Dornan et al 2009, Ashcroft et al 2015). However my study highlighted that 
nurses and pharmacists depend on having an accurate prescription to allow 
them to carry out their role. Whilst the literature described inter-professional 
communication being reliant on having a shared purpose, there is a paucity 
of references explicit to working with medicines. Having an accurate 
prescription also allows efficient use of nurses’ and pharmacists’ time. This 
data could suggest that professional roles and the overall system have been 
designed to manage risk through the adoption of professional standards and 
this ethos of inter-dependency. Such design may also reflect the traditional 
power relationships in acute healthcare (Benner 1984, Nugus et al 2010), 
with both nurses and pharmacists depending on and supporting doctors as 




The healthcare professionals in my study spoke about routinely and 
continually asking questions to clarify how medicines could be used safely. 
Participants gave a number of different reasons for this. Firstly, the use of 
multiple, often new, medicines required all participants to seek advice. 
Secondly, participants did not always have the most up-to-date information 
available about a patient or medicine when a decision was being made. 
Thirdly, doctors-in-training routinely prescribe medicines. This has been 
commented on by Dornan et al (2009). Doctors-in-training ask many 
questions in a learning capacity and the accuracy of their prescriptions are 
queried by nurses and pharmacists. Finally, some participants spoke about 
the rotational nature of junior medical and pharmacy staff not supporting the 
development of inter-professional trust and team-working as well as the 
effect which medical hierarchical relationships between doctors may have on 
patient care (Papoutsi et al 2017). This uncertainty, coupled with professional 
requirements to check prescriptions, meant that nurses and pharmacists in 
particular were not accepting prescriptions at face value, sometimes 
duplicating work. However this potential inefficiency helped to ensure that 
risk was managed and patients had a greater chance of getting the right 
medicines.  
The central tenet of medicines optimisation is patient involvement. Some 
participants spoke of involving patients and their carers in both checking and 
choosing the right medicines. Others aspired to this if they had more time. 
There was one negative case, where a FY1 doctor told how she covertly 
involved patients after a ward round.  Involving patients was self-reported, 
sometimes in response to an open question, and its accuracy cannot be 
confirmed due to the nature of the method used; however participants gave 
specific examples which rang true.  
In looking at the system as a whole, participants spoke of traditional, new and 
overlapping roles in relation to medicines. These included the specific checks 
and balances needed in managing risk. They also highlighted a lack of trust 
of the accuracy of the prescription, with some believing that all colleagues did 
not respect the importance of taking care when using medicines. This is 




such as prescribing, are changing, there is a need to make explicit the 
important roles of each healthcare professional in managing risk associated 
with medicines within the acute hospital eco-system. From my data, this 
supports effective team-working and ensures that current system checks are 
not changed. The development of new roles and practices will impact on the 
current balance of practice in both a positive and negative way and change 
must be managed thoughtfully with this in mind.  
 
7.4 Linking findings to the literature  
 
In this section I will provide an overview of the second literature review and 
link the findings of my research to the literature. 
 
7.4.1 Overview of the second literature review 
 
Grounded theory methodology necessitates revisiting the literature after the 
theory has been generated (Martin 2006). At that stage, I carried out a 
second, literature review, using a systematic approach. My literature search 
strategy is in Appendix 3 and a summary of the quality assessment of some 
of the key papers used is in Appendix 4. This second literature review had a 
new focus on managing risk and the conditions, strategies and 
consequences of the theory, as well as revisiting how healthcare 
professionals worked together in the prescribing and use of medicines.  
I will compare my findings with the literature in Sections 7.4.2 – 7.5; however 
I have provided detail on a number of key studies in this section (7.4.1) and 
quality- assessed a larger number of key papers (Appendix 4) to demonstrate 
my skills in critically appraising the literature. I chose the studies below 
because they were current, well-designed and relevant to my work; the 
authors stated their aim and were clear about an appropriate choice of 
methodology, including sampling, data collection and analysis. All included a 




independent analysts or through team discussion, reaching consensus. I 
have included some professional standards and reports to situate my findings 
within this arena as I hope to use my work to influence managers and policy 
makers. I excluded systematic reviews, comments and editorials apart from 
seminal works by Reason (2000) and Vincent and Amalberti (2016).  
The key studies used were conducted by different research groups 
predominantly in Australia and the United Kingdom. The Australian 
researchers (Manias et al 2014; Manias et al 2015; Rixon et al 2015; Liu et al 
2016; Wilson et al 2016; Borrott et al 2017) focused on inter-professional 
communication and collaboration between doctors, nurses and pharmacists 
in acute hospitals. This field has developed from focusing on two healthcare 
professionals, usually in community settings as seen in my initial literature 
review, to having a focus on three healthcare professionals in secondary 
care. Researchers predominantly have used mixed-methods including 
observations and semi-structured, one-to-one interviews. This methodology 
provided both empirical data as well as more, in-depth descriptions of what 
was happening.    
Manias et al (2014) reported that good, inter-professional, collaborative 
practice (IPCP) was essential to the processes contributing to the safe and 
effective use of medicines. Rixon et al (2015) particularly focused on how 
pharmacists communicated about medicines with doctors and nurses in 
specialist hospitals, using both observations and semi-structured interviews. 
They highlighted that these professionals worked separately on wards, 
coming together for specific short periods to solve a particular problem. 
Pharmacists tended not to communicate proactively, sometimes leaving 
notes for doctors on less urgent queries. Doctors and nurses would sooner 
have asked pharmacists for information on medicines than look for the 
information in the literature. They found minimal inter-professional working in 
fixed gatherings, such as ward rounds, due to all professionals not being 




Borrott et al (2017) carried out a qualitative study using ethnography to look 
at how doctors and nurses communicated about medicines in three acute 
paediatric wards in a tertiary children’s hospital. Junior doctors and nurses 
used roundabout ways of communicating whilst their more senior colleagues 
had a direct communication style. Nurses tended to be more deferential to 
doctors, as reported in earlier studies. Doctors and nurses who had worked 
together over a period of time in static teams demonstrated well-defined 
ways of interacting, working proactively together to make medicines-related 
decisions. Borrott and colleagues discussed their findings within the context 
of identity theory, (Burke and Stets 2009), with each professional being seen 
to carry out their individual role. Nurses, in particular, asked questions to 
ensure that they met their professional requirement to administer medicines 
safely. Interruptions and problems out-of-hours were described in this study 
as in other studies (Dornan et al 2009, Seden et al 2013, Ashcroft et al 
2015).  
Wilson et al (2016) investigated newly qualified healthcare professionals’ 
experiences of inter-professional, collaborative practice. They used thematic 
analysis of data from focus groups of newly qualified, practising doctors, 
nurses and pharmacists in tertiary hospitals. All participants lacked 
knowledge of what other professionals did and knew, although there was an 
understanding of the importance of appreciating and respecting each other’s 
roles. This study reported some examples of good communication and 
teamwork, commenting that healthcare undergraduates needed to be 
exposed to colleagues from other professions to support working effectively 
in teams in their future careers.  
All of these studies on inter-professional collaboration highlighted the 
complex nature of inter-professional interactions and the need for early 
training of undergraduate healthcare professionals together to facilitate 
effective inter-professional collaboration throughout their future careers.     
Researchers in the United Kingdom (Dornan et al 2009, Seden et al 2013, 
Ryan et al 2014, Ashcroft et al 2015) predominantly focused on prescribing 




by being part of larger study programmes such as EQUIP or PROTECT or as 
comparative work, to prove or disprove earlier theories (Seden et al 2013). 
Lewis and Tully (2009) also used grounded theory to demonstrate that junior 
doctors’ prescribing was affected by more senior doctors and nurses. This 
study, using critical incident technique and one-to-one interviews, highlighted 
that junior doctors sometimes prescribed medicines which they were 
uncomfortable to prescribe in recognition of medical hierarchies or to 
maintain the status quo. Their decisions to do so seemed to be risk-based, 
believing that another prescriber would undo the decision later with little 
impact on themselves or the patient. Errors as a result of taking such an 
approach have been reported in subsequent studies (Dornan et al 2009, 
Ryan et al 2014, Ashcroft et al 2015).       
In the EQUIP study, Dornan et al (2009) investigated the causes of 
prescribing errors by FY1 doctors in hospitals. This mixed-methods study 
resulted in at least two publications (Lewis et al 2009, Ashcroft et al 2015) 
although the full analysis is only available in report form (Dornan et al 2009).  
Findings were triangulated, with team discussion used to reach consensus. 
In their semi-structured interviews with thirty FY1 doctors about medication 
errors they had made, the authors defined error types according to Reason’s 
model of accident causation (2000). This recognised tool is widely used in 
the literature. Breakdowns in communication also contributed to errors. 
Dornan et al stated that, “the single most important finding of this study was 
the complexity of the system within which prescribing errors were made” 
(2009:124).This study also showed that FY1 and FY2 doctors made at least 
twice as many prescribing errors as consultants and non-medical prescribers, 
when corrected for volume of prescriptions written. The limitations of this 
study were that it depended on participants being aware of and happy to 
share examples of medication errors.  
A subsequent, similar study by Seden et al (2013) chose a sample size to 
allow comparison with Dornan et al’s findings. The authors however analysed 
prescribing errors both for individual drugs and for whole Kardexes as this 
had been identified as a gap in the literature. They found that the amount of 




errors. In contrast to Dornan et al, these authors found no significant 
difference in rates of prescribing errors between different grades of doctors. 
They highlighted the importance of medication review by pharmacists to 
reduce errors reaching patients. Prescribing error rates were similar between 
the studies by Dornan et al (2009), Seden et al (2013) and Ryan et al (2014).  
Ryan et al (2014) carried out a mixed-methods study of the frequency and 
reasons for prescribing errors made by FY1 and FY2 doctors in acute 
hospitals in Scotland (PROTECT study). This study served to help the design 
of future training programmes for junior doctors. Like Dornan et al, these 
authors reported that there were multiple causes of prescribing errors, 
involving especially environmental conditions and collaborative working. They 
also found that FY1 and FY2 doctors had higher prescribing error rates than 
consultants (FY1s: 7.4%, FY2s: 8.6%, Consultants: 6.3%) but not twice the 
rate as reported by Dornan et al. Ryan et al also determined high levels of, 
“misplaced prescriber confidence” (2014:8),  from responses to 
questionnaires and compared to error rates. They suggested that medical 
students should be taught the reasons for prescribing errors and how to 
avoid them in addition to current teaching on drugs. The overall prescribing 
error rates reported in these three papers were similar (9-10%).  
Two studies focusing on healthcare systems in the English NHS (Dixon-
Woods et al 2014 and Hignett et al 2018) also were of particular interest. 
Dixon-Woods and colleagues carried out a very large, mixed-methods study 
looking at, “culture and behaviour in the English National Health System.” 
Whilst this study did not provide details of results due to the enormity of their 
data (available in a separate paper), it defined high-level themes to help 
healthcare organisations to provide safe, patient-centred care. These 
included understanding improvement through interacting directly with patients 
and staff; reducing the negative impact of environmental factors and low 
staffing levels as well as focusing on effective team-working; listening to staff 
and making sure they felt valued, and clear leadership.  Hignett et al’s paper 
(2018) entitled, More holes than cheese, sought healthcare professionals’ 
examples of barriers to safe and effective health care in England. Data was 




workshops, for which participants self-selected to attend (n=135). Themes 
which evolved were complex and silo working, environmental pressures, 
ineffective communication and distractions.          
In summary, a number of authors have researched specific elements of my 
theory, using a range of methods. Some have focused in general on how 
healthcare professionals worked together in acute hospitals, with others 
focusing specifically on how they worked with medicines. None have 
developed a wider grounded theory of how doctors, nurses and pharmacists 
work with medicines, which incorporates causal conditions, categories and 
strategies to inform future practice.  
I have also included literature on specific theories such as Reason’s model of 
accident causation (2000), specific texts describing High Reliability 
Organisations (HROs) (Weick and Sutcliffe 2001), improvement 
methodologies (Vincent and Amalberti 2016) and Hannawa et al’s work on 
understanding communication in healthcare (2017). These may not be 
founded on published primary literature, but are recognised as seminal 
papers within healthcare and wider afield. In particular, the literature on High 
Reliability Organisations has been built on case studies from the nuclear, oil 
and aviation industries. Lekka (2011:vii) commented that there is, “limited 
empirical knowledge regarding the extent to which HRO processes can be 
meaningfully applied to more mainstream organisations and contexts.” The 
relevant details of these are included in the following sections. 
I will contextualise the findings of my study with those from the literature by 
following the structure of the integrative diagram, for purposes of clarity 



















Ensuring each patient gets the right medicines 
 
 
Figure 5: An integrative diagram giving an overview of the core category – 
managing risk 
 
7.4.2    Working with the complex and the routine 
 
There were four elements of the causal condition, working with the complex 
and the routine - working in a complex system, doing routine work [with 




It was noteworthy that participants in my study spoke of both complex and 
routine medicines tasks contributing to the need to manage risk. Reason 
(2000) also found that both complex and mundane tasks that do not require 
higher-order thinking skills can cause errors. 
The complexity of acute hospitals and patients with multiple co-morbidities on 
large numbers of medicines is described by many authors (Dixon-Woods et 
al 2014, Hignett et al 2018, Keers et al 2018). Dornan et al (2009) found that 
a complex environment in which doctors were unfamiliar with new ways of 
working, busy and under pressure contributed to prescribing errors. The 
doctors in that study described feeling overwhelmed with being asked to 
prescribe many unfamiliar medicines by nurses and blindly doing so to get 
the task done. Junior doctors spoke of adopting this approach, as well as 
being told what to prescribe by senior medical colleagues (Lewis and Tully 
2009). They were unhappy but continued to do so. This was described by 
some of the FY1 doctors in my study also. 
Reason (2000), in his paper on human error outlined two approaches – the 
person approach and the system approach. He used the term, “latent 
conditions”, to describe lack of staff, time pressures, inexperience, tiredness 
and unworkable procedures which lie hidden and later can lead to adverse 
events. He also categorised, “active failures.” These are unintentional and 
intentional errors, the latter happening for three main reasons -  when 
individuals break the rules to save time (believing that they have the skills to 
do this safely), when the work environment makes it hard to follow the rules, 
for example, busyness, and breaking the rules for personal gain. A small 
number of the participants in my study made reference to practice which lies 
within the first two areas. One FY1 doctor spoke of prescribing medicines 
which they did not know, a further FY1 prescribed medicines for patients they 
did not see and a pharmacist did not carry out a full medicines review due to 
lack of time.  No reference was made to breaking the rules for personal gain, 





Vincent and Amalberti (2016), in their well-referenced and regarded book, 
Safer Healthcare, referred to the complexity of healthcare as being, “twenty 
different industries” (2016:33) with different specialties, types of work and 
groups of workers, some being more structured than others and excessive 
numbers of operating procedures. They recommended that a central suite of 
procedures which must be followed should be written for healthcare that 
would provide a level of consistency.  
The medical staff in particular in my study described prescribing, using terms 
such as, “grunt work” and “monotonous”. These views were mirrored in the 
findings of Dornan et al (2009) in which some FY1 doctors referred to their 
prescribing as being tedious and boring, sometimes rushing through the task 
to get it finished. Dornan et al hypothesised that FY1 doctors found the 
prescribing that they did required a low level of skill and thought, which 
resulted in errors being made. Some prescribing tasks in Dornan et al’s study 
were seen as being run-of-the-mill, needing prescribers to pay attention to 
detail as opposed to making difficult decisions. My study found an almost 
hierarchical approach to prescribing with the more routine prescriptions being 
allocated to the most junior doctors. Therefore it could be argued that the 
mundanity of these tasks could have contributed substantially to the higher 
prescribing error rates in the prescriptions written by FY1 doctors described 
by some authors (Dornan et al 2009, Ryan et al 2014).  In comparison, 
Seden et al (2013) did not report differences in prescribing error rates 
between different grades of doctors. Instead error rates were proportionally 
related to the number of medicines a patient had been prescribed. The 
authors of all of these studies identified multiple contributing factors to 
prescribing errors. Junior doctors in all of the aforementioned studies spoke 
of prescribing what their senior colleagues had told them. This may partly 
explain the difference between the prescribing error rates seen between 
studies.   
Outside healthcare, in an early study describing errors in High Reliability 
Organisations such as the aviation industry, Weick and Sutcliffe (2001) in 
their seminal text, Managing the Unexpected, stated that air traffic control 




because higher workloads resulted in air traffic controllers keeping on top of 
everything that was happening, being on a higher state of alert. 
The feeling that they were working under pressure acted as a reminder to the 
participants in my study of the need to take care and adopt various strategies 
such as using checks and balances and seeking advice from colleagues to 
manage the risk of the situation.  
In my study, having easy and timely access to accurate information about 
patients and medicines when making decisions was important to all the 
professionals interviewed. Participants reported that the absence of such 
information, especially when a patient is admitted to hospital, could result in 
tasks such as medicines administration rounds becoming more complicated 
and leading to medication errors.  A lack of access to information was 
highlighted as a major contributing factor to medication errors in an older, 
prospective, cohort study of medication errors detected through interviews in 
two tertiary hospitals (Leape et al 1995). It was also listed as a contributor to 
errors in general by Ryan et al (2014) and Hignett et al (2018).  
Some participants in my study described ready access to information on 
medicines using electronic solutions such as the Northern Ireland Electronic 
Care Record (ECR). However they also perceived this information as often 
being inaccurate, sometimes leading to prescription errors especially on 
admission. This undermined their trust in the reliability of the ECR.  As with 
all such solutions, the data inputted must be accurate. Hannawa et al (2017) 
described how different risks can be introduced into healthcare if electronic 
solutions are not used appropriately.   
In summary, the current literature shows that the safe use of medicines in 
acute hospitals is influenced by many factors including high patient numbers, 
high use of often complex medicines in an environment with underlying risks, 
such as inadequate systems design, time pressures and insufficient skilled 
staff and accurate information. Prescribing is identified by doctors as being a 
mundane task. The literature reflects the causal condition in my study, 





7.4.3      Managing risk  
 
One of my initial research questions was:  
 How do individual healthcare professionals define their role with 
medicines?  
This is addressed in the discussion of managing risk in this section and also 
of the strategies using checks and balances and working together in later 
sections.   
Managing risk is the core category of this grounded theory. It is central to 
what is happening when doctors, nurses and pharmacists work with 
medicines in acute hospital settings in Northern Ireland.  
The need to manage risk came from working with the complex and the 
routine. In my study, the participants described a continual, underlying 
tension and questioning surrounding the use of medicines. The extent of this 
does not appear to be reflected in the current literature although in managing 
risk, all participants were following professional guidance. All participants 
described asking questions if they were not sure. Nurses spoke of their 
professional obligation to ensure that they were administering the right 
medicine, irrespective of what others had said.  This is highlighted in the 
Nursing and Midwifery Council’s Medicines Management Standards (2007) 
and also is a finding in the ethnographic study on communication about 
medicines between nurses and doctors conducted by Borrott et al (2017). 
Pharmacists worked to a constant narrative of managing risk through 
problem-solving and constantly asking questions. To manage risk is standard 
2.2 in the Pharmaceutical Society of Northern Ireland’s Code (2016). Doctors 
in my study sought information on which to make prescribing decisions. The 
General Medical Council’s good practice document on prescribing and 
medicines management and devices (2013) requires doctors to seek advice 
from colleagues if they are unsure about aspects of prescribing. Asking 
constant questions and not trusting the information available or colleagues, 
having a “preoccupation with failure” could be seen as a duplication of work 




This constant awareness and anticipation of possible errors was reflected in 
the general literature on High Reliability Organisations (HROs). A High 
Reliability Organisation is one which, “operates under very trying conditions 
all the time and yet manages to have fewer than their fair share of accidents” 
(Weick and Sutcliffe 2001). These authors described HROs as having a 
focus on changing organisational culture as well as, “collective mindfulness 
and collective enactment”, the impact that people have on how others 
behave. Learning in this area has come from studies of disasters in the 
nuclear, space and aviation industries but a lot of the literature is in narrative 
form.  Urlings and Nijhuis (1988) looked at construction workers’ views of 
safety and found that when safety had to compete with production, then there 
was a reduced focus on safe working.  This was not described by the 
participants in my study. Weick and Sutcliffe (2001) described staff in HROs 
as constantly being aware of the potential for making errors and therefore 
continually making small changes to ensure reliability. Yip and Farmer (2015) 
described the importance of being preoccupied with failure and the possibility 
of failure as underpinning safety in HROs. Such an approach was described 
by all participants in my study.  
Weick and Sutcliffe (2001) identified a number of factors contributing to 
HROs.  From my study, there was an indication that a number of these were 
in place in acute hospitals in Northern Ireland. They included being 
continually aware of what is happening so that risks can be managed, 
respecting expertise, carrying out audits, reporting and learning from 
incidents and a focus on training, with pharmacists in particular having a 
preoccupation with failure. However other factors such as ability to abandon 
work on safety grounds and for nurses, having a fair-blame culture, were 
absent.   
Weick commented that HROs continuously changed how they did things and 
had a, “chronic suspicion” of the potential for small errors potentially having 
big consequences (1987:119).  Reason (2000) stated that, “safety is 
preserved by timely, human adjustments” (2000:770) with control changing 
from being of a hierarchical nature to being in the hands of an individual 




my study described continually, flexing up to manage individual risks 
associated with medicines and through not trusting the Kardex, anticipated 
the worst.  
The variation in the application of strategies to reduce harm from medicines 
has led to the World Health Organisation recently identifying, “Medication 
without Harm” as its theme for the third global patient safety challenge 
(2017). This has been described as a change programme to reduce risk and 
improve the safe use of medicines. Its goal is to reduce the level of severe, 
avoidable harm related to medications by 50% over five years globally. Three 
early priorities have been identified for action. These are using medicines in 
high-risk situations, polypharmacy and at transitions of care. In my study, 
participants spoke of using checks and balances in all three of these areas – 
focusing on the use of critical medicines, reviewing medicines and de-
prescribing when a patient had an acute kidney injury or was taking multiple 
medicines and also focusing on getting medicines right, especially on 
admission and discharge.  
The medicines administration round on the hospital ward has been shown to 
be a high risk process in healthcare. Nurses in my study described 
interruptions as being commonplace, sometimes contributing to errors in the 
workplace. A number of studies have evaluated the numbers and causes of 
medication administration errors made by nurses (Walker and Lowe 1998; 
Deans 2005; Keers et al 2018). Nurses tended to only report medication 
errors which had a negative impact on patient care (Walker and Lowe 1998), 
with fear of retribution and self-preservation being cited as the main reasons 
for not reporting all such errors. However this selective reporting was not 
seen in the anonymous self-report study carried out by Deans (2005) at a 
major Australian regional hospital (n=154).  Contributory factors to 
medication administration errors have been reported as: poor 
communication, human factors such as stress and fatigue of nurses, a variety 
of distractions, confusing the names of medicines and patients, and 
handwriting errors (Phillips et al 2001; Mayo and Ducan 2004). High-risk 
industries, such as aviation and nuclear power, protect such high-risk tasks 




protected from interruptions (Weick and Sutcliffe 2001). The nurses in my 
study described attempts to protect a specific nurse to administer medicines, 
but this was not always successful. 
Administering a medication at the wrong time has been reported as one of 
the main types of such errors (Deans 2005). Walker and Lowe (1998) found 
that delayed doses could be viewed as routine practice by nurses as time 
often had to be devoted to making sure the prescription was correct or 
legible. This view of normality may explain why the National Patient Safety 
Agency had to issue guidance on the importance of administering critical 
medicines on time (NPSA 2010) and also the ongoing focus of the 
Department of Health in Northern Ireland on missed doses. The reasons for 
missed doses are multifactorial but underline the importance of all healthcare 
professionals working together to reduce the incidence of medication errors. 
In Deans’ (2005) study, nurses sought advice from colleagues when 
administering medicines. They also highlighted that they would have liked to 
spend more time with patients when giving out medicines. Nurses in my 
study reported having more time than previously to spend with patients as a 
result of the pharmacy-led integrated medicines management service on the 
ward where this existed. 
The many factors which caused prescribing errors described by Ashcroft et al 
(2015) indicated that a variety of different approaches is needed by all the 
healthcare professionals involved in using medicines.  The complexity of 
managing risk and improving patient safety with respect to the use of 
medicines therefore has been recognised by both the Department of Health 
and healthcare managers, with a need for a multi-pronged, systemic and 
systematic approach and it is unsurprising that it is central to the work of 
participants in my study.  
Having managing risk as the core category initially surprised me as it seemed 
to be a pragmatic approach as opposed to a values-based approach to 
providing person-centred care. However this did not seem to surprise other 
researchers to whom I had presented my findings, especially those who had 




a role which would encourage individuals to follow a career in healthcare 
however by adopting this approach, the participants in my study described 
strategies which led to each patient getting the right medicines.  
 
7.4.4 Using checks and balances  
 
In my study, the strategy using checks and balances describes both 
individual and systemic approaches to managing risk associated with 
medicines.  
Participants used different checks and balances in their day-to-day role. 
These included specific checking and control mechanisms, for example, 
reviewing prescriptions regularly and making the best use of resources.  
Another of my initial research questions was: 
 Do healthcare professionals work to optimise the use of medicines? 
Using checks and balances, which includes encouraging some patients to be 
involved in decisions about their medicines, could be argued as having the 
aim of improving patient outcomes.  Participants in my study described this 
as a work in progress, with healthcare professionals striving to optimise 
medicines use. This will be reinforced in the discussion below.  
Reviewing prescriptions regularly, preferably every day, was described in my 
study as being a core check and balance especially within the dynamic 
nature of illness. For doctors, this was usually carried out by a senior doctor 
as part of a wider patient review. Decisions were made to stop or start 
medicines, sometimes without sufficient information and sometimes an 
informed analysis of risk versus benefit was required. This was difficult for 
inexperienced FY1doctors and Dornan et al (2009) described their inability to 
be able to, “frame their prescribing decision,” as being a contributing factor to 
prescribing errors. Higgins and Tully (2005), in their qualitative study of the, 
“schemas” which hospital doctors used to prescribe, highlighted differences 




reviewed prescriptions each time they administered a medicine or discussed 
medicines with patients. They (as well as pharmacists) used their wider 
experience of the healthcare system and of the use of medicines to examine 
the consequences of each prescription. Pharmacists described reviewing 
medicines especially as part of the medicines reconciliation process on 
admission and discharge – checking they were accurate, appropriate and 
filling in any gaps (either as a pharmacist prescriber or by asking the junior 
doctor to change the prescription). The benefits of pharmacists’ medicines’ 
review, as part of a wider, multi-factorial approach to managing medicines, 
was described by Scullin et al (2007; Scullin et al 2011). Seden et al (2013) 
highlighted the importance of routine medication review by pharmacists. 
Ontade and Quaye (2018), in an observational study of pharmacist 
medicines reconciliations (n=864), reported a benefit: cost ratio of 5:1 to 
11:1. This is higher than the benefit: cost ratio of a full pharmacy integrated 
medicines management service of 4:1 as reported by Scullin et al (2007). 
 Most participants in my study involved patients or carers in making decisions 
about their medicines or in getting accurate information to check how the 
patient used their medicines on a day-to-day basis. Higgins and Tully (2005) 
reported FY2s becoming more aware of the need to involve patients when 
prescribing.  Doctors, in my study, spoke of specifically asking pharmacists to 
give patients information about their medicines. This was reported also by 
Manias et al (2014). They interviewed patients, carers, doctors, nurses and 
pharmacists to determine what factors facilitated or acted as obstacles to 
including patients in using medicines in specialty hospitals in Australia.  
Whilst the authors commented that healthcare professionals should develop 
their communication skills as well as engage with patients and carers about 
their medicines, they did not find that patients were involved as an additional 
check in the system. Hsiros and Thompson (2013) also used semi-structured 
interviews with patients, carers and a range of healthcare professionals in 
two English hospitals to determine whether involving patients in their general 
care helped to improve patient safety. Patients and professionals welcomed 
greater involvement, “feeling more part of things” (2013:4). Concerns were 




inappropriate or may annoy professionals, negatively impacting on care. 
Having a defined approach which patients and carers could agree upon was 
suggested. Macdonald et al (2014) developed a grounded theory of how 
patients in hospital were involved in medicines administration. Interviews 
were carried out with patients and nurses. “Confirming Delivery” (2014:539) 
was the core category, with patients being involved, not being well enough or 
not becoming involved during the administration of their medicines as they 
perceived that nurses were too busy. The authors described this work as 
contributing to future design of medicines management systems to support 
greater patient involvement.   
Vincent and Amalberti (2016) discussed the importance of seeing safety 
“through the patient’s eyes”. Higgins and Tully (2005) observed that 
consultants in their study made prescribing decisions within the context of 
each patient and therefore believed that patients should be fully-involved in 
prescribing decisions. It should be noted that that study pre-dated 
recommendations to use a medicines optimisation approach. Vincent and 
Amalberti also outlined the need to change the focus from identifying a 
patient’s individual incidents to looking at the longer trajectory of a patient’s 
care and the wider implications of medication incidents.  Closer integration of 
care services in Northern Ireland, one of the objectives of Bengoa et al 
(2016) will provide an opportunity to take this wider view and identify 
opportunities to improve patient care which could otherwise be missed. 
Therefore there is a need to teach all healthcare professionals to make 
decisions about medicines within the longer trajectory of a patient’s illness, 
reviewing medicines in the knowledge of all the implications of change. 
In my study, some of the medical staff described feeling empowered through 
their experience of clinical audit to query prescribing decisions taken by 
colleagues in a supportive way.   Actively encouraging staff and patients to 
ask challenging questions is seen as an integral part of an effective safety 
culture (Hannawa et al 2017), an effective check and balance.  
Having experienced professionals making effective decisions was another 




made decisions about the use of medicines by going back to first principles. 
They used higher-order decision-making skills. The need for such high-level 
thinking and reflection was highlighted by Donald Schon (1983) when writing 
about the need to employ professionals as opposed to technicians when 
working with ‘messy’ situations, where there was not always a right answer.  
The less-experienced FY1 doctors in my study made decisions using 
different checks and balances than their more experienced colleagues. They 
prescribed limited ranges of drugs and made risk-based decisions based on 
whether they were transcribing a drug or prescribing it de novo. These junior 
doctors described sometimes signing prescriptions which they had 
transcribed, perhaps not knowing the medicines or the patient. This approach 
was described by Dornan et al (2009) and also by Wilson et al (2016), where 
one doctor commented that junior doctors were often just used for their 
signature. Dornan et al described decisions made by FY1 doctors as being, 
in their eyes, “good enough”.  
Higgins and Tully (2005), in their qualitative study using in-depth interviews, 
outlined how junior doctors and consultants made prescribing decisions, 
“within some form of schema” (2005:190). FY2s identified that they needed to 
widen the schemas which they currently used, described by the authors as, 
“some sort of conscious vigilance or reappraisal was now necessary.” They 
reported a development in the complexity of the schemas used by doctors as 
they gained experience.    
In my study, one FY1 doctor would have liked to be given advice or tips 
about how medicines were used in a new clinical area when starting to work 
there. She described making errors because she had carried her prescribing 
practice her previous post. Junior doctors who participated in the EQUIP 
study (Dornan et al 2009) reported making errors because they had brought 
their different previous prescribing practice to a new job, for example, 
prescribing analgesics. Provision of a card with medication pointers for 
doctors who were new to an intensive care unit was described in Rixon et al 




seen in practice. There may be benefits however in making the norms of 
working on each ward explicit to new team members. 
Nurses use structured checks and balances as highlighted both in my study 
and the nursing literature (Borrott et al 2017, Bryant et al 2018). In my study, 
nurses were the only professional group who described routinely using 
standard checking tools, such as the Five Rights. They described following 
Trust checking policies such as checking the patient’s name and wristband 
before administering a medicine. Nurses also asked pharmacists for advice if 
they were unsure of a dose and involved patients in their checking 
processes. Nurses were described by medical staff as keeping them safe 
and on the right road. Again this is reflected in the literature on inter-
professional collaboration (Wilson et al 2016). Eisenhauer et al (2007) 
published a paper on what nurses reported thinking when they administered 
medicines. They carried out retrospective, semi-structured interviews with 40 
nurses as well as recording information in real time. Checking when 
administering a medicine was the third highest reported thought reported by 
nurses. This included checking that the drug was correct and appropriate, 
when the dose was next due and most frequently, where to find the drug. The 
professionalism of nurses was summarised by one nurse in this study who, 
when commenting on the Five Rights checking process said, “the sixth R is 
the Registered Nurse who makes sure the previous five R’s are correct” 
(2007:87).  
Nurses in my study appeared to use deeper thought processes by looking at 
the implications of prescribing decisions as opposed to the appropriateness 
of the initial decision. This was reflected in the grounded theory produced by 
Dickson and Flynn (2012). The authors carried out 50 semi-structured, in-
depth interviews of nurses to determine a grounded theory on what nurses 
thought and did when they came across a medication error and how these 
impacted on patient outcomes. They reported a general “theme” of “clinical 
reasoning” with two “safety processes,” of, “maintaining medication safety” 
and, “managing the clinical environment” (2012: 6). Dickson and Flynn (2012) 
gave further detail on strategies used by the nurses in their study, many of 




included, taking the patient’s wider clinical condition into account,  linking with 
doctors regarding a patient’s care (including building rapport with doctors and 
communicating well), linking with nursing and other colleagues (many of 
whom had expert knowledge) and minimising distractions and interruptions.   
Nurses’ double-checking systems for medicines were not always seen as a 
failsafe way to reduce risk in my study, as even during the checking process, 
nurses could lose concentration. The literature on the value of double-
checking medicines administration is mixed and there is uncertainty of 
whether any benefits are outweighed by the additional resources needed to 
do this effectively (Alsulami et al 2013; Hewitt et al 2016).  
Pharmacists did not overtly speak about specifically using checks and 
balances, apart from reconciling medicines (NICE 2015) when patients 
moved across interfaces of care. Having a deeper knowledge and 
understanding of a patient’s medicines seemed to be core and also unique to 
the pharmacist’s role. This was also highlighted by Rixon et al (2015) who 
showed a difference between doctors and pharmacists in their knowledge of 
how individual patients took their medicines. This was due to the pharmacist 
having carried out a structured, medicines reconciliation on admission which 
showed gaps in the doctor’s medication history. Pharmacists then, “filled in 
the gaps”, which was a role of pharmacists and nurses described by all 
participants in my study. Rixon et al also highlighted that the medication 
review carried out by a pharmacist, incorporated a wider and deeper look at 
the available patient information when compared to a doctor’s approach, for 
example, noting renal function. This was also described by the participants in 
my study.  
Rixon et al (2015) developed this theme of medicines’ focus seen in 
pharmacists by commenting on the huge importance that pharmacists placed 
on medicines in comparison to doctors and nurses. They gave examples of 
doctors not prioritising medicines which could contribute to errors and missed 
doses. Ryan et al (2014) looked at the frequency of and reasons for trainee 
doctors’ prescribing errors, collecting data through interviews and 




prescribing as a task of low priority. The participants in my study had different 
values relating to their use of medicines. Despite medicines being described 
as one of the few things they could change in caring for patients, the doctors 
in my study did not specifically prioritise medicines when compared to the 
approach taken by nurses and pharmacists. Some nurses spoke with 
passion of the importance of medicines but in the context of their professional 
practice and the patient.  One pharmacist’s comment, “we are all about 
medicines” summed up the all-consuming importance that medicines 
obviously had for this professional group. Therefore in my study doctors, 
nurses and pharmacists carried out different roles with and it could be 
argued, had different value systems, assigning different levels of importance 
to optimising medicines in their practice. These differences between 
professionals may continue to grow as more healthcare professionals work 
directly with medicines as seen in the physiotherapist’s further different 
approach in my study.  
Pharmacists were described by my participants as being, in themselves, 
checks and balances in the system. They checked prescriptions, provided 
advice, solved problems, fixed incorrect prescriptions and facilitated safe and 
timely discharge. Scullin et al (2007) randomly assigned patients in an acute 
hospital in Northern Ireland to receive either an enhanced, “integrated 
medicines management” (IMM) service (n=371) or the usual medicines 
management service (n= 391). The enhanced service involved a ward-based 
clinical pharmacist and pharmacy technician having input throughout a 
patient’s hospital admission, specifically reviewing medicines on admission, 
during the inpatient stay and linking with primary care at discharge. Patients 
were followed up for 12 months post-discharge. The primary outcome of this 
study was that the mean length of stay for patients who received the IMM 
service (p=0.003) was reduced by 2 days. This group also had a reduced 
readmission rate over the following 12 months as well as longer time to 
readmission compared to the patients who received the usual service. The 
authors reproduced this service in a second hospital with similar outcomes 
(Scullin et al 2011). Miller et al (2016) also showed that Consultant 




improved medication appropriateness, contributed to reducing 30 and 90 day 
readmission rates and made cash and non-cash-releasing efficiencies.  
Using checks and balances in my study also involved making the best use of 
resources. This included making the best use of time by assessing risks, 
making decisions, prioritising tasks and implementing new ways of working. It 
appeared that the members of each profession did not necessarily assess 
risks associated with medicines in the same way. This may be due, in part, to 
the lower priority given to medicines by doctors as described by Rixon et al 
(2015).  Doctors and pharmacists in particular, in my study, spoke about 
making decisions by assessing the relative risk of the tasks which they had to 
carry out and then prioritising.  Doctors were more used to making decisions, 
looking at the evidence-base in conjunction with patient factors and making, 
often, complex decisions. This was also reported by Higgins and Tully 
(2005). Senior medical staff seemed to be able to make risk-assessed 
decisions and move on to the next task. Some junior medical staff also risk-
assessed prescribing tasks and prescribed drugs which they were not 
familiar with but on the balance of probability believed that little harm would 
come from the decision. All medical participants made prescribing decisions, 
confident that other members of the team were there to pick up on errors – 
an additional check in the system.  
Pharmacists in my study described being risk-aware as a result of their 
training, with more junior pharmacists needing reassurance that their 
questions were valid and growing in confidence as they developed ward-
based skills. Nurses were cautious about making decisions when they lacked 
knowledge, from both a patient care and personal professional perspective.                                                                                                                                                                                                                                                                                   
Illing et al (2008) in their report for the General Medical Council on how 
prepared medical graduates are to begin practice, showed that two of the 
areas which junior doctors felt least prepared for were prescribing and 
prioritising tasks. This led to a recommendation that final year medical 
students should spend at least a week shadowing junior doctors. There have 
also been studies which showed the benefits of simulated teaching methods 




benefitted most from being given total responsibility for carrying out tasks and 
getting individual feedback.  
The nurses and pharmacists in particular in my study, described 
implementing new ways of working, developing new professional roles to 
help in managing risk and improving the quality of patient care. These 
included having ward-based clinical pharmacists and technicians -an 
integrated medicines management approach (Scullin et al 2007; Scullin et al 
2011), independent prescribers (Abuzour et al 2018) and specialist roles 
such as consultant pharmacists (Miller et al 2016) and specialist nurses 
(Royal College of Nursing 2014). Gregory and Austin (2016) commented that 
current trends towards inter-professional working and new scopes of practice 
have led to tensions over professional boundaries, with the importance of 
protecting professional boundaries described as defining a profession.  
Professional tensions were not described by the participants in my study, 
with doctors in particular supporting the further development particularly of 
pharmacist prescribers.  
There was support for the development of other, new professional roles in my 
study in which nurses and pharmacists described proactively engaging in 
change and taking on new roles. In this way they were adding additional 
checks and balances into the system to help with managing risk. This ability 
to develop practice however was not reported by Penm et al(2017) in which 
85% of Canadian pharmacists surveyed described facing challenges when 
trying to develop their professional role due to workplace culture and time 
constraints. These differences may reflect the passage of time, having a 
greater service need to develop such roles and the size of Northern Ireland 
which could be an enabler of new ways of working.  However, there are 
implications for all three professional groups of professionals in relinquishing 
their traditional roles to take on what are viewed as much-needed, new 
responsibilities. Such change needs strategic oversight to support these 
developments within the context of maintaining safe services. Current 
hospital medicines systems have embedded the traditional roles of nurses 




The benefits of non-medical prescribing in providing safer, more efficient and 
timely care were described by the nurses, pharmacists and senior doctors in 
my study. Nurses described being more cautious than doctors in their 
approach to prescribing but less cautious in certain instances than 
pharmacists. Nurses seemed to prescribe new drugs in line with guidelines 
whereas the pharmacists tended not to prescribe de novo but use their 
prescribing skills to stop short- term treatments and correct inaccuracies in 
prescriptions. Dornan el at (2009) and Ashcroft et al (2015) stated that the 
accuracy of pharmacist and nurse prescribers was similar to that of 
consultant medical staff with the pharmacists involved in the earlier study 
making no prescribing errors. Error rates reported reflected the number of 
prescriptions written. One participant in my study, who was a non-medical 
prescriber, commented that perhaps non-medical prescribers (NMPs) who 
are meticulous in their approach and almost reverent of being able to 
prescribe, will lose this focus as time passes- just as she believed doctors did 
currently. I also wonder if the NMPs of today are accurate and safe because 
of their broad background in nursing and pharmacy and knowledge of the 
pitfalls of prescribing. The NMPs in ten years’ time, who will have been 
trained differently perhaps, may have less focus on being safe prescribers. 
This is an area for future research.  
Specialist nursing and pharmacist practice was also described by participants 
as being an additional check and balance, adding resilience to the medicines 
system.  Examples of this practice given in my study were Diabetic Nurse 
Specialists and Consultant Pharmacists for Older People. Whilst it seems 
logical to deduce that having expert practitioners working at a strategic level 
within a clinical setting would make a difference to patient outcomes, little 
research has been carried out on the benefits of having specialist nurses 
(Royal College of Nursing 2014) or consultant pharmacists. Miller et al, in 
their work with consultant pharmacists in older people (n=355) in Northern 
Ireland concluded that, consultant pharmacist case management resulted in 
both cost savings and more appropriate prescribing with safer, seamless and 




The need for checks and balances such as uniformity and a more managed 
system, as seen in high performing industries described by Vincent and 
Amalberti (2016) contributed to effective risk management. Such change 
would rely on cultural and hierarchical shifts. The need for this was described 
also by Dornan et al (2009). The participants in my study described a less 
hierarchical model of healthcare which they seemed to embrace. 
Pharmacists in particular had a recognised role in managing medicines risk 
and the central role of nurses in managing the whole picture and knowing 
patients was described by all. 
An aspirational check and balance referred to in my study was the use of 
electronic prescribing. This is designed to limit the discretion of workers and 
reduce worker autonomy by having decision support mechanisms and rules-
based prescribing.  
 
7.4.5 Working together 
 
The last of my initial research questions was: 
 What is each healthcare professional’s contribution to working in a team 
to optimise medicines use and why do they work in this way?  
The answer to this is reflected in the strategy working together. 
The participants in my study spoke about working together which included a 
number of sub-categories - working in teams, having multi-professional 
interdependencies and communicating well with each other. They described 
how they each brought a profession-specific approach to using medicines in 
patient care as well as potentially having some overlapping roles with other 
healthcare colleagues. Professionals working together did not necessarily 
mean team-working although some participants in my study, mainly nurses 
and pharmacists, spoke of belonging to and working as a member of at least 




Each professional spoke differently about working together in my study. 
Nurses were keen to say that everyone worked well together whereas 
pharmacists described almost having to earn their role on the ward-based 
team. Doctors spoke of the benefits of working with and listening to the 
multidisciplinary team but did not describe themselves as being a member or 
leader of such a team. FY1 doctors spoke of their working with different 
teams but again did not refer to themselves as members. This may have 
been because of the rotational nature of their posts. Weller et al (2011) 
reported that junior nurses and doctors “primarily” related to working within a 
team of their own professional group (2011:480). In this qualitative study, 
they interviewed 25 junior doctors and nurses about how they worked 
together and analysed their data using a pre-determined coding framework 
based on the literature on team-working. One senior doctor in my study 
spoke of being part of a regional multidisciplinary team which brought 
together specialists to make an informed decision and manage risk when 
making decisions about complex treatment regimens. Such regional 
networking was recommended by Sir Bruce Keogh (2013a) in his Review into 
the quality of care and treatment provided by 14 hospital trusts in England, 
commissioned in response to the Mid Staffordshire Public Inquiry. 
Working together was seen as being important to all the participants in my 
study. Spence Laschinger et al (2001) in a cross-sectional study of 3,016 
nurses (representative of the nurses on the register) in Canada, using 
validated instruments, found that having good relationships with physicians, 
as well as having a sense of autonomy and control, contributed to nurses’ job 
satisfaction and the, “perceived quality of patient care” (2001:209). 
Estabrooks et al (2005) used multilevel analysis in a cross-sectional study 
where patient outcome data (n= 18,142) were compared against hospital 
nursing data from a survey of nursing characteristics. They reported that 
good relationships between doctors and nurses were factors that improved 
30 day mortality in acute hospitals in Canada. Weller et al (2011) reported 
that whilst junior nurses and doctors recognised the importance of team-work 




particularly working together that well” (2011:481) did not facilitate inter-
professional working.  
Achieving effective team-working in acute hospitals is challenging due 
especially to the transient nature of doctors-in-training and pharmacists who 
move routinely between wards as well as hospital geography and outlying 
patients.  Lewin and Reeves (2011) carried out an ethnographic study in 
which they used periodic (2-3 month) observations on two medical wards and 
semi-structured interviews with healthcare professionals over a two year 
period to explore how inter-professional interactions differed to Sinclair and 
Goffman’s “‘models of front and backstage working.” They went as far as to 
say that teamwork may not be relevant in acute medicine because of, “loose, 
short-lived configurations of professionals” (2011: 1599). Wilson et al (2016) 
described how challenging it was to measure the benefits of working together 
on safer patient care due to the many variables in the working environment 
which were described as, the speed of change in ways of working, the 
frequent turnover of team members and the “fluidity”’ of ways of working. In 
my study, nurses and more senior pharmacists were the static members of a 
team, providing a level of stability and organisational memory as well as 
supporting newer trainees. FY1 doctors valued this support.  
My participants spoke of working together on a multi-professional ward round 
or at a morning ward meeting which helped more-informed decisions to be 
made in real time, as well as the prioritisation of tasks in the context of a 
wider treatment plan. However outside such formal settings, they carried out 
their work individually, approaching colleagues with specific questions. This 
“silo-working” of all healthcare professionals has been described by a 
number of authors. Milne et al (2015) in an ethnographic study of junior 
doctors’ capacities to practice inter-professionally in three teaching hospitals 
in Australia stated that junior doctors worked in isolation except when they 
were on ward-rounds or “bumped into people” from time to time. These 
authors described little interaction or communication between doctors, nurses 
and other professionals on the ward, with middle-grade doctors 




specific task. They described the behaviours seen as occasionally bordering 
on disrespect for other healthcare professionals.   
Rixon et al studied inter-professional communication (2015). This study 
involved semi-structured interviews and observations with 21 pharmacists, 
doctors and nurses in a large, acute teaching hospital in Australia.  Their 
focus was on pharmacists’ communication with other healthcare 
professionals about medicines. Their thematic analysis showed that 
collaborative practice relating to medicines use was not achieved as each 
professional had their own specific responsibility for certain medicines-related 
tasks with the doctor having overall responsibility for deciding which medicine 
to use.   
In contrast, the aforementioned observational study by Lewin and Reeves 
(2011) found that planned, multidisciplinary team meetings and ward rounds, 
established to support collaborative working between healthcare 
professionals, were mainly “ritualistic,” providing a cover to patients and 
others that staff are working openly as a team, with most communication 
happening informally and out of sight. The authors reported that this, 
“backstage working” was used to overcome ineffective, “frontstage working”, 
for example on ward rounds, which the authors linked mainly to problems 
with communicating with doctors. Whatever the limitations of formal and 
informal interaction and communication, the benefits of being physically 
based on a ward seemed to help inter-professional collaboration. 
In my study, I interviewed four individual professionals who worked together 
on a very busy acute medical ward. They described their relatively stable, 
multi-professional team, whose members had not changed substantially over 
the last year. They specifically described working well together, “having each 
other’s backs” and not being afraid to seek clarification or ask questions 
about medicines. They spoke about depending on each other to do their role 
well and described looking out for each other.  
The differences between different professions’ cultures, knowledge and 
values have been reported as contributing to poor team-working. In their 




with 18 doctors and nurses who worked in operating theatres using a 
visualisation technique. They reported that different professional views and 
objectives were barriers to effective team-working. They reported that this 
was due to a, “lack of mediating rules (social relations, norms and 
conventions) that supported interaction between team members” (2011:792).  
Two pharmacists in my study believed that junior pharmacists rotated too 
frequently between clinical teams to allow them both to learn effectively and 
be recognised and trusted by consultant colleagues. A recent study by Bryant 
et al (2018) compared nurses’ perceptions of two different models of clinical 
pharmacy practice, ward-based (where a pharmacist was based on one ward 
and saw all the patients there) and team-based (where pharmacists travelled 
between wards seeing only the patients being cared for by one clinical team 
or specialty). Their study was carried out in acute medical and surgical wards 
in Australia, using a mixed-methods approach. Team-based pharmacists 
were able to carry out more medicines reconciliations and potentially reduce 
medication errors. Nurses however reported disadvantages of team-based 
pharmacists. These included nurses having to spend more time chasing 
medical staff to clarify prescriptions, reduced information written by 
pharmacists on patients’ Kardexes to support medicines administration, 
reduced accessibility of pharmacists and a negative impact on pharmacist-
nurse relationships. The authors suggested that ward-based pharmacists 
helped nurses to, “overcome the authority gradient” or gap in expertise in 
medicines between nurses and doctors (2018:95). This way of working was 
reinforced by some of the nurses in my study who waited for the pharmacist 
to resolve medicines queries, using them as an initial sounding board to test 
out the validity of the query.  
Some pharmacists in my study described being members of both the 
pharmacy and the ward-based clinical team, with a preference of being seen 
as ward-team members. They had to work to develop relationships at ward 
level, describing the importance of being on the ward and other healthcare 
professionals coming to them to ask questions. Their accounts suggest that 
they almost had to, “seek approval” to belong to the multi-professional, 




has been described in other studies (Makowsky et al 2009). Rixon et al 
(2015) observed that pharmacists tended to work as sole practitioners 
alongside other healthcare professionals as opposed to being integrated into 
the clinical team with most communication happening informally. In their 
study, pharmacists rarely were part of formal opportunities to discuss 
medicines use, for example, on ward rounds. This contrasted with my study, 
in which pharmacists spoke about their active and integrated involvement in 
ward rounds and the associated benefits of this approach in allowing them to 
prioritise their work. One junior pharmacist in my study did describe coming 
along after the ward round to review Kardexes, usually due to competing 
priorities. Two doctors in my study initially had to get used to having a ward-
based pharmacist question their prescribing but now spoke of being lost 
without one. This was also reported by Makowsky et al (2009). Being a 
member of the clinical team did not seem to detract from the pharmacists in 
my study meeting their professional obligation to do the right thing, for 
example, report medication incidents. Overall, pharmacists in my study 
highlighted greater integration into the clinical team than reported in other 
studies. This may be due to the pharmacist’s role being better defined than in 
the past, some of the pharmacists being experienced practitioners who were 
able to prescribe and the benefits of the pharmacist to the smooth running of 
the ward, which were described by all participants.    
Understanding the roles of other healthcare professionals has been cited by 
a number of authors as being important to effective inter-professional 
collaboration (Makowsky et al 2009, Makowsky et al 2013). Pharmacists in 
my study felt that others did not understand the complexity of their work and 
this sometimes resulted in others having unrealistic expectations of 
timescales. Makowsky et al (2009), albeit in an older study, carried out a 
multi-centre, controlled clinical trial of team-based pharmacist care in 
hospitalised medical patients. They collected data from interviews and 
reflective journals using a phenomenological approach to identify themes. A 
clinical pharmacist was introduced to the multi-professional team. The 
pharmacists in that study found that they had to explain their role especially 




pharmacist’s skills and knowledge. In a later study, Makowsky et al (2013) 
conducted an online survey of doctors who had worked with pharmacists at 
ward level, using a validated questionnaire. Response rates were described 
as, “low but typical.” (2013:125). Results showed high scores from doctors for 
collaborative working relationships with pharmacists, suggesting that they 
respected team-based pharmacists, trusting them to complete 
recommendations. It was noted that further clarification of roles was needed.    
Some studies described an almost subservient role of the hospital 
pharmacist. Rixon et al (2015) noted that pharmacists asked medical staff if 
they were “happy” to change prescriptions, in recognition that the doctor had 
overall responsibility for this. The approach of the pharmacists in my study 
seemed to differ according to their level of clinical experience as well as 
whether they were a prescriber and their sense of being a recognised 
member of the multidisciplinary team. A more junior pharmacist in my study 
did adopt the approach described by Rixon and colleagues; another more 
experienced pharmacist prescriber spoke of prescribing within the context of 
checking with the medical team, almost as a courtesy, whilst a third 
pharmacist routinely made changes to prescriptions with the confidence of 
her position in the team, a sense of knowing more than the FY1 doctors and 
that this was her role. 
All of these studies highlighted a dichotomy between the difficulties of 
forming effective teams in acute hospital care, taking into account the 
differences between professions, the frequent turnover of teams in acute 
hospitals and the need for doctors, nurses and pharmacists to work in the 
most effective way when using medicines. A balance could be achieved by 
the collaborative production of a number of organisational principles which 
defined how individuals should work with medicines at ward level. This 
protective framework, alongside a level of autonomous practice, may achieve 
the best outcomes for patients and models should be explored further.    
My study appears to illustrate how the use of medicines in acute healthcare 
in Northern Ireland is going through a period of transition due to many 




changed, with flatter, multidisciplinary working being valued and seen, on the 
whole, as providing support for each professional as well as patients and 
carers. This change may explain why junior doctors in my study felt 
supported in their practice, albeit within traditional working hours. This 
contrasted with the comments made by FY1 doctors in Dornan et al’s study 
(2009), who spoke of feeling unsupported, in particular during ward-rounds 
and  when working out-of-hours. It also contrasted with the observations of 
Milne et al (2015) of a perceived disrespect of doctors for other professionals. 
The authors commented that this could have emerged due to an unconscious 
appreciation of the need to work collaboratively with other professionals or 
alternatively from the hierarchical nature of healthcare which doctors 
dominated without a need to link with other healthcare professionals. This 
was not reflected in my study. 
Kennedy et al (2009) produced a grounded theory of why junior doctors were 
reluctant to ask for help with prescribing and clinical decision making. The 
authors highlighted the pressures on trainee doctors to work independently, 
allowing them to feel that they are closer to becoming a doctor, as well as 
responding to the busyness of the clinical environment and a need to get 
things done.  
Gregory and Austin (2016) studied how doctors and pharmacists developed 
trust in each other. They interviewed doctors (n=8) and pharmacists (n=11) 
who worked collaboratively in primary care teams in Canada. Little was 
known about how healthcare professionals developed mutual trust. They 
determined that pharmacists tended to trust doctors because of their position 
of authority and role. However doctors valued competence and working 
effectively. The authors stated that these differences in approach could 
impact on good relationships if there were expectations of having mutual 
trust. The pharmacists in my study spoke of respecting the role and 
responsibility which medical consultants had, seeing other grades of medical 
staff as their peers.  
Working together in healthcare is about more than providing support to each 




interdependencies where certain roles could only be carried out if other 
professionals had carried out their role effectively and accurately, for 
example, nurses cannot administer medicines unless they are certain that a 
prescription is accurate and appropriate. The system is forcing the 
management of risk by placing a professional obligation on nurses and 
pharmacists to check that prescriptions are right. There may be a relationship 
between the design of these interdependencies in not just protecting patients 
but also doctors, reflecting an imbalance in professional power in acute 
hospitals.  This is touched upon by Borrott et al (2017) in their ethnographic 
study of medication communication between nurses and doctors for 
paediatric acute care, where there was some rebalancing of power through 
nurses refusing to administer medicines which had been prescribed 
inaccurately.  
In looking at the literature, I cannot find a statement which specifically 
describes these inter-dependencies with regard to medicines-use in acute 
hospitals in this way. Borrott et al (2017) commented on how the requirement 
for nurses to meet professional standards affected the way they 
communicated with doctors when querying prescriptions.  
A second type of inter-dependency was described by some of the medical 
staff at all grades in my study who spoke of using the nurse and pharmacist 
safety net as being part of their prescribing process. When they were 
uncertain of their prescribing they relied on pharmacists to pick up their 
errors, or fill in gaps in their prescribing. They also relied on nursing staff to 
pick up on their errors before administering a medicine.  This has been 
described by other authors (Dornan et al 2009).  
Communicating well is the third sub-category of working together. 
Participants in my study described working together and communicating well 
with their colleagues and patients. On reviewing the literature, I found three 
recent studies looking at how healthcare professionals communicated with 
each other about medicines in acute hospitals in Australia (Rixon et al 2015, 
Liu et al 2016, Wilson et al 2016). I will make reference to these three papers 




were used by these authors allowed them to describe how doctors, nurses 
and pharmacists communicated, who they spoke to and the language used. I 
am unable to provide the same level of detail from the analysis of semi-
structured interviews, in which participants may be providing a more positive 
view of reality; however by using the constant comparison method in my 
analysis, the strategy working together contains rich and thick description of 
what is happening here.  
In my study, communication about medicines fell into one of two categories - 
seeking clarification or further information about a prescription or asking for 
information about a drug. Communication was usually verbal or through 
writing on the Kardex which was done by both the doctor and the pharmacist. 
Rixon et al (2015) commented that nurses and doctors tended to seek 
information directly from other healthcare professionals whereas the 
pharmacists in their study tended to access the literature. In my study, nurses 
and doctors described seeking information on medicines predominantly from 
pharmacists or sometimes specialist colleagues, for example, renal 
physicians. The pharmacists in my study described seeking information from 
the literature but also valued information on the use of a drug in practice from 
a pharmacist experienced in a specific clinical field or from another 
healthcare professional, for example, a palliative care nurse. They seemed to 
value a more in-depth knowledge of the use of a drug.  
The “language discourses” used by doctors, nurses and pharmacists were 
investigated by Liu et al (2016) who adopted a critical ethnographic approach 
to determine how doctors, nurses, pharmacists and patients communicated 
when working with medicines in an acute hospital in Australia. They 
specifically looked at communication strategies. Their methodology included 
observations, field interviews using video recordings to improve reflexivity. 76 
nurses, 31 doctors, 1 pharmacist and 27 patients consented to be part of the 
study. 
Liu et al (2016) described nurses as filling gaps in patient care. The 




study were also perceived as “filling the gaps” in prescriptions, providing 
clarity, correcting errors and helping the system to flow more easily. 
Rixon et al (2015) stated that when asking questions about medicines, 
pharmacists tended to approach doctors to clarify prescriptions, whereas 
nurses tended to approach pharmacists about medicines supplies. They 
described this as, “reactive communication” which happened because the 
professionals were carrying out “traditional roles.” They did not see 
pharmacists proactively educating other healthcare professionals. I was 
unable to gather this detail. In my study, medical staff in particular described 
proactively updating nurses on recent prescribing decisions which they had 
made as they were aware of the implications to their practice, for example, 
having to make sure the medicine was available or chase a discharge letter. 
This also was described Liu et al (2016) who described nurses getting 
information on medicines from the pharmacist in a timely way, especially 
when the doctor was not on the ward.  
In my study, nurses and pharmacists spoke about choosing what doctor to 
question as well as the approach to use. This also was described by Borrott 
et al (2017) who observed nurses speaking to doctors as part of inter-
professional care. Wilson et al (2016) stated that nurses and pharmacists in 
their study did not feel confident in approaching doctors to query 
prescriptions and so used indirect communication methods for example, 
leaving notes on charts and not asking direct questions. Their participants 
described medication errors occurring as a result of, “poor communication 
and passive aggressive behaviours” (Wilson et al 2016: 653). Liu et al (2016) 
also commented that it was common practice for the ward pharmacist to write 
medication instructions for nurses on medication charts and leave notes for 
doctors to consider modifying medication orders. Pharmacists in my study 
described leaving notes for doctors in the past. This was described within the 
context of the benefits of being able to prescribe and make the change to the 
prescription themselves.  
Junior doctors (FY1s) also spoke of feeling encouraged to seek advice from 




with one exception, described feeling well-supported by senior medical staff 
and by the other members of the multi—disciplinary teams in which they 
worked. They felt less-supported by medical colleagues when working out of 
hours. This may be because there are fewer staff around to provide support. 
This is a weakness in the system which may affect the way FY1 doctors work 
and make decisions out-of-hours. The literature supporting a move to seven-
day working in the NHS described higher patient mortality rates for patients 
who had been admitted at weekends (out-of-hours) (Keogh 2013b). The level 
of support from senior medical colleagues described by FY1 doctors in my 
study seems greater to that described by Dornan et al (2009).  These 
descriptions in my study of an open culture where professionals were able to 
ask for advice without concern were not mirrored in the literature. Papoutsi et 
al (2017) described what influenced how doctors-in-training prescribed anti-
microbial agents. They described doctors making decisions within the context 
of managing their professional reputation within the clinical team. The 
authors also commented that newly qualified doctors may find it easier to ask 
a pharmacist for help as they had less concerns about being looked upon 
negatively by the pharmacist with whom, “relative status differences are more 
ambiguous” (2017:2420). The differences may be attributed to the 
participants in my study presenting an inaccurate, more positive picture, to 
the smaller number of participants in my study or may be because there is 
greater support in the system here.  
All participants commented that the doctors, nurses and pharmacists on the 
ward communicated well, with a small number saying that in the past, 
communication could have been poor, for example about drugs being 
withheld, but now with medicines being reviewed more regularly, this has 
improved. Dornan et al (2009) describes miscommunication on the part of 
third parties, including patients, leading to FY1 trainees’ errors. 
Hannawa et al (2017) reinforced the ease with which errors can be made due 
to poor communication. She described communication in healthcare as, “an 
intensive, interactive, error-prone activity that often fails to achieve its 
purpose of creating a shared understanding. As a result, it has the potential 




communicating well as ensuring communication and thought is given over a 
continuum of time as opposed to in one moment, thinking about the 
consequences of specific actions and how they could be better implemented. 
Nurses in my study described their key role in ensuring information was 
communicated between shifts and over time. They also had a longer term 
view of patient care, describing “seeing the whole patient.”  
In my study, verbal communication was most commonly used by medical 
staff sometimes adding notes such as, “critical medicine- give on time” to a 
prescription for additional clarity. In 2010, the National Patient Safety Agency 
asked hospitals to put together a list of critical medicines which must be 
given on time (omitted doses). These lists are updated regularly. The 
importance of focusing on giving critical medicines on time was mentioned by 
almost all participants in my study, with nurses and pharmacists particularly 
focused on this. It is interesting to see that such clarity would be needed over 
and above the prescription of a medicine to be administered at a specific 
time. On paper the instruction looks fairly straightforward but in reality, there 
seemed to be shared, implicit deviations from prescribed practice. A system 
which is able to flex quickly in response to an incident is a resilient system 
but if there is constant flexing in the system, it may be time to involve the 
system users in re-design. Further research is needed in this area.  
 
7.4.6 Ensuring each patient gets the right medicines 
 
One of my first research questions was: 
 Why do they (health care professionals) work this way?  
The answer to this question is in the consequences of the theory which is 
ensuring that each patient gets the right medicines. This may not always 
have been the outcome for each patient and this knowledge spurred on the 
healthcare professionals in my study in actively managing risk.  
Leger and Phillips (2017) developed a grounded theory, “Exerting Capacity,” 




in acute hospital wards in Australia. Nurses believed that it was their duty to 
keep patients safe from harm. The authors described, “me-centric” and 
“patient-centric” nurses in their study. The former kept patients safe as best 
as they could whereas the latter used their gut feeling (as described by 
participants in my study) and anticipated problems to help keep patients safe.  
All participants in my study spoke about ensuring each patient gets the right 
medicines. Each professional played their own part by prescribing, 
administering, checking and supplying the right medicines. Using checks and 
balances and working together allowed this to happen. Each participant 
focused on getting it right for each individual patient and this approach is 
central to optimising the use of medicines.  
Medicines optimisation is defined by the National Institute for Health and 
Care Excellence (NICE) as, “person-centred approach to safe and effective 
medicines use to ensure that people obtain the best possible outcomes from 
their medicines” (2016). Achieving the best outcomes for patients however 
was not mentioned specifically by the participants in my study. This may be  
because, “getting the right medicines” and, “achieving the best outcomes” for 
patients have been viewed as synonymous terms by those who were 
interviewed. Also, it is challenging for healthcare professionals to measure 
the impact of their work in terms of patient outcomes, with outcomes-based 












7.5 Summary of findings   
 
This section initially provides a summary of new findings from the research. I 
also go on to discuss implications of the research for future practice.  
 
7.5.1 New findings  
 
A number of new findings came from the data.  
1. A grounded theory emerged from the data. Existing literature on inter-
professional collaboration in acute hospitals used thematic analyses, 
adopting ethnographic or phenomenological approaches. My research 
has located process in how doctors, nurses and pharmacists work to 
optimise medicines in acute hospital settings within the context of 
Northern Ireland.  
 
2. Key findings have uncovered a continual, underlying questioning 
surrounding the use of medicines, which fuelled an implicit understanding 
that individuals needed to continually manage risk. It also meant that 
additional checks and balances existed which could be viewed either as 
duplication of effort or indicative of a culture of safety.  
 
3. Multi-professional inter-dependencies with respect to how the medicines 
management system is designed were highlighted. The relative 
responsibilities of each profession may reflect where power sits within 
acute hospitals. The importance of all healthcare professionals having a 
personal obligation to provide balanced, mutual support for each other 
when working with medicines should be made explicit and power 
rebalanced. The need for an accurate prescription, as well as the lack of 
medical staff and the need to improve access to medicines, has been one 
driver of the development of new professional roles such as pharmacist 





4. A healthcare culture which actively recognises and supports the 
development of new professional roles in acute hospitals in Northern 
Ireland is evident from this research. Such a culture was not reflected to 
the same extent in studies from other countries, for example, England, 
Australia and Canada.  This may be indicative of the passage of time 
since these studies were carried out or of the size of Northern Ireland 
facilitating the development of practice. Also the participants, in particular 
FY1 doctors and pharmacists, described a more positive experience of 
practice when compared to that described in existing literature. These are 
two indicators of a positive continuum of change which can be harnessed 
for future work.   
 
5. Studies have demonstrated the importance of getting medicines right on 
admission of a patient to hospital.  A depth of knowledge of the patient 
and of medicines is needed to do this accurately. The pharmacist was 
identified in my study, and also in previous studies, as having this depth 
of knowledge both as a result of their approach and training. The 
developing role of the prescribing pharmacist, along with their specific 
focus on getting medicines right, could be targeted to prescribing at 
admission, in collaboration with medical colleagues. It was anticipated in 
my study that this would result in more streamlined working as well as 
more accurate and timely prescribing on admission.   
 
6. Doctors described almost a hierarchical approach to prescribing with the 
more routine prescriptions being written by the most junior doctors.  
 
7. Whereas this seems a common-sense approach, I have not seen it 
specifically described in the literature or practice.  
 
7.5.2 Implications for future practice 
 
“Apart from the logical soundness of the formation of a theory, its real test is 




When establishing the context for this study (Section 1.1), I stated that the 
theory produced would act as baseline information to inform the future design 
of a safe process for optimising medicines use in hospitals which would 
ensure best patient outcomes. 
I have drawn out a number of practical implications of the theory in this 
section. These have been discussed with Trust Heads of Pharmacy and 
Medicines Management in Northern Ireland and Directors of Pharmacy in 
Scotland. A strategic paper is being finalised, incorporating the 
recommendations, which will be presented at the Northern Ireland Medicines 
Optimisation Strategic Group. This is a multi-professional group, chaired by 
the Chief Pharmaceutical Officer at the Department of Health in Northern 
Ireland. This also will be shared through publication of the study and as a 
two-country opinion article.   
     
1. The theory demonstrates that healthcare professionals are managing risk 
through working together with a high level of inter-professional 
dependency in the system. This is a key check and balance. It may be 
indicative of a High Reliability Organisation and safety culture. It also may 
be indicative of a system which needs specific clinical leadership. The 
theory does provide an insight into the importance of making the implicit 
beliefs of doctors, nurses and pharmacists, such as using pharmacists 
and nurses as safety nets, explicit. The specific responsibilities and 
benefits of each professional’s role with medicines should be defined, 
helping to establish specific ground-rules at ward level for the safe use of 
medicines. This would underpin each professional’s personal 
responsibility to support their colleagues in having a collaborative focus 
on safe patient care. Making responsibilities clear, building mutual trust 
and an agreed set of cultural norms could support the safer use of 
medicines and the better use of resources. Health service managers and 
healthcare professionals need to be aware of specific professional roles 




highlighted some new roles, beliefs and relationships. These will be 
defined in the paper to the Strategic Group. 
 
Recommendation 1 
The roles and practices of doctors, nurses and pharmacists with medicines in 
acute hospitals should be defined explicitly to inform health service 
managers, healthcare professionals and educators. Inter-dependencies will 
be highlighted. This will reinforce the current Northern Ireland Medicines 
Optimisation Framework which outlines what patients should expect with 
regard to medicines in different healthcare settings. This knowledge will help 
to underpin any medicines-related service redesign.  
 
2. Drawing from the analogy of an orchestra in Table 18, in order to optimise 
medicines well, each player in this system has to listen to each other, take 
their cue from each other and the “conductor”. It is clear that the 
medicines optimisation system in acute hospitals in Northern Ireland does 
not have one leader and there are multiple healthcare professionals 
involved. Highly experienced and competent individuals as well as 
professionals-in-training work with medicines routinely and need support. 
Current problems should be named and practical solutions sought and 
implemented. In healthcare, it is important to strike a balance between the 
individual practice of intelligent, high-performing healthcare professionals 
and introducing key principles into how professionals work with medicines 
that would make things safer and easier for all concerned.  
 
Recommendation 2  
The role of a professional acting as the “conductor” or the Medicines 





3. The current development of non-medical prescribing roles was mentioned 
by almost all of the participants in my study. The increasing number of 
non-medical prescribers will change the dynamic on acute wards. It is 
important to have a joined-up understanding across Northern Ireland of 
how and where these roles are developing to ensure that each patient 
gets the right medicines and provide safer patient care.  
 
Recommendation 3 
A regional multi-professional group should be established to map out, 
commission practice research on and determine the direction of travel for 
non-medical prescribing roles in the Province. This group would report to the 
Chief Professional Leads at the Department of Health in Northern Ireland.  
 
4. Managing risk was a result of working with the complex and the routine. 
This study clearly has shown the important role of each professional in 
medicines optimisation. It also has highlighted the multi-factorial role of 
the medicines administration round, the key role of the nurse in knowing 
patients and the changing role of the pharmacist from, “filling the gaps” to 
prescribing and carrying out medicines reconciliation. The focus on 
getting the prescription, supply and administration of critical medicines 
right may be a symptom of a wider system which is not working 
effectively. Learning from the effort which is needed to use a small 
number of critical medicines well should be used to help inform system 
redesign. In the theory, healthcare professionals are working together, 
asking questions and seeking accurate information. Accurate and up-to-
date information must be made easily available. This must be mapped out 
and its importance highlighted in the development of electronic 
prescribing and administration systems. The participants in my study 
spoke of wanting a simpler medicines system. The literature on Human 
Factors and Ergonomics advises that we train individuals in this science 




a more systematic way to designing safe medicines management and 
optimisation systems in acute hospitals and across transitions of care. 
 
Recommendation 4 
There needs to be a renewed focus on the medicines management and 
optimisation processes at ward level. These need to be mapped out, 
resulting in innovative solutions which are patient as opposed to process-
focused. 
   
5. This study showed that there are a number of developments in medicines 
practice in acute hospitals in Northern Ireland and that these are broadly 
welcomed by all professions. This should be built upon and a medicines 
optimisation route map, linked to Bengoa’s Transformation agenda, driven 
forward. This work could be supported by appointing Clinical Fellows from 
each profession with a focus on collaborative inter-professional working. 
 
Recommendation 5  
Write a regional medicines optimisation route map to support the 
Transformation agenda in Northern Ireland, linked with workforce plans. 
     
6. The theory underpins the need for doctors, nurses and pharmacists to 
learn about managing risk in a multi-professional way, with true 
collaborative working. Healthcare professionals also should be taught 
how to make clinical decisions about the use of medicines as part of an 
overall continuum of care for each patient as opposed to focusing on 
discreet, acute decisions. This joined-up approach would allow healthcare 
professionals to see care from the patient’s perspective and could support 
a reduced use of resources, as well as potentially improving quality of life. 




This needs to begin during undergraduate training. The theory will be 
shared with undergraduate and postgraduate training leads in the two 
universities in Northern Ireland and with the Northern Ireland Medical and 
Dental Training Agency which has recently incorporated Pharmacy post-
graduate training. Key influencers will be targeted.   
 
Recommendation 6 
Share this research with current undergraduate and post-graduate medical, 
nursing and pharmacy Course Directors, highlighting the importance of 
cross-professional learning.  
 
7. This study gives a feel for progress in acute hospitals in Northern Ireland 
on the involvement of patients in medicines optimisation, although this is 
at an early stage. A specific focused piece of work is needed to provide 
and make available tools to support practitioners to do this routinely as 
part of their practice. This work will also provide guidelines on meaningful 
and proactive patient involvement in the development and review of 
medicines optimisation services.   
 
Recommendation 7  
Establish a regional group of healthcare professionals, patients and carers to 
provide practical guidance on involving patients at every stage of medicines 




7.6 Implications for further research 
 
From this process, there are a number of areas where further research could 
be carried out.  
 Participants in my study and the early literature on non-medical 
prescribers suggests that non-medical prescribers have a focus, 
interest in and experience of prescribing which results in greater 
accuracy. Future work could build on current baseline data and 
measure the approach of non-medical prescribers over time to 
determine whether their prescribing role becomes monotonous and if 
this has an impact on their prescribing error rates. 
 Comparison of my theory with the outcomes of other studies suggests 
a development in confidence and integration of pharmacists, 
especially those who are prescribers, into the multidisciplinary clinical 
team in Northern Ireland. Further work is needed to assess the risks 
and benefits of this change, measure the implications for patient care 
and make recommendations for new ways of working.  
 I would like to work with doctors, nurses and pharmacists initially to 
pilot the development of a Medicines Charter at ward level. This 
Charter would be written collaboratively and would make the cultural 
norms for working with medicines on that ward explicit. The impact of 
this on patient outcomes and medicines risk could be measured.  
 Research into the role of a professional acting as the “conductor” or 
the Medicines Optimisation Lead on a ward or clinical area should be 
carried out. 
 Each professional described, “bringing something different” to the use 
of medicines. It would be interesting to define what the differences are 
between each profession which are important to safe practice and 
what we would lose if we blurred professional roles. This would help 
inform what must be incorporated into undergraduate training to 




engender all of the approaches taken by other professionals into all 
professional training or is there a benefit in maintaining strong and 
specific professional boundaries to maintain rigor in the system. 
Further work could be carried out on measuring patient outcomes from 
autonomous clinical practice as compared with more shared decision 
making with shared accountability for medicines-related decisions.   
 Implement and carry out research into training doctors, nurses and 
pharmacists together to allow true inter-professional collaboration and 
effective communication as well as new models of multi-professional 
working. This can build on the current literature in this area. 
 Further research into the relative frequency with which the system 
flexes up when busy or when there is perceived additional risk is 
needed. This could inform future system redesign. 
 




My study provides an insight into how doctors, nurses and pharmacists work 
to optimise medicines in acute hospitals in Northern Ireland. I believe it 
achieved its aim and provided answers to my initial research questions. 
It is the only study that I have found which produces a grounded theory of 
how all three healthcare professionals work with medicines in the acute 
hospital setting. Much of the literature on the inter-professional working of 
these professionals either focuses on community practice, on specific roles, 
for example non-medical prescribing, on inter-professional working between 
two professional groups or inter-professional communication. This study 
therefore adds to the body of knowledge in this area. 
My study also provides a theory of how these professionals work with 
medicines in Northern Ireland at a time of healthcare transformation, as 




et al 2016). The theory also acts as a baseline to measure against as the 
Northern Ireland Medicines Optimisation Quality Framework (2016) is 
implemented and embedded into practice.  
Many of my findings and elements of the theory reflect the literature on 
managing risk with medicines, looking at the complexity and mundanity of 
medicines’ use and the importance of communication. Both this and 
feedback from the Directors of Pharmacy in Scotland and the members of the 
University of Bradford Medicines Optimisation Research Group support the 
credibility of the theory. I also presented an early poster at the University of 
Bradford. 
Reflexivity and transparency are important features of the credibility of a 
study using qualitative methods. I am the Head of Pharmacy and Medicines 
Management in a Health and Social Care Trust in Northern Ireland. Whilst it 
is recognised that the experience and views of the researcher cannot be 
completely removed from a study, I wrote a reflexive personal statement at 
the outset of the study and have described the approaches I have taken to 
reduce the impact of this in the Methods Chapter. 
I also used a specific Framework to critique my study (Appendix 18). This 
also shows credibility of this study.  
 
7.7.2  Limitations 
 
The lack of homogeneity of the sample used in this study could be viewed as 
a potential limitation, especially as the sample size is small in a grounded 
theory study. I used a heterogeneous sample (doctors, nurses and 
pharmacists), as the research question asked how members of these three 
professions optimised medicines. An initial sample of a doctor, a nurse and 
two pharmacists provided a breadth of data as a basis for theoretical 





Creswell (2013) stated that theoretical sampling in grounded theory should 
begin with a homogeneous sample of, “individuals who have commonly 
experienced the action or process” (2013:154).  My participants will have 
experienced working with medicines in acute hospitals but may not have 
commonly experienced this, due to their professional background and the 
hospitals that they have worked in.  However, Strauss and Corbin (1998) 
described sampling in open coding as being, “open to those persons, places, 
and situations that will provide the greatest opportunity for discovery” 
(1998:206).  
A different option would have been to gather initial data from one 
professional group, for example, doctors, and then continue with theoretical 
heterogeneous sampling; a further option would have been to change the 
research question to determine the views of, for example, doctors on how 
healthcare professionals optimise medicines. In deciding on my sample, I 
had to balance gathering data from a single professional perspective against 
having a breadth of data from each of the three professional groups. I am 
confident that the heterogeneity of the sample yielded rich data that provided 
a focus on how these healthcare professionals worked with medicines as 
members of inter-professional teams.    
To reduce the potential limitations of a heterogeneous sample, I could have 
interviewed more participants, aiming to analyse the data from each 
professional group, saturate the data from each group and compare the 
results, as described by Morse (2007).  Morse highlighted that pooling data 
from a range of cultural groups could result in it taking longer to reach 
saturation due to, “increasing noise (variation)” (2007: 232) in the sample. 
Morse also stated that initial selection of a demographically homogeneous 
sample is the most appropriate way to deal with this variation. 
I did not analyse separately the data from the small sample size of each 
professional group (7 doctors, 4 nurses and 6 pharmacists) nor seek to 
saturate the data from each professional group. I analysed the data from the 
whole group. The importance of reaching saturation has been debated in the 




focused and reflected on the quality of the theory being produced, through 
the use of effective interview techniques, analysis and theoretical sampling 
and that I have produced a thick description of what is happening here.    
Therefore on balance, I am confident that the data is sufficient to support my 
theory. 
Using semi-structured interviews, did not allow me to actually see how 
individuals worked with medicines in practice. The use of observational 
methodology may have given a greater insight into the actions of individuals. 
I had looked at adopting this method when designing my study but realised 
that limitations in scope and time did not support the use of observations. An 
additional method, using focus groups, may have helped me to see how 
multi-professional teams interacted, albeit in the interview setting, but again 
this may have restricted open dialogue.  
By looking at how individuals work in acute hospitals in Northern Ireland, I am 
narrowing the context of the study and limiting its generalisability within the 
framework of qualitative research. Also the nature of qualitative research is 
such that a representative sample of participants is not sought as would be 
the case in a quantitative study.  Instead the rigor of the study design 
supports the potential for generalising findings within this context. I believe 
this study was carried out in a rigorous manner and this has been described 
more fully in Chapter 3.  
I tried to ensure that the recruitment of participants was unaffected by the 
undue influence of colleagues. I had no links with and had not worked with or 
managed any of the participants apart from the person who I piloted the 
interview with, whom I had managed 10 years previously in a different 
hospital. Due to the challenge in recruiting individuals, some participants 
worked in the same clinical team. However all of these individuals, with the 
exception of one nurse, had previously worked in other clinical teams.  
I gained experience and learning as an interviewer as I carried out the study. 
I used an outline interview guide and was aware of the importance of not 




transcripts from early interviews and reflected on interview technique and 
how I could improve it. However there were times when I felt, on reflection, 
that I could have chosen my words more effectively.  It could be argued that 
an experienced interviewer would also be able to pick up on specific 
nuances.  
Following three or four interviews, I was concerned that participants may not 
be clear what the term medicines optimisation meant.  I discussed this with 
my supervisors and then checked what each participant’s understanding was 
of the term at the end of each interview. Only one individual, a staff nurse, 
was not familiar with the term and was not able to define it; however she 
understood what optimising medicines meant in a general sense.  
 
7.8 A personal reflection, outlining how I could improve the study 
 
I enjoyed carrying out this study. If I was to carry out this study again I would 
try to improve it in the following ways: 
I would allow myself more time to collect data using observation of the 
practice of doctors, nurses and pharmacists in acute hospitals. The richness 
of the data on inter-professional communication in the papers by Rixon et al 
(2015) and Wilson et al (2016) highlighted the benefits of that approach.  
I would try to involve more medical consultants and staff nurses to participate 
in the study. This would have provided a wider perspective on using 
medicines in acute hospitals.  
I would discuss and test my final findings with more colleagues to support my 







7.9 Conclusions  
 
Through this work, I achieved my aim to produce a theory grounded in data 
from participating doctors, nurses and pharmacists working with medicines 
each day in acute hospital settings. There are a number of new findings from 
my study which have addressed gaps in the literature.  
Medicines optimisation involves a person-centred approach and participants 
reported ways in which they involved patients in checking and in decision-
making about their medicines. One negative case was documented.  
The theory describes how the complex and routine nature of acute 
healthcare leads up to professionals managing risk through using checks and 
balances and  working together to ensure that each patient gets the right 
medicine. The core category managing risk resonates with the literature 
which adds credibility to the research.   
My motivation and interest in producing a theory was to have a robust way of 
making explicit what is implicit in the day-to-day work of professionals with 
medicines. Having such clarity can help inform how cultural norms are 
agreed with all members of the team on each ward. Finally it can be used to 
establish pillars in the redesign of safer, more streamlined ways of using 
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9.0   Appendices 
Appendix 1      A reflexive personal statement 
 
I am a hospital pharmacist with 31 years’ experience. I have worked in the 
management roles of Director of Pharmaceutical Services and Head of 
Pharmacy and Medicines Management in two of the five Health and Social 
Care (HSC) Trusts in Northern Ireland  - Area Pharmaceutical Service, 
Craigavon Area Hospital (currently Southern HSC Trust) from 1998-2005 and 
the Western HSC Trust from 2005 to present. I have been in a management 
and leadership role within pharmacy in Northern Ireland for 20 years. This 
may introduce a potential power imbalance between me as researcher and 
participants, especially the pharmacists. To reduce the impact of this, I did 
not recruit participants from my current Trust. I recruited participants who I 
have never managed or worked with (apart from the pilot interview – see 
memo in Appendix 7). When initially recruiting participants, colleagues in 
other Trusts who know me were trying to help to proactively recruit other 
healthcare professionals. I was concerned that my participants therefore may 
be more positively predisposed to the role of pharmacists and following 
discussion with my supervisors, I explained this dilemma to colleagues, 
thanked them but did not interview the participants identified by them. Three 
of the doctors made reference to the benefits of having clinical pharmacists 
at ward level, in a way which made me assume that they believed that I could 
influence them getting a higher level of service. These comments were made 
at the end of interviews and felt almost out of context from the earlier 
discourse.   
As a registered pharmacist, I also have an ethical and professional obligation 
to highlight any concerns from interviews to the appropriate professional 
leads in each Trust. I explained this to participants at the outset (see 





I have a breadth of experience in hospital pharmacy, having worked in large 
teaching hospitals in England and District General Hospitals in Northern 
Ireland. I have worked in a number of different roles - as a rotational, on-call 
pharmacist, a radio-pharmacist, a clinical pharmacist in care of the elderly, 
surgery, haematology, bone marrow transplantation and palliative care. I 
have also worked as a Teacher Practitioner and as a hospital pharmacy 
manager. The strength of this is that I know the language used in the field, 
but I must be aware of not assuming meaning or projecting my views onto 
the data. I worked closely with doctors and nurses on ward-based multi-
disciplinary teams for over ten years, and now work closely with medical and 
nursing colleagues in a management role. I also have experience of being a 
patient in an acute hospital. In my current role, I want to lead on and 
influence practical changes which will make sure that medicines are used 
well in hospitals, both for patients and the healthcare professionals involved. I 
am particularly interested in systems-working, how healthcare professionals 
interact and how this impacts on day-to-day practice. I am aware, from 
experience, that using medicines is a complex process at which people are at 
the centre. I want to understand more about this and that has influenced my 
choice of research project. However my experience and views could 
influence what I hear in the interviews, how I interact with participants and 
how I code and analyse the data. To minimise this influence, I have adopted 
a reflexive approach. This includes, being open about my background and 
interests in this statement; using a structured methodology (Strauss and 
Corbin 1998) to help to reduce subjectivity; recording interviews and 
transcribing them verbatim and using memos; writing comments and 
concerns in a researcher diary, in which I regularly reflect on my thinking and 
whether I need to take a step back, how I carried out interviews, the 
questions I used, whether I influenced participants; and sharing and 
discussing recordings and coded transcripts with my research supervisors. I 
also have put myself in participants’ shoes when writing up the research, 
taking care to protect their anonymity in my quotations and references as well 
as trying to be true to the essence of what they said. I have listened to 
interviews a number of times to help with this. Just before I started data 




questions, listening and asking powerful questions, with supervised practice. 
This, I believe, gave me an increased sensitivity when interviewing 
participants- although I did not always get it right! 
My early career research was quantitative and although I did some qualitative 
research in education, my current research has been a completely new 
experience, with wide learning in qualitative methodologies and getting used 
to a new language, which took some time. I also have tried to use the first 
person singular (‘I’) in my thesis where appropriate to place me in the work. I 
realise also that I have developed as a researcher through my interactions 
and presentations at the University of Bradford, becoming more involved with 
local practice research and linking with the wider research community 
through conferences and tools such as ResearchGate. This greater 
awareness of the literature and of research thinking will further develop my 
role and approach to using medicines safely and appropriately.  I particularly 
want to continue to build upon this through further development of an 














Appendix 2   Non-committal outline literature review (first) 
 
Search strategy  
1. I accessed specific databases as outlined below. The search 
strategies used on the following pages.  
Databases Platform Dates carried out 
Medline EBSCO host 18- 25 January 2015 
CINAHL EBSCOhost January 2015 
Web of Science  Web of Science January 2015 
 
In approaching this literature search I sought the advice of the subject 
librarian at the University of Bradford. 
 
Medline (1990- January 2015) 
Search Term Results 
1      “Medicines Management” 294 
2      “Medicines Optimisation” 6 
3      (MH “medication system,  hospital”) 1937 
4      (MH “qualitative research”) OR 
“qualitative” 
15 
5      1 OR 2 299 
6      4 AND 5 3,310,727 (SmartText) 
7      3 AND 4 33 




10    (MH “Attitude of Healthcare 
Personnel”) 
80,319 
11    (MH “ Focus Groups”) 19,042 
12    ‘Grounded Theory’ 6490  
13    ‘Phenomenology’ 5314 
14    ‘anthropology’ OR (MH 
‘Anthropology, cultural’) 
4376 
15    (MH ‘Narration’) OR ‘Narration’ 5984 
16    (MH ‘Interviews as Topic’) 43,028 
17    4 OR 12 OR 13 OR 14 OR 15 OR 16 78,006 
18    1 OR 2 OR 3 2,231 
19    17 AND 18 47 
20   (MM “Prescription 
drugs/AD/AE/CT/DU/ST/SD/TU/TO”) – 
limiter English Language 
2323 
21   (MM “Patient Care Team”) AND 
(“Nursing, Team”) AND (MM “Institutional 
Management Team”) AND (MM “Hospital 
Rapid Response Team”) AND (MM 
“Secondary Care”) – limiter English 
Language. Boolean and SmartText 
searching. 
92,684 





Inter-professional working and medicines management 
Medline and CINAHL (Years: January 1990 – January 2015) 
Search Term Results 
1   Inter-disciplinary 58,771 
2   Inter-professional working 458 
3   Inter-professional relationships 102 
4   Multidisciplinary team 1402 
5   1 OR 2 OR 3 OR 4 60,556 
6   Medicines management 6,287 
7   Medicines optimisation 204 
8   6 OR 7 6487 














PRISMA 2009 Flow Diagram  




















Records identified through 
database searching 






























Additional records identified 
through other sources, for 
example, reference lists from 
papers, grey literature 
(n = 14) 
Records after duplicates removed 
(n =161 ) 
Records screened 
(n = 161 ) 
Records 
excluded 
(n = 140), (not in 
English (36), not 
related to 
subject)   
Full-text articles assessed 
for eligibility 




of paper)  
(n = 4) 
 
Studies included in 
qualitative synthesis 




Appendix 3 Integrative literature review (second) 
 
A second, systematic, literature review was carried out following generation 
of the theory. This was used to situate the theory in the current literature as 
well as identify if my research had filled any gaps in the field. 
Search Strategy  
I searched the literature as follows: 
2. I accessed specific databases as outlined below. The search 
strategies used are on the following pages.  
Databases Platform Dates carried out 
Medline EBSCO host September – 
December 2018. 




Elsevier December 2018 – 
January 2019. 
 
I set up search alerts on EBSCOhost to ensure the searches remained up-to-
date.  I searched databases with no date restrictions initially, but narrowed 
these dates to the last 20 years, English Language and Full Text if there 
were too many references initially.  
3. I also used Summon, the University of Bradford’s search engine which 






4. I accessed references from the reference lists of primary papers, 
review papers, as well as articles which had cited these references 
and publications from individual researchers.  
5. I used specific textbooks, especially key texts on research 
methodologies and Grounded Theory.  
6. I accessed the grey literature available on the websites of the following 
organisations: 
 Department of Health and Social Care and Department of 
Health Northern Ireland www.gov.uk and www.health-ni.gov.uk 
 General Medical Council (GMC) 
 Kings Fund 
 National Patient Safety Agency (NPSA) 
 National Institute for Health and Care Excellence (NICE) 
 Nursing and Midwifery Council (NMC) 
 Pharmaceutical Society of Northern Ireland(PSNI) 
 Royal College of Nursing (RCN) 
 Royal Pharmaceutical Society of Great Britain (RPS)  
I also had short email correspondence with Zubin Austin, a Canadian 
professor, who has published in the area of pharmacy education and 
personality traits.  
I critically assessed articles for use in my thesis by using a critical appraisal 
tool (Mukadam et al 2011). I have populated this tool below for the key 
papers used in the discussion. I also accessed key texts, for example, 
Reason (2000), which set out seminal  or new thinking on subject areas and 







Database Search Strategies 
Systematic literature searches were carried out using Medline- using MESH 
(Medical Subject Headings) and non- MESH terms, CINAHL Plus with Full 
Text and EMBASE. 
Search strategy – Medicines management/optimisation, qualitative 
research, categories – CINAHL Full Text 
(Searches carried out between September 5th and November 23 2018) 
(Years, when restricted, 1998 -2018) 
Search Term Results 
1    (MH “ medication management”) 373 
2    “Medicines Management”  1971 
3    1 OR 2 2323 
4    “Medicines Optimisation” 196 
5    (MH ‘medication systems’) 1758 
6     (MH ‘qualitative studies’) 92,779 
7    3 OR 4 OR 5 4144 
8    6 AND 7 144 
9    (MH ‘Focus Groups’) 37,135 
10    (MH Grounded Theory’) 13,945  
11   (MH ‘Phenomenological research’) 13,685 
12    (MH ‘Narratives’)  15,673 
13    (MH "Semi-Structured Interview") OR 






14    6 OR 9 OR 10 OR 11 OR 12 OR 13 250,119 
15    7 AND 14 324 
16    (MH "Decision Making, Clinical") 25,901 
17    7 AND 16 54 
18    “prioritising resources” 0 
19    “prioritising resources” (smart text) 66 
20   7 AND 19 0 
21  “checks and balances”  76 
22  7 AND 21 0 
23  “Checks” 3,014 
24  “Checking process” 17 
25   22 OR 23 OR 24 3,089 
26   7 AND 25 12 
27  “working together” 2108 
28  7 AND 27 3 
29  (MH ‘Teamwork’)  13,633 
30  (MH "Interprofessional Relations") OR 
(MH "Joint Practice") OR "interprofessional 
collaboration"  
24,194 
31 (MH "Multidisciplinary Care Team")  37,144 
32  27 AND 29 AND 30 AND 31 3,089 





Search Strategy – Medicines management/optimisation, qualitative 
research, categories - Medline 
(Searches carried out between September 5th 2018 and 2 January 2019)  
(Years, when restricted, 1998 -2018) 
Search Term Results 
1      “Medicines Management” 10,786 
2      “Medicines Optimisation” 483 
3      (MH “medication system,  hospital”) 11,245 
4.     (MH “qualitative studies”) 60,250 
11    (MH “ Focus Groups”) 25,720 
12    (MH “Grounded Theory”) 1061  
13    (MH “Phenomenology”) 53 
14   (MH “Anthropology”) 3,251 
15    ‘narration’ 7,809 
16    (MH "Interviews") OR (MH "Semi-
Structured Interview") OR (MH 
"Unstructured Interview") OR (MH 
"Structured Interview") 
60,584 
17    4 OR 11 OR 12 OR 13 OR 14 OR 15 
OR 16 
37,454 
18    1 OR 2 OR 3 18,759 
19    17 AND 18 
(Restricted to English Language and 






20    (MH "Decision Making") OR (MH 
"Decision Making, Clinical")  
86,104 
21    18 AND 20 15 
22    “prioritising resources” (smart text) 168 
23   18 AND 22 0 
24  “checks and balances” 225 
25  “checks” 7,771 
27  18 AND 24 AND 25 2 
28  “working together” 2,908 
29 18 AND 28 11 
30    (MH "Teamwork")  46 
31   "teamwork and collaboration" 162 
32  (MH "Multidisciplinary Care Team") OR 
(MH "Research, Interdisciplinary")  
52,662 
33  "inter-professional working AND inter-
professional collaboration 
6,044 
34   "inter-professional collaboration" OR 
(MH "Interprofessional Relations")  
49,940 
35. (MH "Multidisciplinary Care Team")  49,802 
36.  28 OR 30 OR 31 OR 32 OR 33 OR 34 
OR 35 
53,090 
37.  18 AND 36 





published between Jan 1998 – December 
2018). 
38. Power (psychology)  
 
12,054 
39. 18 AND 38  
(Restricted to English Language and 
published between Jan 1998 – December 
2018). 
26 (21) 
40. “Power theory” 21 
41. 18 AND 40 0 
 
Search strategy - Risk Management – CINAHL Plus with Full Text  
(Search carried out on 3 December 2018) (Years: 1998- 2018)  
Search Term Results 
1    (MH “Risk Management” (IOWA NIC)+”) 
OR (MH “Risk Management +”) OR 
“managing risk ” 
17,320 
2    risk management 20,682 
3    1 OR 2 25,710 
4    (MH “Grounded Theory”) OR “grounded 
theory” 
14,142 
5    3 AND 4 104 
6    “medicine” OR (MH “Medicine+”) 301,640 





8    6 OR 7 403,187 
9    5 AND 8 12 
10   (MH “Medication Errors+”) OR 
“medication errors”  
13,471 
11   4 AND 10 17 
12   (MH "Medication Management") OR 
"medication management" OR (MH 
"Medication Management (Iowa NIC)") OR 
(MH "Medication Managements (Iowa 
NIC)+") 
2,079 
13          4 and 12 17 
14         (MH "Risk Assessment")   OR "risk" 680,608 
15         4 AND 8 AND 14 104 
16         5 OR 15 197 
17         16 NOT 5 93 







Search strategy - Risk Management – Medline  
(Search carried out on 3 December 2018) (Years: 1998- 2018) 
Search Term Results 
1    (MH “Risk Management” (IOWA NIC)+”) 
OR (MH “Risk Management +”) OR 
“managing risk ” 
240,692 
2    risk management 37,896 
3    1 OR 2 262,324 
4    (MH “Grounded Theory”) OR “grounded 
theory” 
9,271 
5    3 AND 4 194 
6    “medicine” OR (MH “Medicine+”) 3,779,397 
7    (MH “Medication Errors+”) OR 
“medication” 
235,871 
8    6 OR 7 3,922,309 
9    5 AND 8 80 
10   (MH “Medication Errors+”) OR 
“medication errors”  
12,849 
11   4 AND 10 22 
12   (MH "Medication Management") OR 
"medication management" OR (MH 
"Medication Management (Iowa NIC)") OR 
(MH "Medication Managements (Iowa 
NIC)+") 
2,585 




14         (MH "Risk Assessment")   OR "risk" 1,780,112 
15         4 AND 8 AND 14 377 
16         5 OR 15 507 
17         16 NOT 5 309 
18         9 or 11 or 13 108 
 
EMBASE 
Search strategy (Search carried out on 2 January 2019)  
Search Term Results 
'medicines management' OR 'medicines 
optimisation' 
1511 
('medicines management' OR 'medicines 
optimisation') AND ('interprofessional 
collaboration'/exp OR interprofessional) 
19 
('medicines management' OR 'medicines 
optimisation') AND ('risk management'/exp 
OR 'risk management' OR 'risk sharing, 
financial' OR 'managing risk') 
25 
'medicines management' OR 'medicines 
optimisation' 
1511 
('medicines management' OR 'medicines 
optimisation') AND ('interprofessional 
collaboration'/exp OR interprofessional) 
19 
('medicines management' OR 'medicines 
optimisation') AND ('risk management'/exp 





financial' OR 'managing risk') 
('medicines management' OR 'medicines 
optimisation') AND ('risk management'/exp 
OR 'risk management' OR 'risk sharing, 
financial' OR 'managing risk' OR 'risk'/exp 
OR 'risk' OR 'risk hypothesis') 
353 
('medicines management' OR 'medicines 
optimisation') AND ('risk management'/exp 
OR 'risk management' OR 'risk sharing, 
financial' OR 'managing risk' OR 'risk'/exp 
OR 'risk' OR 'risk hypothesis' OR risk) 
AND ('qualitative research'/exp OR 
'qualitative research' OR 'qualitative 
studies' OR 'qualitative study' OR 
'grounded theory'/exp OR 'grounded 
theory' OR qualitative OR 'focus groups' 
OR 'phenomenology'/exp OR 
'phenomenologic research' OR 
'phenomenological research' OR 
'phenomenological study' OR 
'phenomenology' OR phenomenology OR 
narration OR narrative OR 'interview'/exp 
OR 'interview' OR 'interview guide' OR 
'interviews' OR 'interviews as topic' OR 
interview* OR 'ethnography'/exp OR 'ethno 








PRISMA 2009 Flow Diagram 

















Records identified through 
database (Medline, CINAHL Full 
Text, EMBASE) searching 





























Additional records identified 
through other sources (from 
reference lists, grey literature) 
(n = 17   ) 
Records after duplicates removed 
(n =552 ) 
Records screened 
(n = 552) 
Records 
excluded 
(n = 425) not 
English  








age, relevance  
 






Appendix 4       Assessment of quality of some of the key papers used in the second literature review 
Checklist (Mukadam et al 2011)  
    Quality Score 
(indicators differ 
for qualitative and 
quantitative 
studies) *see key 
below.  
Comments  
Paper and Country Type of Study Sample Number of 
Participants 
1 2 3 4 5 6  




severity and risk 
factors for 






All newly prescribed or 
rewritten inpatient medication 
orders as part of their usual 
practice (hand-written and 
electronically prescribed). 
Grade of prescriber and 
prescribing errors noted 
(validation panel). 
 
26,019 patients with 
124,260 medication 
orders across 20 UK 
NHS hospitals. 
  
1 1 1 1 1 0 Data collected on 7 days 
one month apart. 
Data collectors were 
trained and data collection 
information book. Two 
error validation panels. 
























observations.   
Three different wards in a 
tertiary, paediatric teaching 
hospital. 
Nurses and doctors who 




40 nurses interacted 
with 30 doctors -200 
hours of recorded 
observations. 
6 focus-groups (59 
nurses, range of 
experience). One-to-
one interviews – 7 
doctors, 11 nurses 
(range of 
experience). 
1 1 1 0 1 0 Inclusion and exclusion 
criteria. 
Methods to reduce 
intrusiveness of 
observations. ‘General 
schedule’ for data 
collection. 
Model used for thematic 
analysis.  
Themes discussed among 
team members and 
consensus reached.  
Dixon-Woods, M. et 







data from a 
range of 
sources. 
Data summarised from 7 
separate sub-studies. 
Interviews, ethnographic 
observation, surveys, focus 
groups and documents.  
Very large. Total of 
304 semi-structured 
interviews. 
650 hrs observation. 
715 cross-sectional 
1 1 0 0 1 0 Low scoring due to lack of 
information. High-level 
summary. No formal 
protocol but “interpretive, 
narrative approach.” Full 
information on methods or 




Behaviour in the 
English National 
Health Service: 
overview of lessons 
of a large, 







793 sets of minutes 
plus other data. 
primary data (due to 
quantity) – available in 
second report. Authors 
describe “careful data 
scrutiny, extensive 
discussion and detailed 
analysis of themes” - 
believe provided rich and 
powerful picture.  
  





EQUIP final report - 






and synthesis of 




methods used.  
 
One-to-one interview sample: 
Purposive (not 
representative) sample – 
‘maximum variability sample.’ 
Different ethnicities from 
variety of medical schools 
and both genders.  
 
Email and presentations used 
30 FY1 doctors 




worked in teaching 
hospital / 16 in a 
District General 
Hospital. Covered 
18 out of 31 UK 
1 1 1 0 1 0 Methods included 3 
systematic literature 
reviews (note letter by 
Dean 2010 on published 
review 2009), a large 
empirical evaluation of the 
prevalence and nature of 
prescribing errors made by 
FY1 trainees (range of 
educational backgrounds)- 




prescribing errors by 
foundation trainees 













medical schools.  
17 different hospital 
sites. 85 errors 
discussed.  
al 2015, qualitative, one-to 
–one interviews using a 
critical incident approach, 
and telephone interviews 
of medical school leaders.  
Note report for the GMC – 
not published in journal.  
Interview schedule used. 
Panel discussion of errors. 
Higgins, M.P. and 
Tully, M. (2005). 
England.  
 
Hospital doctors and 











using a modified 
Grounded 
Theory 
7 pre-registration (FY1 
doctors),5 senior house 
officers FY2 doctors) and 5 
consultants from different 
medical specialties in a 
teaching hospital  
17 doctors 1 1 1 1 0 0 Interviewer carried out 
main analysis but two 
researchers read the 
interview transcripts and 
discussed analysis. 
 






approach. Limitations- excluded 
alternative ‘paradigms of 
psychological research.’ 


























support staff (n=35). 
63% from acute 
sector.  
 
1 1 1 1 0 1 Limitations – participants 
were self-selecting both in 
attending the workshops 
and completing the on-line 
survey. Survey was 
piloted. Different workshop 
locations -poor attendance 
registers kept. 
Generation of codes until 
‘theoretical saturation.’ GT 
not stated. No additional 
data recorded form the 
workshop discussions. 
Higher level codes were 
presented to healthcare 
audiences – external 




Hrissos, S. and 
Thomson, R. (2013). 
 England. 
 
Do approaches to 
involving patients in 
improving their 


















Patients, carers and 
healthcare professionals in 
general medical and surgical 
wards in two English 
hospitals.  
16 patients, 4 
relatives (mead age 
60 years (sd 15): 12 
female, 8 male). 
 
39 healthcare 
professionals – 11 
doctors, 12 nurses, 
9 pharmacists, 7 
healthcare 
assistants.  






Interviews in patients/ 
carers homes.  
Project team discussed 
findings and included 
patient representatives.  
Key themes not a 
grounded theory 
discussed. 
Lewis, P.J. and 
Tully, M. (2009). 
 
Qualitative 




12 hospitals – all doctors 
invited to participate. 
Purposive sampling frame 
(32 doctors) - different 
experiences, followed by 




1 1 1 1 1 0 All authors read the critical 
incidents, discussion and 











































(doctors, nurses or 
pharmacists) working at least 
one day a week in 
Emergency Dept (ED) or 
medical wards. 
Stable, adult patients 
presenting to ED and family 
members of patients in ED or 
medical wards.   








doctors) – 12 focus 
groups and 3 
individual interviews.  
1 0 1 1 1 1 Data collection until 
repetitive findings. 
Only English speaking 
patients and family were 
recruited. 
Time pressures to 
interviewing.  
Audio-recorded. Rigor- 
memos, minutes and field 
notes. Triangulation 
between patients, family 


























Pharmacists, nurses and 
doctors working in a range of 
clinical settings.  
 
Sampled through information 
sessions, referrals from 




73 individuals: -  
21 participants 
working in a range of 
clinical specialties in 
a large teaching 
hospital.  
76 observations of 
56 individuals in 
similar settings. 
13 pharmacists 
46 nurses  
14 doctors. 
1 1 1 0 1 0 Used a 5-stage thematic 
framework to analyse the 
data. 
 
Data analysis by first 
author and discussed by 
team to reach consensus. 
 
Quotations from 
participants included in the 
text.  
 
4 different interviewers. 









All doctors prescribing in 8 
purposively selected Scottish 















outcomes for trainee 
doctors engaged in 







causation used.  
Wards had at least one fy1 
doctor who prescribed and a 
clinical pharmacy service.   
(observational study). 
 
Reliability of pharmacists’ 
routine error reporting was 
checked in 10% of 
samples.  


















Two hospitals – potential 
under-reporting of pharmacy 
interventions. Concerns 
expressed regarding control 
of ‘processes due to 
naturalistic setting.  
1049 patients 
recruited with 833 
patients analysed.  
Authors commented 
on need for a larger 
sample size. 
1 0 1 0 1 0 Measured outcomes from 
a new service. Concerns 
re controlling approach in 
naturalistic setting. Not 
clear about how patients 
were chosen. ‘Control’ and 
intervention groups – note 
latter may not have got full 
intervention. Cannot fully 









study of prescribing 
errors in patients 









analysis of data.  
Nine hospitals, each asked to 
audit a minimum of 400 
prescriptions (empirical 
choice of numbers – related 
to a previous study). 
Nominated ward-based 
pharmacists collected data as 





1 1 1 1 1 0 Numbers to compare with 
EQUIP study. Training of 
data collectors not 
mentioned but 
standardised data-
collection tool used. 
Looked at errors on whole 
prescription as well as 
individual errors. 










study   
Convenience sampling to 













 Key to quality assessment scores (1-6) for quantitative and qualitative studies (Mukadem, N. et al 2011)*  
 Quality assessment tool for quantitative studies Quality assessment tool for qualitative studies  
1. Was the target population defined by clear inclusion and 
exclusion criteria? 
Were the aims of the research clearly stated? 
2. Probability sampling used to identify potential respondents (or 
whole population approached)? 
Was a clearly defined method of recruitment used? Were there 
inclusion/exclusion criteria?  
3. Did characteristics of respondents match the target population 
i.e. was response rate >80% or appropriate analysis included 
comparing responders and non-responders? 
Was the process of data collection and analysis explained clearly? Was data 
collection standardised? 
4. Were data collection methods standardised? Did the researchers attain saturation of data?  
5. Was the measure used valid? Was the process of data analysis sufficiently rigorous, i.e. at least two raters, 
some method of resolving discrepancies? 
6. Was the measure used reliable? Have the findings been validated by participants? 




Appendix 5 Outline interview guide for initial one-to-one interviews 
 
Outline interview guide  
Introduction 
 
Hello – my name is Anne Friel and I am a 
Doctor of Pharmacy student at the University 
of Bradford. 
 
Thank you for agreeing to be interviewed as 
part of my research study. 
 
The aim of the research is to produce a 
theory which explains how doctors, nurses 
and pharmacists work to optimise the use of 
medicines in acute hospital settings in 
Northern Ireland. 
 
Can I confirm that you have received written 
information on this study and that you have 
given your consent to participate? 
 
You know that you do not have to answer all 
of my questions and may withdraw from the 






The information which you give me will be 
treated confidentially. However as I am also 
a registered pharmacist I have a professional 
obligation to highlight to the relevant Trust 
professional lead any concerns raised during 






Best way to contact you – to check the 
transcript of the interview, share results of 
the research. I will not use your name to 
directly identify your interview transcript. I will 
use a code.  
 
Profession: 







I would like to understand your experience in 
your own words without imposing my words 





time to time but I will not ask lots of 
questions. 
 
I am interested in your personal experience 
of working with medicines in hospital 
Tell me about your role(s) working with 
medicines in hospital? 
 
Describe what impacts on and influences 
your approach to working with medicines. 
 
Can you tell me how you interact with other 
healthcare professionals when working with 
medicines? 
 
Can you tell me how your role or the roles of 
others with medicines has changed over the 
last number of years? 
 
What did you think then? 
 
Can you tell me about the most important 
learning you have had from your work with 
medicines? 
  






How has your professional training prepared 
you for working with medicines? 
 
Professional barriers/ approach 
 
Prompt questions 
Tell me about / could I ask you what that is 
like for you? 
 
What does that mean for you? 
 
What were you thinking? 
 
Who influenced your actions? 
 
Could you say something more about that? 
 









I’d like to draw the interview to a close. 
 
Is there anything which you would like to say 
that you have not had an opportunity to? 
 
Thank you for taking part. I appreciate having 
this opportunity to talk to you. 
 
I will be typing up the transcript of this 
interview for analysis. Would you like to read 
through it for accuracy purposes? 
 
If you have any further questions please 
contact me or…. 
  
Manually record any additional comments 
made by the participant after the tape-
recorder has been switched off- keep 
separate for analysis purposes. 
 
 
Additional questions added to subsequent interviews (theoretical 
sampling): 
 What information do you use (or seek)when making decisions about 
medicines?  
 What is your and other professionals’ responsibility with respect to 






 What informs your prescribing decisions? Just checking out some 
comments from others – they describe a holistic assessment – is there 
time for that, is evidence-base foremost?  
 What are the drivers in your use of medicines? For example,  
discharge, flow, medium term thinking- system 
 How do you work as an autonomous healthcare professional when 
working as a member of a multi-professional team? What are you 
accountable for with regard to medicines? 
 How has your approach to using medicines changed with experience?  
 Talk me through the things which go through your head when 
reviewing a patient’s medicines. , for example  
 Ask about the weight of responsibility of roles. 
 Explicit knowledge – do you have access to all information – what 
information do you use to make decisions? 
 What kind of skill is prescribing?   
 What words would you use to describe other healthcare professionals’ 
roles with medicines? 
 How do you get information from patients relating to medicines use 
and the effects of medicines? 
 Where does prescribing sit among the roles of the doctor? 
 How can I explore this with other healthcare professionals – the 
relative importance given to medication and getting it right?  
 How are healthcare professionals trained with regard to making 
decisions which affect patients’ lives?  Are junior doctors trained any 
differently to do other practical things as opposed to prescribing? Is 
prescribing a practical thing or a higher order thinking process? 
 Test out- fast paced world – make bolder decisions regarding 





Appendix 6    
An armchair walk-through (Richards and Morse 2007) 
I am interested in exploring the perceptions or beliefs which healthcare 
professionals have of their roles in medicines optimisation. Doctors, nurses 
and pharmacists are involved in this process. The process has developed to 
include pharmacy technicians (not registered in Northern Ireland), as well as 
newer non-medical prescribers including physiotherapists, optometrists and 
chiropodists. The role of nurses and pharmacists has changed with respect 
to prescribing. My focus is on medicines optimisation on acute hospital wards 
and this involves the traditional three professional groups only. Will I look at a 
sub-section of nurse and pharmacist prescribers? I will not plan to include 
pharmacy technicians- but may there be a subculture in general of non-
registered staff seeing a role in optimising medicines (maybe don’t close the 
door on exploring this at this stage). There is variation between doctors, 
nurses and pharmacists with respect to grade, years of experience, range of 
experience and training. Do I look at sub-groups, for example,  newly 
qualified professionals and professionals trained more than 20 years ago (I 
would need to choose the number of years for a reason, for example  when 
training methods changed). I want to hear perceptions which may impact on 
current practice – do I want to look at variation and how important is that? 
Eventually I need a homogeneous sample? I think I will start by having one-
to-one interviews with a member of each of the three professions with at least 
one year’s acute hospital ward experience (so that their views are based on 
experience as opposed to being solely theoretical) and a member of each of 
the three professions who has been practising for more than twenty years. 
Initial convenience sampling however means involving, “experts” at the start 
to get an overall feel for the process. All of these individuals will be, “experts” 
to differing degrees as they have at least one year’s experience of working 
with medicines and their different levels of experience will allow me at the 
outset to, “define boundaries” to see whether I should explore further different 
views of professionals with different levels of experience. (Six one –to-one 




Appendix 7   Memo –  pilot interview (1.4.18) 
I looked at the pilot interview which I had carried out on 25 July 2016 with a 
pharmacist in a different hospital who I had worked with 10 years ago. I had 
planned to use this interview solely to test my interview technique and 
whether the initial questions made sense, to give me confidence. However, 
there is rich data in the interview which develops and provides greater depth 
to some of the categories. 
I cannot find a reference to this in the literature, mainly because pilot studies 
are rarely used in grounded theory methodology.   
I have not looked at the pilot interview at all until now. Its content has not 
contributed to the coding and analysis of the data. However at this late stage, 
I have gone back to the interview to see what was said and have included 
some direct quotations in areas which already exist. 
Further thoughts – December 2018 
I have discussed whether to include the codes and quotations from the pilot 
interview in the theory and in my findings with my supervisors. There are a 
number of points to balance: 
1. I know and used to manage the pilot participant. The individual works 
in a different Trust and I have no management responsibilities and do 
not attend meetings with the individual now.  
2. The individual has a wide range of experience of working with 





3. The pilot interview was structured and formal. The individual gave 
informed consent at the outset. I double-checked that she was happy 
for me to use the data from her interview in my analysis and findings. 
She has read through the Findings chapters and is happy with this. It 
could be argued that the individual was more open and free with her 
views than other participants who had never worked with me, but I 
believe this would add to the richness of the data. 
4. The individual works to a high moral, professional and ethical code. 
5. I did not code and analyse the pilot interview until I had coded and 
analysed all of the other 16 interviews. Therefore the data from the 
pilot did not shape the theory but added depth to the findings. 
I have decided to use the data from the pilot interview and this is made 
transparent in laying out the theory. I believe that inclusion of the data from 

































Appendix 11:  University of Bradford email and Ethics Reviewer’s 
comments form, confirming ethics approval 
 
From: nhs-ethics [mailto:nhs-ethics@bradford.ac.uk]  
Sent: 22 April 2016 09:48 
To: nhs-ethics; Friel Anne 
Cc: Beverley Lucas; Alison Blenkinsopp 
Subject: RE: IRAS Application - Blenkinsopp/Friel 2015/16 
Importance: High 
Dear Anne 
IRAS Application:              Blenkinsopp/Friel                            Life 
Sciences                      2015/2016 
Title:                                      How HCPs work to optimise medicines in acute hospitals in NI 
Your IRAS submission has now been reviewed by an internal IRAS reviewer. 
I am pleased to inform you that your study has ethics approval to proceed to the NHS for 
consideration  and ethical review. 
NOTE the actions that are now required: 
1) You must submit your application via the IRAS portal using the details below for the 
University Sponsor: 
a. Sponsor:                              Tamsin Holt 
b. Email:                                    nhs-ethica@bradford.ac.uk 
2) You must make sure that before submitting the documents, all your documents are 
consistent in regards to version numbers, etc. You may also need to contact the 
Central Booking Team within the NHS to confirm a reference number before you 
submit, please make sure any such reference numbers are included in your 
documents before you upload them to the IRAS portal for submission. 
3) Once the documents are submitted via the IRAS portal, a notification will be 
received by the University Sponsor that your study needs sign off. I will notify the 
sponsor that we have reviewed and approved the study for ethics. 
4) The University Sponsor will sign off on the study, which means your study will be 
submitted through the portal for review by the NHS. 
 













Research Funding Co-ordinator             
RKTS, F.24 Richmond Building 
 
+44 (0) 1274 233112   
 
o.f.ali@bradford.ac.uk    
 
www.bradford.ac.uk    
 
 




























Appendix 13 : Letters confirming Health and Social Care (HSC) 
Trust final research governance permission from Belfast, Northern, 






































































































Appendix 14 Examples of extracts of initial line-by- line codes for three 
interviews – a doctor, a pharmacist and a nurse 
 
Interview 6 Interview 7 Interview 8 









- 3.5 years’ 
experience 








Clarifying and adjusting 
drugs. 





Reviewing patients daily. Prioritising work in overall 
context. 
Working in a 
structured system. 
Making decisions in real-
time. 
Educating patients. Being made aware 
of ad hoc doses. 






Planning for discharge. ‘So from the very 
beginning to the very 








support. are accessible [to 
administer]. 
Seeking alternatives routes 
of administration. 
“If time permits” (in vivo 
code). 
Using skill mix to 
improve flow. 
[Pharmacists] having role in 
discharge. 
Using time to do tasks. Saving time. 
Admission-related medicines 
review. 








Reviewing medicines at 
interfaces. 
Serving medicines 
to patients, “we 
administer each 
tablet into our 
cups and taking it 
to the patient” (in 
vivo code). 
 
Routine working. Prioritising discharges. Checking allergy 
status. 
Writing up admitting drugs. Focusing on medicines 
reconciliation. 
Including the 
patient in checking 
process. 
Leaving tasks to FY1s. Making sure medicines 




Knowledgeable doctor not 
easily accessed. 
“Although I have to 







Asking questions of easily 
accessible doctor. 
Using guidelines. Opening dialogue 
on medicines. 
[FY1] not attending ward 
round. 
Putting the patient first – 
Medicines Optimisation. 




Taking complexity into 
consideration. 
Valuing patients' views. Accessing ECR 













Weighing up risk/benefit.  Putting guidance into 
practice. 
Getting it right. 
Looking at the whole picture. Improving 
communication skills. 
“We are not afraid 
to ask” (in vivo 
code). 
Reducing harm. Working in a peer 
network. 
Using BNF to 
prescribe. 
Forward thinking. Moving practice forward. Correctly 
prescribing 
usually. 
Rationalising medicines. Actively de-prescribing. Seeking advice 
from others. 
Prescribing purposefully. “To try to improve their 







Impact of condition on 
medicines choice. 






Multi-factorial influencing. Learning from consultant 
experience. 
Putting systems in 




















Appendix 15   Interviews with Jayne and Sally (Doctor 2 and Doctor 3) – 
what is happening here? 
 
What is happening 
here? 
Getting the best for patients from the use of medicines. 
Doing the best job with what we have – knowledge, 
time. 
These senior doctors describe a very purposeful 
approach to prescribing medicines – being thoughtful, 
using their experience of medicines, using guidelines in 
the context of the patient to make decisions, seeking 
advice when its needed, listening to others, taking 
care, actively stopping medicines – thinking about what 
is best for that patient. And so it is important to have 
the right information available – information on how the 
patient is from the nurses, on the medicines the patient 
is on from the pharmacist and knowing how to get 
things done. Being able to look things up- having 
information available so that they do not have to rely 
on memory or make decisions with only some 
information. Engaging the brain so that the focus is on 
medicines – not a similar approach in all specialties. 
What happens when medicines are not proactively 
reviewed? Using medicines is a proactive process 
which changes with time as the patient’s condition 
changes. So there has to be a proactive process to 
manage risk and get the best care for the patient.    So 
we need to have things which make it easier to do well- 
information, people who can make things happen, and 
that’s what it’s all about- not relying on one 
professional to do everything with medicines but to 
support each other – being thoughtful about medicines. 
There is a complex interlinking system with 




medicines in context of the patient, making sure that 
the patient gets the right drug on time, reviewing 
medicines – tying up loose ends as well. One big 
complex task with lots of different parts- needs people 
to pay attention to detail, to be able to do that and with 
more people involved does that take the pressure off 
the original prescriber when prescribing – knowing that 
someone else will pick that up? Knowing there are 
checks and balances in the system.   
Who? Middle and senior grade doctors. 
Pharmacists and nurses.  
When? Medicines review and prescribing is integrated into the 
daily review of patients.  
Where? On acute hospital wards. 
Why? Personally accountable for prescribing.  
Striving to get the patient better. 
Being responsible for patient safety. 
All hcps responsible for empowering patients. 
“The buck stops with you.” 
Preventing harm. 
“Prescribing is one of the few things we can twiddle 
with.” 
Benefiting patient outcomes. 
How? In built alarms, “I don’t rely on my memory”. 
Questioning, engaging my brain, thinking when 
prescribing, checking with the patient, taking care, 




decision making, using guidelines, de-prescribing, 
actively managing prescriptions, making conscious 
decisions, involving other team members – 
encouraging questions, auditing practice, asking 
specialists, seeking advice from pharmacists and 
nurses, looking at BNFs, taking complexity into 
consideration, taking lots of factors into account, 
rationalising medicines, being thoughtful and making 
purposeful decisions, pharmacists backing us up/ 
keeping us right, knowing how to get things to happen, 
seeing gaps, getting things done, sometimes there are 
problems when not enough information, for example,  
no BNF and a decision is made and almost left 
hanging – realise that you have created a problem for 
someone coming along later. Making the best out of a 

















Appendix 16   Selective coding – integrating and refining the theory 
 
Writing the storyline 
I have given an example of a storyline written in April 2018 when I was trying 
to refine my theory. I found this a very helpful tool to use particularly when I 
was feeling overwhelmed by data and when I believed I was completely on 
the wrong track.  
 Writing the storyline   3.4.18 
I revisited the data – the open codes and the integrative diagram for checks 
and balances. Looking at flow and narrative and asking more questions. 
All participants described taking care of patients who are sicker than before 
(would have died in the past). These patients have a number of disease 
states and are taking a number of different medicines to treat them as well as 
preventative medicines.  There are a greater number of medicines to choose 
from and therefore more medicines to know about and interactions – so there 
is potentially more risk in the system. There are also specialist medicines. 
The implication of using some of these medicines is that more help is needed 
for example district nurses and so prescribers need to understand the social 
context in which they prescribe as well as the side effects and evidence-base 
behind the drugs they prescribe. Nurses and pharmacists understand the 
wider implications of the use of certain medicines by virtue of their 
professional training and practice and so they fill the gaps and make sure 
that the right questions are asked. Their specific roles are dependent on 
prescriptions being accurate and appropriate for each patient and so they are 
almost forced into checking and asking questions and making sure they are 
right before they administer a medicine or clinically check a prescription and 
authorise it to be dispensed. 
At the same time there is a lot more information available to healthcare 
professionals. A senior pharmacist mentioned this and the impact of it is that 
there need to be lots more pharmacists to access and check this information. 




using guidelines and asking experts and other healthcare professionals for 
advice. There were examples of junior doctors prescribing or transcribing 
drugs which they had little knowledge of for patients that they did not really 
know as they hadn’t been on the ward round.  IT systems are used more 
now, one junior doctor described that these facilitate shortcuts, for example, 
not taking a full drug history, but the information on the ECR may not be 
complete or fully accurate and so, especially on admission, the list of drugs 
prescribed may not be accurate. One nurse described there being lots of 
errors on prescriptions on admission and the pharmacist coming along to do 
a medicines reconciliation. So this is having a dedicated person who knows 
where to get an accurate medicines list and has a dedicated role to do this. 
And this makes it easier for and gives confidence to the nurse to administer 
medicines. Other things which give confidence in using medicines are asking 
the patient what they are taking or what has worked well for them in the past. 
They will tell the real story of the medicines which they have been prescribed 
but don’t take and this information helps to get an accurate medicines list. 
Senior doctors review patients each day. This includes a review of their 
medicines, a process which may differ between medical teams. Surgeons 
may only focus on the medicines which change because of surgery, for 
example, analgesics and antibiotics. Different medical teams may pay more 
or less attention to the detail of the medicines. The prescribing decisions 
made impact on the nurse’s role and doctors described telling the nurse 
about these as soon as possible. One nurse spoke of a perfect system as 
being one when all of those prescribing changes had been made before the 
medicines administration round but was aware of the physical limitations of 
this. Doctors make prescribing decisions using a lot of information – 
guidelines, their experience of what has worked well in the past, the potential 
benefits to the patient, rationalising medicines, and thinking about the 
patient’s quality of life. When they do not have all the answers they ask 
others, for example, nurses who know the patient, pharmacists who know the 
medicines and the patient and specialists who use particular medicines or 
treat specific diseases routinely. And all of this takes time and requires focus. 




check your prescription and a nurse will query anything they are 
uncomfortable with before administering the drug all gives reassurance to the 
doctor. There are checks and balances in the system and these keep 
patients and other healthcare professionals safe.  
The importance of having a plan for a patient’s medicines on discharge is 
described by a junior doctor and a ward manager. The junior doctor will be 
tasked with writing the patient’s discharge letter but does not really know the 
patient or been part of discussions of their care on the ward round. So the 
written plan is important for him to write an accurate discharge letter. He also 
does not have enough experience or knowledge of the social or other 
implications of the prescription. The pharmacist focuses on helping to 
produce an accurate discharge prescription as they are responsible for 
clinically checking it and making sure it is dispensed accurately. So their 
professional role depends on this and over time they improve their skills and 
knowledge of what to look for and the questions to ask to get this right. A 
senior doctor talked about pharmacists’ magical skills and secret database 
which they used to sort out things. And so junior doctors, or anyone else, will 
rarely have the level of skills or knowledge or experience to write an accurate 
discharge letter as pharmacists have. So should pharmacists write the letter? 
Will junior doctors get deskilled? What do they need to know? 
The increase in workload and busyness is recognised by everyone and 
pharmacists and nurses in particular have looked at ways of making things 
easier and safer. This includes working in structured ways, having acronyms, 
for example, 5 Rs and no more than three rules to act as a trigger for 
questioning a prescription.  These professionals have also looked at where 
errors are made and have changed the way they work to help make things 
safer. This includes having a dedicated nurse to administer medicines. This 
person has one focus and should have minimal distractions. Pharmacy has 
introduced a range of different ways of working to make things easier and 
safer. These include having pharmacists on each ward who make sure the 
medicines are right on admission and discharge especially. These seem to 




only get to see the changes made to medicines during the patient’s stay if 
they have time, if they are highlighted as critical drugs or queried by others. 
So pharmacists are working on the ward and are part of the ward team, 
helping to solve medicines problems as opposed to working in pharmacy and 
checking prescriptions by telephone. This makes it easier for everyone. 
Pharmacists have a dual focus however. They clinically check prescriptions 
on the ward but they also have a role in overseeing how medicines are 
stored and used on the ward in line with legislation and guidelines. 
Pharmacists described a tension between having two roles and belonging to 
two teams and feeling a greater sense of belonging to the ward team. 
Pharmacy technicians have also been introduced onto wards to make sure 
the medicines are available for nurses to administer, reducing missed doses. 
They also expedite supply of individual items and discharge medicines.  
Pharmacists and nurses can now prescribe medicines and this helps to make 
things move more smoothly as well. They can know patients more and make 
prescribing decisions using not only their knowledge of medicines but also 
the wider knowledge they have by virtue of their professional roles and 
experience. They described being cautious prescribers but being able to 
correct prescriptions and provide a joined-up service which made a 
difference to patient care as opposed to leaving messages for junior doctors 
to change a prescription at a later time. So this improves efficiency, 
timeliness of administering the correct medicine and also gives the nurse or 
pharmacist a sense of making a greater difference to patient care. They 
describe bringing something extra to these prescribing decisions, “we are all 
about medicines’, ‘we see the whole patient.” 
Doctors, nurses and pharmacists speak to each other and to patients. Nurses 
are on the ward all of the time and know the patients best. They will know 
what support a patient needs to take medicines, how they feel when they 
take them, whether they need additional medicines to control symptoms and 
whether they can swallow medicines. They pass this information on to 
doctors to aid prescribing decisions. Nurses also need to know about 




sure that the prescription is right and if they have any queries, ask questions 
either of the pharmacist or the prescriber. They also need to know about 
medicines so they can tell patients when they ask what this is for or does it 
have any side effects. Pharmacists describe coming along afterwards and 
checking that prescriptions are right. They carry out a medicines 
reconciliation when the patient is admitted and then get any changes made to 
the Kardex. The Kardex is often incorrect for a variety of reasons including, 
the prescriber used one information source (ECR) which may not be 
accurate, the prescriber didn’t speak to the patient, the prescriber didn’t have 
sufficient focus, the prescriber missed or prescribed drugs they were 
unfamiliar with resulting in an error, the prescriber knew that the prescription 
would be checked by someone later and that is their safety net. Pharmacists 
describe checking prescriptions and asking doctors why they prescribed 
certain drugs. They identify gaps and fill them; they tidy up discharge letters 
and make sure everything relating to medicines is correct at the point of 
discharge. They know the patient quite well as well and see prescribing 
decisions in the context of the patient as well as the guidelines. A pharmacist 
described feeling conflicted when looking at a prescription which did not fall 
within guidelines and having a duty of care to the patient to make sure it is 
right. One pharmacist liked to talk through her questioning process with 
another pharmacist to check out the validity and significance of her concern – 
like- minded people who take the same approach to medicines. Another 
pharmacist described needing to have all the facts when querying a 
prescription but also needing to approach different prescribers in different 
ways. She spoke about having to decide whether a drug being used outside 
a guideline was going to harm a patient and what were the implications of the 
prescribing decision. Pharmacists (and junior doctors) described knowing 
individual doctors’ favourite drugs and understanding why they made 
particular prescribing decisions. They described being listened to. Doctors 
and pharmacists commented that pharmacists should be present when 
prescribing was happening as opposed to coming along after the event and 





Appendix 17   Memo - looking again at consequences    (15.5.18) 
 
I have gone back to the categories from the data which I have labelled as 
“consequences.” In the most recent version of the theory I have one single 
consequence of keeping everyone safe which includes patients but also 
other healthcare professionals. This came from comments from nurses and 
pharmacists about sign-posting doctors to make certain prescribing 
decisions, filling the gaps in each other’s knowledge but also in prescriptions 
(pharmacists tended to do this) and checking things out. It also came from 
doctors who recognised that other healthcare professionals played a big role 
in making sure patients get the right medicines and also “have their [doctors] 
backs”. However this consequence does not feel fully robust and I have gone 
back to the data. 
 
What is happening here?  
Healthcare professionals are not working to reduce harm but to make sure 
patients are treated well and getting the right medicines. Are they trying to 
protect patients? No- they are treating patients and trying to make sure that 
patients get the right medicines. The system is complex and there is a lot to 
do including routine work. They are trying to do the best they can to keep 
things safe. So they are using a variety of checks and balances, they are 
working together to keep patients safe and they are trying to change the 
system, developing professional roles, to ensure that they make the best use 
of resources and can do the best they can. So the consequences from the 
data are: 
 Ensuring each patient gets the right medicines 
 Getting it right 
Is there a difference between ensuring each patient gets the right medicines 
and getting it right? Getting it right is about healthcare professionals doing a 
good job and using medicines accurately, safely and appropriately. Doing this 
leads to ensuring each patient gets the right medicines. It is “each patient” 
because all healthcare professionals involved in this study described making 
decisions in the context of an individual patient, looking into the implications 




decisions using the information available. Optimising medicines means 
putting the patient at the centre of decisions about medicines and whilst this 
specific term was rarely used, professionals did describe practice moving in 
this direction. Making the best use of resources is an approach to ensuring 
each patient gets the right medicine and can be incorporated into that. 
Therefore there is one integrated consequence which is: 







Appendix 18 Framework for assessing research evidence  
Framework for assessing research evidence- a quality framework (Spencer et al 2003) 





How credible are the findings? 
Reflexivity, transparency and critical examination of evidence in light of the relevant 
theory provide credibility in qualitative research. 
I have positioned myself in my writing and analysis through my initial personal 
statement. The Findings describe how the Theory was developed from the data. 
Individual quotations are used and referenced. A rich, structured description is given 
of how the Theory emerged. A negative case (Mary) was disclosed.  
The findings of this study have been compared and contrasted with the recent 
literature and new statements made explicit. 
The findings were presented both to the University of Bradford Medicines Optimisation 
Research Group (April 2018) and to the Directors of Pharmacy in Scotland (August 






2 How has knowledge/understanding 
been extended by the research? 
Yes. This is the only research that I can find that produces a Grounded Theory of how 
doctors, nurses and pharmacists work to optimise medicines in acute hospitals. There 
are 7 statements of new findings which I believe extend the knowledge and 
understanding in this area. 
3 How well does the evaluation address 
its original aims and purpose? 
 
The evaluation identifies how doctors, nurses and pharmacists optimise medicines in 
acute hospitals by: 
 Evaluating the categories of the theory in light of the current literature 
 Providing a focus specifically on the roles of these healthcare professionals in 
optimising medicines 
 Reviewing recent research findings on inter-professional collaboration and 
comparing and contrasting with the outcomes of the study 
 Linking the outcomes of the study to the literature on medicines optimisation 
(albeit relatively sparse) 
4 Scope for drawing wider inference – 
how well is this explained? 
 
The transferability of the findings of a qualitative study is described in the 
methodology. The results section highlights that there were 17 participants. The 
strength of the theory lies in the robustness of the study design, data collection and 






5. How clear is the basis of evaluative 
appraisal? 
 Clearly set out 
6 How defensible is the research 
design? 
 
The research design involves semi-structured interviews using Grounded Theory 
methodology. Clear justification of research methodology following review of 
methodologies and linked to aim of research. It follows a standardised approach 
(Strauss and Corbin 1998). 
7 How well defended is the sample 
design/ target selection of cases/ 
documents? 
Semi-structured interviews were carried out with 17 participants (including one pilot 
interview). Data collection and analysis in GT should continue until saturation is 
reached. No new data was coming from the latter interviews and I believe saturation 
was achieved. However, I would have liked to have interviewed some medical 
consultants and some more staff nurses in the study. I found it challenging to get 
volunteers. Also towards the end, some of the participants had worked/ were still 
working on the same clinical team. They all had experience of working in other teams 
beforehand. I see this as a positive and negative of the study as described in the 
Methodology, in which I defend the sample used. There is an argument that greater 
numbers of each professional group would have been needed if looking for saturation 





8 Sample composition/ case inclusion – 
how well is the eventual coverage 
described? 
This is well-described in the Methodology.  
 
9 How well was the data collection 
carried out? 
The data was collected using semi-structured interviews using an outline interview 
template. This is described in the Methodology. Reflexive statements are made 
relating to this.  
10 How well has the approach to, and 
formulation of, the analysis been 
conveyed? 
 
In Chapter 3 I have described how I used a Grounded Theory approach to data 
analysis.  In Chapter 4, I have clearly walked through each stage of the analysis of the 
data – using constant comparison, memo-ing and coding (open, axial and selective).   
11 Contexts of data sources – how well 
are they retained and portrayed? 
 
I have given a description of each participant in Table 2. Within the text I clearly 
identify the profession and gender of each participant when quoting from their 
interview. 
12 How well has diversity of perspective 
and content been explored?  
I have tried to highlight when data came from one, two or three professional groups as 
well as individual participants. I have included a negative case. I have compared and 
contrasted the views and roles of the participants and also discussed the difference 
between professionals operating with different levels of experience. In Table 2 I have 
listed the number of quotations I have used from each of the participants. I have tried 




analysis towards the end of the collection period. 
13 How well had detail, depth and 
complexity (i.e. richness) of the data 
been conveyed? 
The data has been laid out using multiple quotations from participants. The interview 
structure changed over time as codes and categories emerged and I adopted a more 
purposeful approach. 
14 How clear are the links between the 
data, interpretation and conclusions – 
i.e. how well can the route to any 
conclusions be seen? 
The data are laid out a8nd discussed following the structure of the Grounded Theory, 
leading to conclusions. Individual conclusions are sign-posted in the discussion 
especially when they are believed to add to the knowledge of the subject.  
 
15 How clear and coherent is the 
reporting? 
 
I have tried to structure my work, using sub-headings where appropriate and 
balancing this with trying not to detract from incorporating categories and sub-
categories into the Theory. I have used diagrams and tables to present some of the 
findings in a clear way. I have tried to use sign-posting. I asked a critical friend to read 
the thesis and advise on its clarity.  
16 How clear are the assumptions/ 
theoretical perspectives/ values that 
have shaped the form and output of 
the evaluation? 
 




17 What evidence is there of attention to 
ethical issues? 
 
Ethical considerations are laid out in detail in the Methodology. Trust(s) and University 
Research Ethics approval was sought and awarded. Participants were sent an 
information sheet on the study two weeks before their interview. They gave informed 
consent and also were given the opportunity to withdraw from the study at any stage. 
Participant anonymity was maintained and detail in quotations which could have 
identified individual was removed without changing the meaning of the data. 
18 How adequately has the research 
process been documented? 
 
I have documented the data collection and analysis clearly in Chapter 4. This includes 
quotations from each of the participants. I have retained memos, early codes and 
drawings as well as a researcher diary throughout the process. I have added the 
codes from each interview into an Excel spreadsheet for the sole purpose of ensuring 
that I have not missed codes.  
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